Trace Elemental Concentration in 'Normal' and Alzheimer's Disease Human Brain Tissue Using Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and Instrumental Neutron Activation Analysis (INAA). by Panayi, Antonia Electra.
TRACE ELEMENTAL CONCENTRATIONS IN ‘NORMAL’ AND 
ALZHEIMER’S DISEASE HUMAN BRAIN TISSUE USING INDUCTIVELY 
COUPLED PLASMA MASS SPECTROMETRY (ICP-MS) AND
INSTRUMENTAL NEUTRON ACTIVATION ANALYSIS (JNAA).
Antonia Electra Panayi
Thesis submitted to the University of Surrey for the award of the degree of
Doctor of Philosophy.
September 2000
Supervisor: Professor N. M. Spyrou, Department of Physics, School of Physics 
and Chemistry, University of Surrey, Guildford, Surrey, GU2 5XH, U.K.
ProQuest Number: 27733204
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 27733204
Published by ProQuest LLC (2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
A utti T| s p y a a i a  a ç isp co v E T a i otouç  y o v s iç  p o v
A cknow ledgem ents
I would like to express my gratitude to my supervisor at the University of Surrey, 
Nicholas Spyrou for his advice, support and encouragement throughout my PhD 
period. I would also like to thank Funso Akanle for his, support and assistance 
throughout this period.
From the JRC, I would like to thank my supervisor at the Joint Research Centre, Peter 
Part for his advice and support and Jean Marie Martin for helping me to get started 
with my samples and for supporting my PhD work. I would like to thank Livio 
Ubertalli for all his help and advice, especially through the difficult times and I would 
like to thank Miguel Angel Serra for all his help and assistance.
I would like to especially thank Mark White not only for his advice and support 
during his period at Ispra but also for the use of the facilities at the HSL. I would also 
like to thank Warren Cairns for his excellent advice on analytical chemistry.
I would like to thank Felix Cruz-Sanchez, Institute of Neurological and 
Gerontological Sciences, Barcelona for introducing me to the Netherlands Brain Bank 
and I would like to thank Rikka Ravid and Michiel Kooreman of the Netherlands 
Brain Bank for supplying me with samples and all the necessary information to 
complete my work.
I would like to thank Peter Bode and the INAA team at the IRI, Delft, Netherlands, 
for the use of their facilities and for their assistance during this period and Joseph 
Conrad and Martin Siebert for all their assistance whilst irradiating my samples at 
Petten, Netherlands.
I would like to thank Bent Iversen for proof reading my PhD and all excellent advice 
on all aspects, especially the statistics. I would also like to thank Manuela Trevisan 
for all her advice and suggestions.
I would like to express my gratitude to Maryanne Thompson at Perkin Elmer, UK for 
all her excellent advice on ICP-MS and for the CD’s, books and encouragement. I 
would also like to thank Willi Barger, Perkin Elmer, Germany and the Perkin Elmer 
team in Italy for their support.
I would like to thank the Medical Service at the JRC for their support, Michele, 
Giancarla and Gianfranco and I would also like to thank Frances Mousty for all his 
advice and experience on ICP-MS and INAA.
I would like to thank A. Ramponi from the Hospital of Varese for all his excellent 
advice on brain dissections and brain functions, Maurizio Cermesoni for all his advice 
and support on medicinal matters and Mario Gallorini for all his advice on INAA.
I would like to thank Aurelio Galbersanini for all his help in the development of the 
NED A software and Giorgio Tettamanti for all his assistance on the detector systems.
I would like to thank the personnel of the library of the JRC for all their assistance 
and interest in my work.
I would also like to take this opportunity to thank Enrico Sabbioni and Bruno Versino 
for giving me the opportunity to carry out my PhD work at Ispra.
I would like to thank Elizabeth, Maria, Cristina, Fabrizio, Dassia, Stelios, Charlotte 
R, Charlotte M, Elena, Carine, Neus, Juan Pablo, Lazarus, Emilio, Richard, Annarita 
and An for all their friendship through this period.
I would like to acknowledge the financial support of the European Commision for a 
three year category 20 fellowship and a three month auxialliary.
Most of all I want thank my family Stelios, Antigone, Armin and Artemis for their 
complete moral and financial support. I would also like to thank Leto for her 
friendship and thanks to Ethymios and Andrianna for all the times I stayed with them 
in London.
C ontents
Abstract 1.
1. Introduction 3.
References for Chapter 1 9.
2. The Human Brain and Alzheimer’s Disease 13.
2.1 Introduction 13.
2.2 Structure of the Human Brain 13.
2.3 Brain Function and Mapping 16.
2.4 Other Neurological Diseases 17.
2.5 Alzheimer’s Disease 18.
2.6 Smoking 20.
2.7 Oxidative Stress 20.
2.8 Toxins 22.
2.9 Literature Review on Elemental Composition of Human Brains 22.
2.10 Human Subject and Sample Details 25.
3. Analytical Techniques 83.
3.1 Inductively Coupled Plasma Mass Spectrometry (ICP-MS) 83.
3.1.1 Introduction to ICP-MS 83.
3.1.2 Components of the ELAN ICP-MS System 83.
3.1.2a Sample Introduction to system 83.
3.1.2b Excitation Source (ICP Source) 84.
3.1.2c Ion Transport System, Interface and Lens System 85.
3.1.2d Mass Separation Devices (Quadrupole Mass
Spectrometer) 86.
3.1.2e Detector (Discrete Dynode Electron Multiplier) 86.
3.1.2f Pentium PC with Windows NT and Elan NT Software
Spectrometer Control and User Interface 87.
3.1.3 Tuning and Optimisation 87.
3.1.4 Optimisation Procedures 88.
3.1.5 Peak Hopping and Peak Scanning 89.
3.1.6 The ELAN Analytical Techniques 89.
3.1.6a Calibrations in Quantative Analysis 91.
3.1.6b External Standardisation 91.
3.1.6c Method of Standards Addition and Standard
Additions Calibration 91.
3.1.6d Internal Standard 91.
3.1.7 Interferences in ICP-MS 92.
3.1.8 Spectral Interferences 93.
3.1.8a Plasma Induced Polyatomic Effects 94.
3.1.8b Matrix Induced Polyatomic Effects 94.
3.1.9 Reducing Spectral Interferences 95.
3.1.10 Dissolved Solid Limitations 96.
3.1.11 Non Spectroscopic Interferences 96.
3.1.11a Sample Introduction and Transport Interferences 96
3.2 Electrothermal Atomic Absorption Spectrometry (ETAAS) 98.
3.2.1 Introduction to ETAAS   98
3.2.2 Zeeman Effect Background 99
3.2.3 SIMAA 6000 100
3.2.4 ETAAS 5000 100
3.3 Instrumental Neutron Activation Analysis (INAA) 101
3.3.1 Introduction to INAA 101
3.3.2 Reactions 101
3.3.2a Radiative Capture 101
3.3.2b Transmutation 102
3.3.2c Inelastic Scattering 102
3.3.3 Neutron Activation Analysis 103
3.3.4 The Activation Equation 104
3.3.5 The Kq Method 108
3.3.6 Flux Monitors 110
3.3.7 Irradiation and Counting Times 111
3.3.8 Pile Up and the Puiser Method 112
3.4 Conclusions 117
References for Chapter 3 121
4. Experimental Arrangement and Operating Conditions 126
4.1 ICP-MS 126
4.1.1 Introduction 126
4.1.2 Influence of Instrument Parameters on ICP-MS
Analysis 126
4.1.3 Optimisation Solutions 128
4.1.4 Selected Elements 129
4.1.5 Calibration Method 134
4.2 ETAAS 134
4.3 Neutron Activation Analysis 139
4.3.1 Irradiation Facilities of HFR, JRC, Petten 139
4.3.2 Characterisation of GeLi and HPGe Detectors,
Ispra, Italy 142
4.3.2a Calibration of Channel Number Versus Energy 142
4.3.2b Energy Resolution 149
4.3.2c Absolute Efficiency 150
4.3.2d Effective Interaction Depth 156
4.3.3 Irradiation Facilities of IRI, Delft 157
References for Chapter 4 159
5. Porcine Brains 161
5.1 Introduction to Porcine Brains 161
5.2 Pre- analytical Factors 162
5.3 Freeze Dried Certified Reference Materials 166
5.4 Sample Preparation for ICP-MS and ETAAS 167
5.4.1 Calibrations 168
5.5 Sample Preparation for INAA 169
5.6 Homogeneity 171
5.7 Results 171
5.7.1 Dry to Fresh Weight (DFW) Conversion Ratios 171
5.7.2 Results 172.
5.8 Correlation Coefficients 184.
5.9 Discussion 184.
5.10 Comparison with Literature 184,
5.11 Conclusions 185.
References for Chapter 5 186.
6. Titanium Tools and Dry to Fresh Weight Conversion Ratios 190.
6.1 Titanium Tools Used for Sample Collection 190.
6.2 Lillifors Probabilties 191.
6.3 Dry to Fresh (DFW) Conversion Ratios 191.
6.3.1 DFW Conversion Ratios for ‘Normal ’ Subjects 192.
6.3.2 DFW Conversion Ratios for Alzheimer’s Subjects 200.
6.3.3 DFW Coversion Ratios for Subjects with Senile
Involutive Cortical Changes 206.
6.4 Comparing the three subject groups 214.
References for Chapter 6 217.
7. Elemental Concentrations Determined by ICP-MS 219.
7.1 Methods 219.
7.2 Determination of Selenium 219.
7.3 Determination of Lithium 219.
7.4 Recovery, Precision, Accuarcy and Homogeneity 222.
7.5 Elemental Concentrations 227.
7.6 Variations in Concentrations Between Hemispheres 245.
7.7 Variations in Concentrations Between Regions of the Brain 245.
7.8 Concentration Correlations with Age 250.
7.9 Concentration Correlations with Post Mortem Interval 251.
7.10 Interelement Correlations 262.
7.11 Effect of Disease Duration in Alzheimer’s Subjects on 
Concentrations 262.
7.12. Correlations with DFW Conversion Ratios
and Brain Weight 266.
7.13. Dementia Scale and Tangles 267.
7.14. Effect of Sex on Elemental Concentrations 268.
7.15. pH 268.
7.16. Concentration Variations Between ‘Normal’, Alzheimer’s
Disease and SICC Subjects 269.
7.17 Cluster Analysis 274.
7.18 Conclusions 275.
References for Chapter 7 279.
8 Elemental Concentrations Determined by INAA 281.
8.1 Elemental Concentrations Determined by INAA using
HFR Reactor, Petten 281.
8.1.1 Variation in Concentrations Between Hemispheres 281.
8.1.2 Variation in Concentrations Between Regions 282.
8.1.3 Interelement Correlations 282.
8.1.4 Conclusions 282.
8.2 Elemental Concentrations Using IRI Reactor, Delft 285.
8.2.1 Detection Limits 285.
8.2.2 Elemental Concentrations
8.2.3 Variations in Concentrations Between Hemispheres 286.
8.2.4 Variations in Concentrations Between Regions 286.
8.2.5 Concentration Correlations with Age 294.
8.2.6 Concentration Correlations with Post Mortem
Interval 294.
8.2.7 Interelement Correlations 294.
8.2.8 Effect of Disease Duration in Alzheimer’s Subjects on 
Concentrations 295.
8.2.9 Correlations with DFW Conversion
Ratios and Brain Weight 295.
8.2.1 ODementia Scale and Tangles 302.
8.2.11 pH 302.
8.2.12 Concentration Variations Between ‘Normal’ and 
Alzheimer’s Disease Subjects 302.
8.2.13 Cluster Analysis 305.
8.2.14 Bromine 305.
8.2.15 Method Intercomparison 307.
8.2.16 Conclusions 308.
References for Chapter 8 310.
9 Conclusions and Further Work 311.
Abstract
! The techniques of Inductively Coupled Plasma Mass Spectrometry, (ICP-MS), 
Instrumental Neutron Activation Analysis, (INAA) and Electrothermal Atomic 
Absorption Spectrometry, (ETAAS) have been applied to the determination of trace I 
elements in brain tissue. The experimental arrangement and operating conditions have 
been described for all techniques and the HPGe detector used in INAA has been 
calibrated.
Method development initially was carried out on porcine brain tissue and the 
homogeneity and precision of the methods is described. Accuracy of the methods was 
evaluated using NIST Certified Reference Materials and IAEA Animal Blood.
Human brain samples from ‘normal’ , Alzheimer’s subjects and subjects with Senile 
Involutive Cortical Changes, (SICC) were sent from the Netherlands Brain Bank. 
Brain samples were taken from the frontal, parietal and temporal lobes of the cortex, S 
| hippocampus and thalamus of both hemispheres. All samples were freeze dried and 
the Dry to Fresh Weight (DFW) conversion ratios were found to be age related. DFW 
ratios were increased in the temporal lobe and hippocampus of ‘normal’ subjects, 
when compared to the Alzheimer’s subjects and DFW ratios were increased in the 
temporal lobe of the ‘normal’ subjects compared to the subjects with SICC.
!
For elemental concentrations determined by ICP-MS, the ‘normal’ subjects Cu, Zn 
I and Cd showed positive correlations with age, at significance (p<0.02), (p<0.002) and 
(pcO.OOl), respectively. For the Alzheimer’s Disease subjects, negative correlations ! 
with disease duration were seen for Cu and Zn, at significance (p<0.001). Cd and Hg 
in the ‘normal’ subjects and Cd in the Alzheimer’s subjects correlated negatively with 
the degree of tangles at a high level of significance, (p<0.001). When comparing 
groups, it was found that Cu, Zn, Hg and Li were found to be increased in ‘normal’ 
subjects compared to the Alzheimer’s. No significant differences for Fe, Mn, Se, Cd 
and Pb were found. When comparing the ‘normal’ and the SICC groups, Fe, Zn, Cd 
and Hg were found to be higher in the ‘normal’ subjects. No significant differences
! '  ■
(p>0.1) were found for Mn, Cu, Se and Pb. When comparing the SICC subjects and
1
Alzheimer s subjects, Fe, Mn, Zn and Cd were found to be increased in the 
Alzheimer’s subjects and no significant differences were found for Se, Cu and Hg.
!
INAA was carried out on samples taken from the cortex only. Br, Se, Ag and Eu 
correlated positively with age in the ‘normal’ subjects, at significance (p<0.002), 
(p<0.02), (p<0.1) and (p<0.1), respectively. Negative correlations with age were 
found for Fe, at significance (p<0.1) and positive correlations with age for Cs at 
significance (p<0.05). With disease duration, negative correlations for Zn, K, Rb and 
Se were seen, at significance (p<0.02), (p<0.02), (pO.OOl) and (p<0.1), whereas for 
Ag and Ba positive correlations were seen, at significance (p<0.05). Positive 
correlations with the dementia scale was seen for Br, at significance (p<0.02). In the 
‘normal’ subjects, tangles correlated positively for Se and Br, at significance (p<0.1) 
and (p<0.01), respectively and correlated negatively for Cs at significance (p<0.1).In 
the Alzheimer’s subjects, negative correlations were found for K, Zn, Rb, Se and Cs j 
with the tangles, at significance (p<0.02), (p<0.05), (pO.OOl), (p<0.1) and (p<0.001), | 
respectively and a positive correlation was seen for Br, at significance (p<0.1).
When comparing ‘normals’ and Alzheimer’s subjects, Br, Na and Fe were found to be I 
increased in the Alzheimer’s subjects and K, Zn, Se, Rb, Ba and Eu showed no 
significant differences. Cs and Hg were found to be increased in the ‘normal’ 
subjects.
A method intercomparison for ICP-MS and INAA was undertaken for Fe, Se and Zn, 
no significant differences, (p>0.1) were found between the two methods for the same 
samples using the Wilcoxon Matched Pairs Test.
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CHAPTER 1 
Introduction
The elementary constituents of human and animal organisms may be classified into 
the following groups, non metals, major elements, (or electrolytes) and trace 
elements. The non metals are C, H, N, O, F, P and S, the major elements are Ca, P, K, 
Na, Cl and Mg, (Sei94). Trace elements which occupy only 0.012% of the body 
weight of humans was the name given to elements that occurred in such low 
concentrations (pg/g to pg/g range) that analytical methods in the early days were 
unable to measure. Today, however most trace elements occurring down to the pg/g 
levels in biological materials may be accurately measured with great precision, 
(Iae80).
Trace elements may be divided into two groups, essential or toxic. Liebscher, (Lie68) 
distinctly expressed these two groups in mathematical terms. Essential trace elements, 
Cu and Zn have 'normal' distribution or at least a symmetrical distribution pattern 
while non essential trace elements such as As, Sb and Hg follow a lognormal 
distribution. Liebscher gave an explanation for this; the essential element 
concentration mechanism is internally controlled or homeostatically controlled. This 
means that if this concentration is disturbed there is a mechanism in the chemical 
behaviour which corrects for it, whereas the non essential levels are externally 
controlled and represent a contamination of tissues, therefore the distribution pattern 
is similar to the external environment, generally low with occasional high values.
The criteria for an element to be considered essential has been discussed in great 
detail by Cotzias, (Cot67). The trace elements declared clinically essential for human 
health by Underwood, (Und77) are iron (Fe), iodine(I), copper(Cu), manganese(Mn), 
zinc (Zn), cobalt (Co), molybdenum (Mo), selenium (Se), chromium (Cr), tin (Sn), 
vanadium (V), fluorine (F), silicon (Si) and nickel (Ni), (Und87). Current research is 
investigating bromine (Br) and strontium, (Sr), (Sco98) and Rb rubidium (Mer87), 
where no essential role has yet been found but which occur in concentrations in 
humans well above those found for the essential trace elements, (Mer87).
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The most commonly investigated toxic trace elements are lead, cadmium, mercury 
and arsenic, which are widely used in industry. Examples of toxicity are the 
Minamata disease, induced by mercury and the Ouch Ouch Disease which is induced 
by cadmium, (War89).
This classification however of essential or toxic is limited because Fe, Ni, Co, Mn, 
Zn, Cu, Se and Cr are all toxic at high dosages and As, Cd and Hg are essential at very 
low doses, (Mer93). For some elements this safety margin between the toxic and 
essential dose is quite small, (Osk95). Also for some elements the distinction depends 
upon the dosage, route of administration and the chemical species form, (Sco98), 
(Wal98).
A recent review by Mertz of essential elements states that this division of elements 
into essential or toxic is being replaced by the concept of the total dose response 
curve, (Mer93). Toxicity of essential elements at sufficiently high concentrations and 
for long periods was recognised by Betrand, (Betl2) who formulated dose- 
dependence into Betrand’s Law. Venchikov, (Mer87) presented a dose response curve 
with three phases of action and Mertz, (Mer87) divided the group of trace elements 
into five concentration levels where the dose dependent biological functions are 
shown in Figure 1.1.
Hypomicroelementosis is the second marginal level of trace element deficiency and 
results in the development of trace element diseases. Hypermicroelementosis is the 
fourth level of a marginal increase of element concentration and results in signs of 
toxipathy. Examples of trace metal deficiency may be given for selenium and zinc; 
where selenium deficiency results in muscular dystrophy and cardiovascular disease 
and zinc deficiency results in impaired wound healing and retarded growth, (Sei94). 
Examples of trace metal toxicity may be given for manganese and zinc; where 
manganese toxicity has been associated with dementia, (Lin85), (Zay90) and 
increased levels of zinc have been found in multiple sclerosis and in neural tube 
defects, (Lin85).
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Figure 1.1: Dose Dependent Effects of Various Concentrations of Elements, (Mer87).
BIOLOGICAL
FUNCTION
HypermicroelementosisHypomicroelementosis
OPTIMUM CONCENTRATION
Range of Safe 
ConcentrationDEFICIENCY, TOXICITY
CONCENTRATION
Mertz, (Mer93) also stated that trace elements must be studied in the context of 
interactions among themselves. On element may increase or decrease the absorption 
of another (antagonistic) or a deficient element may be replaced by other diet 
constituents (synergistic). An antagonistic interaction is between Zn and Cu, Pfeiffer 
(Pfe80) found a large intake of Zn marked a depletion in Cu and ceruplasmin and 
anaemia, which could be reversed with a normal Zn intake and Cu supplements. A n  
example of a synergistic interactions is between Se and Vitamin E, (Wal98).
Mertz in his review finally stated that the role of the concept of deficiency in 
determining nutritional requirements is being complimented by the concern of the 
total health effect of elements. This can be demonstrated by the long term benefits for 
higher than habitual intakes of Se, which is considered to be anticarcinogenic, 
(Mer93).
The reduction of health hazards due to toxic metals is also important at the European 
Community level. Currently there are only regulations for metallic lead and its 
compounds ranging from the prohibition of lead an lead compounds in cosmetic 
products to occupational exposure limits such as biological monitoring, lead in petrol, 
paints and drinking water, (Ber87). For certain other metals there are only semi- 
efficient guidelines, (Ber87),
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Interest in the role of trace metals in different diseases or disorders is increasing. 
Alterations in trace elemental concentrations may give knowledge about the disease 
or disorders and thus a possible cure. A disorder where trace metal therapy has been 
used to influence biochemical processes is Li in the treatment of manic 
depression and supplementation has been given in genetically determined trace metal 
deficiency, such as Cu in Menkes Disease, (Sei94).
A disease which is receiving much attention at the moment is Alzheimer’s Disease. 
Traditionally, Alzheimer’s disease is defined as severe presenile dementia developing 
before the age of 65 and senile dementia developing after the age of 65 is known as 
‘senile dementia of the Alzheimer type’(SDAT). In this work SDAT is also referred to 
as Alzheimer’s Disease. It is a progressive disease causing accumulation of amyloid 
containing neuritic plaques and neurofibrillary tangles. Death occurs from secondary 
effects usually 10-12 years after onset. Currently there is no treatment proven 
effective in preventing this disease that afflicts some 5-10% of people over the age of 
65, (Hur98). Most cases of early onset Alzheimer’s Disease are familial, (Har98). 
Familial Alzheimer’s Disease has been linked to a mutation on chromosome 19, 21 
and 14 but only 5-10% of Alzheimer’s Disease is caused by hereditary factors 
(PraOO), the rest is sporadic. In the late onset form of Alzheimer’s Disease, no 
inheritance gene has been found but specific alleles, apolipoprotein E4 (apoE) and a2 
macroglobulin are associated with an increased risk of the disease, (Har98).
Research points to the possible role of environmental toxins such as Al, Cd, Hg and 
Pb and or free radicals in Alzheimer’s Disease. Free radicals contain one or more free 
electrons and are highly reactive and are generated in vivo as by products of normal 
metabolism. Free radicals cause damage by reacting with lipids and proteins and 
altering their structure and functions, (Hal89). Certain trace metals are important in 
these free radical processes, such as free Fe, Cu and Mn, (PraOO) because they act as 
catalysts in the production of free radicals via the Fenton and Haber Weiss reactions. 
Cu, Zn and Mn which form part of the enzymes superoxide dimutase, (SOD) which 
catalyse the production of H2O2 and 0 2 from the free radical e02 and Se because it is 
present in the enzyme glutathione peroxidase, (GSH-PX) which reduces H2O2 to H20
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and also glutathione in its reduced state nonenzymatically scavenges free radicals 
such as ©OH, (Coy93). ‘Oxidative stress’ is the term used in literature and is when 
free radicals are greater than antioxidant defense mechanisms due to an increase of 
the former or a reduction of the latter, (Mar99).
The aim of this work is to establish the concentration of major and trace elements in 
regions of ‘normal’ brain and Alzheimer’s Disease brain using Inductively Coupled 
Plasma Mass Spectrometry (ICP-MS) and Instrumental Neutron Activation Analysis 
(INAA) and to determine any significant differences between the two groups. A 
‘normal’ subject was defined as a person with no family history of any form of 
dementia showing no neurological signs of dementia and or other neurological 
diseases. This work looks at brain regions specifically related to Alzheimer’s Disease 
from both hemispheres. For the ‘normal’ and Alzheimer’s disease subjects, elemental 
concentrations cure correlated with many factors such as Dry to Fresh Weight, 
(DFW) Ratios, Brain Weight, Age, the degree of tangles and pH. For the Alzheimer’s 
group, elemental concentrations are correlated with disease duration, previously 
neglected by the literature.
Obtaining trace element concentrations in ‘normal’ brain and comparing with 
Alzheimer’s brain was a difficult task, not only because of the heterogeneous nature 
of brain but also because where specific parts of the brain have been measured, the 
variations in trace element concentrations are great, sometimes ten fold for the trace 
elements such as Cd and although geography, diet, age, sex and smoking habits play a 
part the inconsistencies found in the literature are probably due to a lack of quality 
control in the techniques and methods used. Also most cases of Alzheimer’s Disease 
occur after 65 years old and obtaining age matched ‘normal’ human brain tissue 
where ‘normal’ is defined as no neurological damage is difficult after the age of 65 
and may involve long waiting periods. It is not known whether literature values from 
‘normal’ subjects over 65 years old have no neurological damage or are not simply 
Alzheimer’s Disease victims. It may be possible that subjects have not developed 
Alzheimer’s Disease but may have some degree of senility. In this work using ICP- 
MS, a group of subjects with Senile Involutive Cortical Changes, (SICC) have also
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been compared. These do not contain the degree of plaques and tangles as in
Alzheimer’s Disease but they contain more than ‘normal’ subjects and there is some
disruption of the inter-neuronal fibre network. This group may be important because
on
Ehmann, (Ehm86) suggested that brain trace elements may be altered as early event in 
Alzheimer’s Disease and may not persist until the end when the autopsy is performed, 
so obtaining data from subjects with developing senility may be important.
Chapter 2 is a summary of the functions of the ‘normal’ human brain, relevant to this 
work , a review of current research into Alzheimer’s Disease, a literature review of 
elemental concentrations in ‘normal’ and Alzheimer’s Disease brain tissue and finally 
a summary of samples obtained from the Netherlands Brain Bank1, Amsterdam, The 
Netherlands.
For samples obtained from the Netherlands Brain Bank, waiting periods were long, 
over a year for the first samples. During this period, the techniques and methods were 
controlled and developed using porcine brain tissue, which was easy to obtain in fresh 
form in Lombardy, Italy. The accuracy and precision of the methods were determined 
using a variety of Certified Reference Material (CRM) and homogeneity of the 
porcine samples was determined. This is described in chapter 5. This work was 
carried out at the Environment Institute2, Joint Research Centre, (JRC), Ispra, Italy, 
the porcine samples were prepared at JRC, Ispra. ICP-MS and ETAAS were carried 
out at JRC, Ispra and samples were irradiated at the High Flux Reactor3 (HFR), Joint 
Research Centre, (JRC), Petten, Netherlands and transported to JRC, Ispra for 
counting.
The human sample preparation was made at the Health and Safety Laboratories4, 
(HSL), Sheffield, U.K. because the JRC did not have the grade 2 facilities, absolutely 
necessary for working with human tissue. The samples were sent by the Netherlands 
Brain Bank under dry ice to the HSL where the samples were freeze dried and
1 Netherlands Brain Bank, Meibergdreef 33, 1105 AZ Amsterdam ZO, Netherlands
2 Environmental Impact, Environment Institute, TP 460, European Commission, JRC, Ispra 21020,
(Va), Italy
3 Isotope Production, Institute for Advanced Material, P.O. Box 2, NL-1755, ZG, Petten, Netherlands
4 Health and Safety Laboratories, Broad Lane, Sheffield, S3 7HQ, U.K.
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digested for Inductively Coupled Plasma Mass Spectrometry, (ICP-MS) or placed in 
quartz vials for Instrumental Neutron Activation Analysis, (INAA). The digested 
samples were packed according to United Nations regulations for dangerous goods 
(Diluted Nitric Acid, UN2031, Class 8, Group 2) and sent to JRC, Ispra by special 
courier for analysis with (ICP-MS). The elemental concentrations determined in ten 
different brain regions, using ICP-MS, for ‘normal’s Alzheimer’s Disease and 
Subjects with Senile Involutive Cortical Changes (SICC), are described in chapter 7.
The first set of samples were packed in quartz vials, were sealed, then packed in 
aluminium cans, closed and sent from the HSL, Sheffield, UK to the HFR, Petten, The 
Netherlands for irradiation. After irradiation the samples were the sent to JRC, Ispra, 
Italy for counting. The results are discussed in chapter 8. Due to the closure of the 
fourth framework program in 1998, NAA at the Environment Institute, JRC was 
closed and it was decided that the remaining samples also packed and sealed at the 
HSL, UK would be irradiated and counted at Interfaculty Reactor Institute5 (IRI), 
Delft, The Netherlands. The elemental concentrations in six different brain regions, 
cortex only, for ‘normal’s and Alzheimer’s Disease are also described in chapter 8.
Both laboratories, HSL, Sheffield, UK and IRI, Delft, Netherlands are accredited and 
follow the relevant criteria from ISO 9001/9002. This accreditation covers the quality 
system of the laboratory.
The techniques used in this work are Inductively Coupled Mass Spectrometry (ICP- 
MS), Instrumental Neutron Activation Analysis (INAA) and Si multaneous 
Multielelemental Electrothermal Atomic Absorption Spectrometry (ETAAS). These 
techniques were chosen because apart from being multielemental they have low 
detection limits and they were available for use: ICP-MS was carried out at Ispra 
using the Perkin Elmer, SCIEX, ELAN 6000, In ICP-MS the singly charged positive 
ions which predominate after ionization in the 6000°C plasma are extracted. Using 
the quadrupole mass filter the ions are separated based on their mass to charge ratio. 
Ions with a minimum mass difference of 0.6 atomic mass units (amu) are separated.
5 Interfaculty Reactor Institute, Mekelweg 15, 2629, JB Delft, The Netherlands
The ions then enter the detector which is an electron multiplier and the ion intensities 
are processed to obtain the elemental concentrations of the sample. In this work using 
ICP-MS the following elements were determined; Li, Mn, Fe, Zn, Cu, Se, Cd, Hg and 
Pb.
INAA involves samples being irradiated in the high neutron flux of a nuclear reactor. 
This technique is dependent on the high radiative capture cross sections of the 
thermal neutrons. The delayed gamma rays produced by the unstable nuclei may be 
detected by a Ge(Li), HPGe detector or germanium well type detector, the 
concentration of the elements may then be determined quantitatively. At JRC, Ispra 
the following elements were detected Fe, Rb, Se, Zn, Ag, Co, Cr and Hg whereas at 
IRI, Delft where the reactor and counting facilities are all on site in addition to Fe, Zn, 
Se, Rb, Ag, Cs, Ba and Eu, the shorter lived elements, Na, K and Br were also 
determined.
With ETAAS, small aliquots of the digested sample are pipetted into an injection hole 
in the centre of a graphite tube and the furnace is heated via a furnace program so the 
sample is dried, vaporised and finally atomised. A radiation source emits the 
spectrum of the element being determined and the atomised substance absorbs the 
radiation (using the Beer Lambert Law, absorbance is proportional to the amount of 
analyte in the aliquot). A mon°chromator allows the analytical line to be separated 
from other radiation and a solid state detector is used for quantitative analysis. 
However, due to time limitations Cd, Pb, Cu, Mn, Se and Li were only determined in 
the porcine brain tissue.
The three techniques are discussed in chapter 3 and the instrumentation and methods 
are discussed in chapter 4. In addition, in chapter 8, a method intercomparison has 
been carried out for samples which have been determined both by ICP-MS and INAA. 
Fe, Se and Zn were the only elements determined by both techniques, so comparisons 
of elemental concentrations obtained and detection limits have been made for these 
elements.
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CHAPTER 2
The Human Brain and Alzheimer’s Disease
2.1 Introduction
There is a wide range of functions of elements in the human brain. The following 
elements Na+, K+, Mg2+, Ca2+, are moved around as simple ions and their 
concentrations are controlled by membranes and the position of pumps and channels 
in the membranes, whereas some trace elements, such as Cu, Mn and Se, function as 
catalysts in metabolic processes. The history of the influence of trace elements on 
brain function have been discussed by Stanstead, (Sta86) and Prohaska, (Pro87). 
There has also been significant interest in elements as a cause or a therapy in disease 
and their role in neurological and psychiatric disorders have been discussed by Emard 
et al., (Ema95) and Linter, (Lin85).
In this chapter, an introduction to the structure of the human brain, Alzheimer’s 
Disease and recent developments in Alzheimer’s Disease research are discussed and 
also literature values for both ‘normal’ and Alzheimer’s Disease brains have been 
tabulated and discussed. In addition, for the samples used in this work, a description 
of the subject details, obtained from the Netherlands Brain Bank have been 
summarised.
2.2 Structure of the Human Brain
Because of the complexity of the human brain only important structures mostly 
relevant to this work, have been described below. The brain is split into three parts, 
the cerebrum, the brainstem, the cerebellum,.
The brainstem is the lower extension of the brain when it connects to the spinal cord 
and consists of the medulla, pons and midbrain. The cerebrum, which is the largest of 
the three divisions is split into two hemispheres. Deep separations are called fissures 
and the deepest fissure is the longitudinal fissure which separates the two cerebral 
hemispheres. The two cerebral hemispheres are joined by the corpus callosum. The 
corpus callosum connects left and right hemisphere at cortical level to allow for
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communication between hemispheres. The cerebrum consists of the cerebral 
hemisphere and the diencephalon containing the thalamus and hippocampus. The 
cerebral hemisphere consists of the superficial cerebral cortex which is convoluted to 
form gyri and sulci, (the up points of the convolutions are called gyri and the 
depressions inbetween are called sulci). The superficial cerebral cortex is the layer of 
grey matter covering the surfaces of the hemispheres. The grey matter is enriched in 
nerve cell bodies. Beneath the cerebral cortex is white matter consisting of cortical 
afferent and efferent fibres. White matter contains the nerve processes (mostly axons) 
and are ensheathed in myelin thus giving them a white appearance. These cortical 
afferent and efferent fibres which pass between the cortex and structures such as the 
thalamus and brain stem are arranged in a radiating pattern called the corona radiata 
which deep inside concentrate into a narrow, dense sheet of white matter known as 
the internal capsule. Deep inside there are also additional masses of grey matter 
known as the basal ganglia. The largest being being the corpus striatum which 
consists of the caudate nucleus, putamen and globus pallidus. The cerebellum is like 
the cerebral hemisphere in that it consists of an outer layer of grey matter with white 
matter inside. Figure 2.1 shows the sagittal section of the human brain with important 
structures, mostly relevant to this work.
The brain which floats in the cerebrospinal fluid is surrounded by the meninges 
consisting of three membranes which provide protection.
Each hemisphere of the cerebral cortex is divided into four lobes (frontal, parietal, 
temporal and occipital). Divisions between lobes are the lateral fissures, central 
sulcus and parietal-occipital sulcus. The frontal lobe is divided from the parietal lobe 
by the central culcus. The cortex is the part of the brain most strongly associated with 
human intelligence and compared to other mammals, is proportionally larger in 
humans, (Tho93). Figure 2.2 shows the the lateral aspect of the cerebral hemisphere. 
On the lateral surface the temporal lobe is divided into three principle gyri, the 
superior, medial and inferior gyri. On the medial surface of the temporal lobe lies the 
parahippocampal gyrus, where deep inside lies the hippocampus. The amygdala 
which also forms part of the basal ganglia is located near the temporal lobe. The
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Figure 2.1: Sagittal Section of the Human Brain
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hippocampus, parahippocampal gyrus and amygdala form part of the limbic system 
which lies on the medial rim of the brain.
2.3 Brain Function and Mapping
Brodmann tried to correlate function and structure in the brain. The functional areas 
form a map of the brain and the Brodmann areas usually map onto functional areas.
The Brodmann areas relevant to this work are shown in Figure 2.2. Brodmann divided 
the cortex into 45 regions. A complete map is shown in Stedman’s work (Ste96).
The posterior frontal lobe is the primary motor cortex, whose function is the control 
of movement, whereas the prefrontal cortex is important in cognitive functions 
(behaviour and emotions). Sensory information is received in the primary sensory 
areas of the parietal lobe, (somatosensory), occpital lobe, (vision) and temporal lobe, 
(hearing). The two hemispheres have different functions. In right handed persons the 
right hemisphere is involved in spatial perception, (arts and music) and the left lobe is 
involved in logical ability, (mathematics and languages). The left hemisphere is 
concerned with motory and sensory aspects of the right side of the body and vice
versa.
Almost all information that enters the cortex first comes through the thalamus and 
hippocampus. The thalamus is the processing centre of the cerebral cortex and 
coordinates and regulates all functional activity of the cortex. It forms a sensory area 
with all input, except smell, passing through the body. The hypothalamus is the 
integration centre of the Autonomic Nervous System (ANS), controlling homeostatic 
mechanisms such as gland secretion and regulating body temperature and endocrine 
function.
The hippocampus is a structure comprising of nuclei, (primitive grey matter regions 
of the cerebral cortex). Its main functions are memory and emotional aspects of 
behaviour. The amygdala receives afferents from the olfactory tract and is used for 
sensing smell. The caudate nucleus, putamen and globus pallidus are involved with 
the control of posture and movement.
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The cerebellum houses complex motor programs and helps coordinate movement, 
(balance and muscle coordination). In contrast to the cerebral hemispheres, lesions of 
the cerebellar hemisphere cause symptoms on the same side of the body. Cerebellar 
lesions also cause impairment of coordination of eye movements.
The brainstem and spinal cord are involved in monitoring controlling basic life 
systems eg breathing and heart function. The mid brain contains many regions 
involved in sound and eye movement.
2.4 Other Neurological Diseases
When the basal ganglia are damaged it affects the motor systems. Wilson’s Disease is 
an inherited disorder of copper metabolism where the basal ganglia changes leads to 
progressive dementia in childhood and youth.
Parkinson’s Disease is a neurodegenerative disease and is characterised by rigidity 
and tremor. It is characterised by degeneration of dopaminergic neurones of 
substantia nigra.
Huntingdon’s Disease is an inherited degenerative disorder causing dementia. It is 
characterised pathologically by degeneration of the cortex.
Multiple Sclerosis is the most common immune disorder of the Central Nervous 
System, (CNS). Axons or nerve bodies carry information away from the cell body. 
The Schwann cells produce the myelin sheath which surrounds many axons in the 
CNS. Myelination increases the rate of conduction of axons. In Multiple Sclerosis, 
episodes of demyelination and remyelination of axons occur resulting in relapses and 
reeission of neurological symptoms aand signs. Since this is a disorder mainly of 
axons and not cell bodies. Magnetic Brain Imaging can detect abnormal signals from 
demyelinating components in the cerebral white matter, (Cro98).
17
2.5 Alzheimer’s Disease
Alzheimer’s Disease is the most common form of dementia but only about 5-10% of 
Alzheimer’s Disease is caused by hereditary factors, (PraOO), the rest is sporadic. 
Parkinson’s Disease and Multiple Sclerosis are less common than Alzheimer’s 
Disease occurring at less than 1%, (Har98). In the final stages of Alzheimer s Disease, 
the patient needs complete care and becomes vulnerable to infectious diseases, so 
death occurs from secondary effects. In some cases there is a genetic predisposition 
and familial Alzheimer’s Disease has been mapped to chromosome 19, where it is 
linked to the apolipoprotein E (apoE) gene. An allele of this gene (apoE4) has been 
linked with an increased risk of developing Alzheimer s Disease in late onset. In early 
onset familial Alzheimer’s Disease has been linked to both chromosomes 21 and 14. 
Also changes identical to those observed in Alzheimer’s Disease occur in all patients 
with Down’s Syndrome who survive beyond 45 years old. Patients with Alzheimer’s 
Disease frequently develop Parkinsonism, (Har98).
The symptoms of Alzheimer’s Disease are disorientation in space, loss of language 
and memory with the first symptoms being loss of recent memory and behavioral 
changes. Alzheimer’s disease leads to atrophy of the temporal, parietal lobes and 
hippocampus which are areas associated with memories. The substantia innominata 
which lies beneath the corpus striatum ,contains several groups of neurones, one 
being nucleus basalis (of Meynert) which project to the cortex and use acetylcholine 
as neurotransmitter. These neurones undergo degeneration in Alzheimer’s Disease, 
(Cro95).
Formal diagnosis of Alzheimer’s Disease is by postmortem examination of the brain. 
Alois Alzheimer a neuropathologist in 1907, reported in a demented patient the 
pathological findings of amyloid containing neuritic plaques and neurofibrillary 
tangles. The core of the plaque is a protein called amyloid beta protein which is 
produced by a protein known as amyloid precursor protein (APP). This gives rise to 
beta amyloid peptides that accumulate in the brain, (Wil99), (Jen99). The plaques are 
surrounded by mishapen nerve terminals (dystrophic neurites) and are formed mainly 
in the cortical regions, hippocamus and amygdala. Since neuronal degeneration is
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found around senile plaques, it has been suggested that beta amyloid peptide is 
neurotoxic (Sel91). The neurofibrillary tangles are characterised by helical filaments 
that are coiled together in a double helix and are formed in the cytoplasm of neurons 
primarily occupying the cerebral cortex and hippocampus. A component of the tangle 
is a microtubule associated protein (MAP) called tau.
At present, there is no treatment for Alzheimers Disease and the cause or causes are 
unknown but some knowledge has been gained with advances in imaging techniques 
such as positron emission tomography, (Cut99), (CutOO), which are important in the 
preclinical and early stages of neurological diseases. Much research is being carried 
out in Alzheimer’s Disease, especially on the proteins Apo-E and amyloid beta 
protein and tau and their involvement in Alzheimer’s Disease.
Some therapies are being used presently to slow the progression of the disease, eg 
pharmocological agents such as Tacrine (Cognex) and Donepezil (Aricept), (Kno95), 
(Eco98). These drugs are cholinesterase inhibitors. Alzheimer patients are deficient in 
acetycholine (Ach), the neurotransmitter. The enzyme cholinesterase reduces excess 
acetycholine, so by reducing cholinesterase, the reduced acetycholine in Alzheimer’s 
cases may be restored. Cognex and Aricept are drugs available for this purpose, the 
latter being more effective without causing liver damage, (Eco98). Research shows 
anti-inflammatory drugs may also be effective (Coh96), patients using non steroidal 
anti-inflammatory drugs (painkillers) such as Ibrufen, Naprosyn and Indomethacin 
were half as likely to develop Alzheimer’s as non users, however long term use of 
these drugs may cause stomach irratation and gastric bleeding, (Rog93). Clinical trials 
are currently being undertaken. Elan pharmaceuticals (TimOO) is also currently 
working on a vaccine to treat the amyloid proteins and initial trials are currently 
taking place. Other pharmaceutical companies are trying to inhibit the enzyme, 
gamma secretase which facilitates amyloid production, (TimOO).
There is work also being carried out in antioxidant therapies as decribed below, 
(San97).
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The following three factors smoking, free radicals and toxins are discussed below in 
more detail because of their relations to certain elements which may be associated 
with Alzheimer’s Disease.
2.5.1 Smoking
Lee, (Lee94) found, using Alzheimer’s Disease epidemiological data, a highly 
significant correlation with smoki ng and related this to nicotine intake. In the mid 
80’s, nicotine was found to improve performance in cognitive tasks in ‘normal’ 
adults, it was also found that nicotinic receptor binding sites were reduced in brains of 
Alzheimer’s Disease, (Kel87). Futhermore, low doses of nicotine improved 
information processing and attention in Alzheimer’s subjects, a study carried out in 
1989, (Sah89).One possibility explaining why the smoking, through the action of 
nicotine reduces the risk of Alzheimer’s Disease, is that nicotine intake offsets the 
levels of acetycholine acting at all sites, (Lee94). Several case control studies found a 
negative correlation between Alzheimer’s Disease and Smoking, (Bre93) but it is an 
area of research and drugs which behave as nicotine could be used for restoring the 
memories of patients with Alzheimer’s Disease, (Tim98). Apart from nicotine, 
smoking is also a major source of Cd and it would be expected that increased 
exposure to Cd would cause negative effects since Cd exposure has been linked to 
anosmia, (absence of smell), (Rob91) and has also been linked to Cu and Zn 
deficiency, which cause neurological disorders, (San86).
2.5.2 Oxidative stress
Oxidative Stress is the damage caused by free radicals and is a model which can 
account for Alzheimer’s Disease being an accelerated form of brain aging. (YanOO). 
Many papers have discussed free radicals and a brief description is given below, 
(Fre82), (Fro95), (Coy93),(Mar99).
A free radical may be described as any molecule having an unpaired electron. They 
are generated in vivo as a by product of normal metabolism. Free radical reactions 
may lead to the production of ®02’ (superoxide anion), FI2O2 (hydrogen peroxide), 
®H02, (hydroperoxy radical) and ©OH (hydroxyl radical), (But99).
©02‘ may react with H+ to form H20 2 and 0 2.
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0% +  e  —> ©O2
This conversion is catalysed by three forms of the enzyme superoxide dimutase 
(SOD), CuZnSOD which is found in the cytosol, an extracellular form of CuZnSOD 
and MnSOD. Catalase and gluthanione peroxidase are two other enzymes which are 
responsible for reducing H2O2 and H20  and 0 2 .
©2 O2 + 2H+ —> ©HO2—> H2O2+ O2
In the presence of Fe3+ by the Fenton reaction.
Fe3++ ©02' ->  Fe2+ + 0 2
Fe2+ + H20  -> Fe3+ + ©OH + OH"
©OH may also be formed from ©02' by the Haber-Weiss reaction 
O2 + H2O2 —> 0 2 +  ©OH + OFT
The two reactions described above require a metal Fe(II) or Cu(I), (PraOO).
Reactive nitrogen species ©NO" when protonated (H+) decomposes to reactive nitrous 
and hydroxy radicals. Cigarette smoking increases NO levels and depletes antioxidant 
levels, (PraOO).
Because the brain is composed of easily oxidised lipids, has a high oxygen 
consumption rate and lacks strong antioxidant defenses,it is vulnerable to oxidative 
injury (Mar99). There are mechanisms in the brain dedicated to reducing the levels of 
oxidants such as vitamin C and E in fact vitamin E deficiency is known to cause 
neurological symptoms, (Coy93). Glutathione which contains the Se containing 
enzyme GSH-PX scavenges both singlet oxygen and ©OH, (Coy93). Also recent 
studies have shown that oestrogen reduces the death rate of cells damaged by 
oxidation, (Eco98).
Several recent papers have linked oxidative stress to Alzheimer’s disease such as
Deibel et al., (Dei96). Increases in lipid peroxidation, (Lov95) and decreased
polyunsaturated fatty acids, (Pra98) were found in the CNS of AD cases. Certain trace
metals are important in these free radical processes, free Fe, Cu and Mn (PraOO)
because they act as catalysts in the production of ©OH as described above. Cu and Mn
0 , 02-
form part of the enzymes SOD which important as described above and Se 
because it present in gluthanione peroxidase, which scavenges free radicals.
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Selegilene and alpha tocopherol antioxidants therapy trials were carried out in 
Alzheimer’s Disease patients, (San97). Selegilene has been associated with increased 
life span in animals, (Kno83) and alpha tocopherol, vitamin E was used in patients 
with Parkinson’s but no benefits were seen, (Par93). Sano et al., (San97) found in 
patients with severe Alzheimer’s Disease^treatment with the above antioxidants 
slowed the progression of the disease.
2.5.3 Toxins
Silicon and aluminium have been linked to Alzheimer’s Disease by studies of senile 
plaques in the 70’s and 80’s, (Can86) but not by more recent publications. Much 
work has already been done on A1 and its role in Alzheimer’s Disease. Stedman, 
(Ste96) has discussed this in more detail and because no significant correlation 
between A1 and Alzheimer’s Disease in bulk brain samples was found, we decided in 
this work not to further studies on Al. Cd, Eg and Pb are toxic elements which have 
been studied here, as well as Se which is protective against Eg toxicity, (Lou91).
Other elements have also been related to Alzhimer’s Disease as described below.
2.6 Literature Review on Elemental Composition of Human Brains.
Many articles have been published on concentrations of elements in ‘normal’ human 
brain samples. The following are some examples of earlier workj Cu and Zn were 
determined from at least eight regions by Smeyers Verbeke, (Sme74) using Atomic 
AAS, Co, Fe, Rb, Se, Zn, Cr, Ag, Cs, Sb and Sc were determined by Eock, (Eoc75) 
using INAA. Yukawa et al., (Yuk80) determined 20 elements in the cerebrum and 
cerebellum using INAA and Good& (Goo75) determined 34 elements in whole brain, 
frontal lobes and basal ganglia using spark source mass spectrometry, (SMS) and X- 
ray fluorescence methods. In 1978, Iyengar et al., (Iye78) wrote a compilation of 
concentrations in human whole brain summarising earlier work and these 
concentrations have been summarised by Stedman, (Ste96) who has done a 
comprehensive summary of the literature from 1979-1995. The other values shown 
here are a summary of more recent literature on ‘normal’ tissue after 1985 with
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emphasis on work done in the 90’s and with some references that Stedman, (Ste96) 
didn’t include.
Andrasi, (And95a) and (And95b) studied concentrations of elements in brain tumours 
and Alzheimer’s Disease* Ehmann et al., (Ehm86), (Tho88) studied neurological 
diseases such as Alzheimer’s Disease and Amyotrophic Lateral Sclerosis. Ward, 
(War86) studied 32 elements from normals and compared them with Alzheimer’s 
Disease Subjects from UK and East Canada, one of the few geographical 
comparisons. (Pin90), studied trace element concentrations in atherosclerosis and 
Stedman, (Ste97) compared elemental concentrations in ‘normals’ with Alzheimer’s 
Disease. Kornhuber, (Kor94) compared concentrations in ‘normals’ and 
schizophrenia. Duflou, (Duf87) studied 46 regions of normal human brain separating 
grey amd white matter.
The papers described above used multielemental techniques such as Neutron 
Activation Analysis, (NAA), Proton Induced X-Ray Emission, (PIXE) and Inductively 
Coupled Plasma Atomic Emission Spectrometry, (ICP-AES). Bonilla, (Bon82), (Bon 
84) used Atomic Absorption Spectrometry, (AAS) and Ejima, (Eji97) used 
Inductively Coupled Plasma Mass Spectrometry, (ICP-MS).
A summary of the following areas has been made for ‘normal’ brains, Table 2.1 for
the whole brain, separated white matter, grey matter, the cerebral cortex, frontal area,
parietal area, occipital area and temporal area and Table 2.2 for the amygdala,
hippocampus, hypothalamus, pallidum, putamen, substantia nigra and thalamus. A
CMTC-literature search for the concentrations of elements in Alzheimer’s brain tissue also 
shown, divided into the same regions as above, apart from the hypothalamus in Tables
2.3 and 2.4. From this data it can be seen that more work has been done on the frontal 
lobe than other areas of the brain and much work was done by Ward, (War8% on the 
hippocampus. In general, there are strong variations in the literature between 
elemental concentrations especially for elements such as As, Cd, Cr, Cu, Fe, Mn, Pb 
and Zn. These variations may be due to age, sex, geographical variations, blood 
contamination, variations in Brodmanns areas for the different regions or simply poor
23
analytical methods with no quality control or with element concentrations determined 
close to the limit of detection.
Table 2.5 shows a summary from the literature of the number of elements 
determined, dry to fresh weight, (DFW) ratios, the number and ages of subjects. Table
2.6 continues this description and shows the post-mortem interval, the number of 
subject of each sex, whether the right, left or both hemispheres were used, the 
amounts of grey and white matter and the number of regions studied. Table 2.7 shows 
whether elemental concentrations in different regions of the brain, were significantly 
elevated or decreased.
Problems in the literature can be expressed as follows, most publications don’t 
discuss which hemisphere or if both hemispheres were used for sampling nor the 
approximate relative amounts of grey and white matter used. I f  both hemispheres 
are discussed it is usually in reference to the cortex, however, Andrasi, (And90), did 
determine elemental concentrations in both the left and right thalamus. Few 
publications use primary standards, most use Certified Reference Materials, (CRM’s) 
but Ehmann et al., (Ehm86) controlled their CRM’s with primary standards. Table 
2.8, shows the technique used, the reference material and the type of digestion used, 
where necessary. Futhermore, very few papers have divided groups by sex, Stedman 
et al., (Ste97a) are one of the few publications to compare elemental concentrations 
by sex.
In sampling, most of the papers discuss storage of frozen samples rather than formalin 
fixed samples, therefore reducing the risk of contamination. The only exception is 
Andrasi, (And90), who however, investigated leaching problems and the formalin 
blank and most of the papers use titanium tools for sampling to prevent possible 
contaminations, again, Andrasi, (And90), was an exception but again the authors 
carried out leaching tests on the stainless steel knives. Stedman, (Ste96) also didn’t 
use titanium tools but cut round the samples with sharp polyethylene knives.
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2.7 Human Subject and Sample Details
The human samples used in this work were obtained from the Netherlands Brain 
Bank, Amsterdam, The Netherlands, according to availability. The specimens were 
obtained with post mortem delays, between 2.35 and 16 hours, with an average 5.5± 
2.9 hours. Patients with possible dementia, Alzheimers Disease were clinically 
assessed by family history and tests. The clinical diagnosis followed the NÏNCD- 
ADRDA criteria (Mck84) and the degree of dementia was estimated using the Global 
Deterioration Scale (Rei82). Neuropathological examinations were carried out using 
stains on formalin fixed samples. The density of senile plaques, neurofibrillary 
tangles, disrupted intemeuronal network, neurophil threads, congophylic plaques and 
vessels are estimated in Bodian and Congo stains in 4 neocortical areas are used for 
diagnosis, (Rav99). To control Parkinsons and Lewy bodies, the cingular gyrus and 
the substantia nigra were examined. The list of sample subjects used in this work is 
shown in Table 2.9.
The Netherlands Brain Bank was informed that sampling for trace element analysis 
was to be undertaken and they were supplied with polyethylene containers. The 
containers were left for 12 hours in 10% HN03 acid and then rinsed in MilliQ 
(18MQ) water and then left for 12 hours in MilliQ water (18MQ), numbered and then 
weighed. This procedure took place at JRC, Ispra, Italy.
The regions chosen for each brain was the frontal, parietal and temporal lobesy 
hippocampus and thalamus from both hemispheres, sampling 10 regions in all. These 
areas were chosen because Alzheimer’s Disease leads to, in particular, atrophy of the 
cortex, hippocampus and thalamus. The specific areas chosen from the cortex were 
the superior frontal and parietal gyri and the medial temporal gyri, grey and white 
matter. The tissue blocks were cut from frozen brain slabs and transported under dry 
ice by courier. The samples were treated using the procedures which were established • 
for this study using porcine brain (see chapter 5). The only difference being that the 
samples weren’t homogenised because of the strict rules on working with human 
brain tissue under containment level 2 facilities, HSL, Sheffield. Also on arrival at 
the HSL, Sheffield, UK, all tissue samples were cut around the edges with titanium
25
knives in case of any sample contamination. Table 2.10 shows the number of samples 
obtained from the Netherlands Brain Bank and which samples were freeze dried and 
analysed by ICP-MS at the JRC, Ispra, INAA at the JRC Petten and INAA at the IRI, 
Delft.
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Table 2.7 : From the Literature elements which have been found to be significantly 
increased or decreased or unchanged in Alzheimer’s Subjects as Compared to 
Controls
Elem. INCREASED DECREASED NO SIG DIF
Ag (Ehm8 6 ) cortex 
(War87) hippocampus, 
cortex
A1 (And95b) cortex, basal 
ganglia
(Cor93) hippocampus 
(War87) hippocampus, 
cortex
(Xu92) parietal and 
temporal gyri, 
hippocampus
As (War87) hippocampus, 
cortex
Au
B
Ba
Br (Ehm8 6 ) cortex 
(Ste97a) frontal area 
(Ste97b) frontal area 
(War87) hippocampus, 
cortex
(Wen90) temporal area
(Tho8 8 ), hippocampus, 
amygdala, nbM 
(Her85) frontal and 
temporal area
Ca (Ste97a) frontal area 
(War87) hippocampus, 
cortex
(Her85) temporal and 
frontal areas
Cd (War87) hippocampus, 
cortex
Ce
Cl (Ehm8 6 ) cortex 
(Ste97a) frontal area 
(Ste97b) frontal area
Co (Tho8 8 ) nbM (Ehm8 6 ) cortex 
(War87) hippocampus, 
cortex
Cr (Ehm8 6 ) cortex 
(War87) hippocampus, 
cortex
Cs (Ehm8 6 ) cortex (War87) hippocampus, 
cortex
62
Table 2.7 cont. From the Literature elements which have been found to be
significantly increased or decreased.  .....
Cu (And95b) thalamus (And95b) Basal ganglia 
(Dei96) hippocampus, 
amygdala 
(Pla87) temporal, 
frontal, parietal and 
occipital areas 
(Tho8 8 ) Hippocampus
(Dei96) parietal, 
temporal areas, 
cerebellum
(War87) hippocampus, 
cortex
Dy
Eu
Fe (And95b) cortex 
(Cor98) frontal, 
temporal, parietal areas, 
hippocampus and 
thalamus.
(Dei96) hippocampus, 
amygdala
(Tho8 8 ) amygdala and 
hippocampus
(And95b) basal ganglia (Cor98) olfactory 
pathways, cerebellum 
(Dei96) parietal, 
temporal areas and 
cerebellum 
(Ehm8 6 ) cortex 
(Her85) temporal and 
frontal area 
(Ste97a) frontal area 
(War87) hippocampus, . 
cortex
Ga
Gd
Ge
Hf
Hg (Ehm8 6 ) cortex, 
(Tho8 8 ) nbM, 
amygdala
(Cor98) frontal, 
temporal, parietal areas, 
hippocampus, amygdala, 
cerebellum, olfactory 
(Fun97) frontal, 
temporal, occitipal areas, 
putamen, hippocampus, 
radiata coronata and 
corpus callosum 
(War87) hippocampus, 
cortex
I (War87) hippocampus, 
cortex
Ir
K (Ste97a) frontal area 
(Ste97b) frontal area 
(Tho8 8 ), amygdala, 
hippocampus
(Ehm8 6 ) cortex 
(Her85) temporal and 
frontal areas 
(War87) hippocampus, 
cortex
63
Table 2.7 cont. From the Literature elements which have been found to be
significantly increased or decreased.........
La (War87) hippocampus, 
cortex
Lu
Mg (Her85) temporal and 
frontal areas 
(Ste97a) frontal area 
(War87) hippocampus, 
cortex
Mn (And95b) cortex and 
thalamus
(And95b) basal ganglia (Her85) frontal and 
temporal area 
(War87) hippocampus, 
cortex
Mo (War87) hippocampus, 
cortex
N
Na (Ehm8 6 ) cortex 
(Her85) frontal and 
temporal areas 
(Ste97a) frontal area 
(Ste97b) frontal area 
(Tho8 8 ) hippocampus, 
nbM, amygdala
Nb
Nd
Ni (War87) hippocampus, 
cortex
P (Ste97a) frontal area (Her85) temporal and 
frontal areas
Pb
Rb (Ehm8 6 ) cortex 
(Ste97a) frontal area 
(Tho8 8 ) amygdal and 
hippocampus
(War87) hippocampus, 
cortex
S (War87) hippocampus, 
cortex
(Ste97a) frontal area
Sb (Ehm8 6 ) cortex 
(War87) hippocampus, 
cortex
Sc (Tho8 8 ) amygdala, 
nbM
(Ehm8 6 ) cortex 
(War87) hippocampus, 
cortex
64
Table 2.7 cont. From the Literature elements which have been found to be
significantly increased or decreased.........
Se (Cor98) amygdala 
(Tho8 8 ) nbM
(Cor93) hippocampus 
(Ste97a) frontal area 
(War87) hippocampus, 
cortex
(Cor98) frotal, temporal, 
parietal, hippocampus, 
amygdala, cerebellum, 
olfactory 
(Ehm8 6 ) cortex
Si (Her85) temporal and 
frontal areas 
(War87) hippocampus, 
cortex
Sm
Sn (Cor93) hippocampus 
(War87) hippocampus, 
cortex
Sr (War87) hippocampus, 
cortex
Ta
Te
Tb
Th
Ti
Tm
U
V (War87) hippocampus, 
cortex
w
Yb
Zn (Cor98) frontal, 
temporal, parietal areas, 
hippocampus, 
amygdala, cerebellum 
(Dan97) amygdala, 
hippocampus 
(Dei96) hippocampus, 
amygdala
(Tho8 8 ) amygdala and 
nbM
(And95b) basal 
ganglia, central cortex, 
putamen
(Cor93) hippocampus 
(War87) hippocampus, 
cortex
(Cor98) olfactory 
pathways
(Ehm8 6 ), mainly cortex 
(Her85) temporal and 
frontal areas 
(Ste97a) frontal area 
(Dei96) parietal, 
temporal areas and 
cerebellum
Zr
where nbM is the nucleus basalis of Meynert
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Table 2.8: A survey of the techniques used in the literature with the materials used for 
accuracy and precision and the conditions under which a digestion has been carried 
out.
Technique Accuracy and Precision Digestion Method
Cha92 INAA NIST Biological SRM 1571 
Orchard Leaves, SRM 1577 
Bovine Liver, SRM 1570 
Spinach Leaves, SRM 1566, 
Bowen’s Kale
And90
And94
INAA and 
ICP-AES
NBS Bovine Liver Parr Bomb with Nitric 
Acid
And95a INAA and 
ICP-AES
Comparator, ruthenium powder 
and for ICP-AES NBS Bovine 
Liver 1577a
Parr bomb and 
microwave digestion 
with Nitric Acid
And95b INAA and 
ICP-AES
Comparator, ruthenium powder 
and for ICP-AES Bovine Liver 
1577 SRM
Parr bomb and 
microwave digestion 
with Nitric Acid
Bon82 FAAS ?
Cor93 ICP-MS ?
Cor98 INAA NIST and Bowen’s Kale
Dei96 INAA Cu spectrometric solution, Cu 
NIST 1577b Bovine Liver, 
NIST 1566a Oyster Tissue, 
NBS 1571 Orchard Leaves, 
Bowen’s Kale, Fe and Zn NIST 
1568 Rice Flour and Bowen’s 
Kale
Duf87 PIXE/ENAA Two large grey and white 
matter from dog brain, PBŒ 
and INAA
Eji96 ICP-MS NIST 1577a Bovine Liver, 
IAEA MA-A-2 fish-flesh
Digestion in Microwave 
Oven with Nitric Acid
Ehm93 14 MeV
FNAA
INAA,
Subcellular
fractionation
and NAA,
RNAA,
LMMS
For INAA both comparator 
standard and ko method. 
Bowen’s Kale
Ehm8 6 14 MeV 
INAA, INAA
NBS Biological Reference 
Materials, 1571 Orchard 
Leaves, 1577 Bovine Liver, 
1570 Spinach Leaves, Bowen’s 
Kale
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Table 2.8 cont. A survey of the techniques used in the literature
Ehm82 14 MeV 
INAA, INAA
NBS Biological Standard 
Reference Materials
Fun97 INAA,
RNAA
Bovine Liver Standard 1577a 
and 1577
Her85 ICP-AES NBS Bovine Liver and AAS 
standard reference solutions
Teflon lined acid 
digestion bomb, 
incubated at 125°C 
Nitric Acid and 
Hydrochloric Acid
Kor94 AAS ?
Pin90 PDŒ ?
Plan87 RNAA ?
Raj97 ICP-AES Unpolished rice flour NIES 10 
and a multielement synthetic 
material
Muffle furnace at 600°C 
Samples treated with 
Nitric Acid
Ste95 PDŒ, KBS ?
Ste97a PIXE, KBS, 
INAA
Bowens Kale, IAEA A-13 
Animal Blood
Ste97b PDŒ,RBS,
NAA
Bowens Kale, IAEA A-13 
Animal Blood
Tan94 RNAA NBS 1571 Orchard Leaves, 
1566 Oyster Tissue, 1577 
Bovine Liver 
Bowen’s Kale
Thom8 8 14 MeV 
INAA, INAA
NBS 1571 Orchard Leaves, 
1572 Citrus Leaves, 1577 
Bovine Liver and 1570 Spinach 
Leaves
Ward87 TNAA,
RNAA
NBS Bovine Liver and Spiked 
Samples
Wen90 INAA NIST SRM 1570 Spinach 
Leaves, 1572 Citrus Leaves, 
1577 Bovine Liver and 
Bowen’s Kale
Xu92 GFAAS Spiked samples every 6  
samples
Teflon Bomb Microwave 
Determination
Yan93 INAA ? '
Zecc94 RNAA Primary Standards, AAS 
Standard Solutions, NIST SRM 
1566 and 1577
67
where INAA is Instrumental Neutron Activation Analysis 
TNAA is Thermal Neutron Activation Analysis 
ICP-AES is Inductively Coupled Atomic Emission Spectrometry 
FNAA is Fast Neutron Activation Analysis 
EMMS is Laser Microprobe Mass Spectrometry 
RNAA is Radiochemical Neutron Activation Analysis 
GFAAS is Graphite Furnace Atomic Absorption Spectrometry 
RBS is Rutherford Back Scattering
68
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C H A P T E R  3
T echniques
3.1 Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
3.1.1 Introduction to ICP-MS
ICP-MS is a multi-elemental technique, with the possibility of determining over 75 
elements simultaneously. The analytical advantages of this technique are excellent 
detection limits and rapid analysis. The use of the ICP as an ion source for mass 
spectrometry was pioneered by Date, (Dat83) and Houk, (Hou8 6 ).
The Perkin Elmer ELAN 6000 ICP-MS consists of two major units, an Inductively 
Coupled Plasma Source for ion production and a mass spectrometer for ion detection 
and quantification.
The sample solution is continuously nebulised into the ICP torch . The sample aerosol 
is carried to the plasma where the sample is evaporated and most of the atoms are 
ionised by the 6000 °C plasma. The ions are sampled through the interface and lens 
system and then channelled to the quadrupole mass separation device which separates 
the ions based on their mass to charge ratio. The ions are then captured by an electron 
multiplier and quantified by the pulse and analogue stages of the dual detector. The 
system computer controls the sample introduction, ionisation and detection and then 
also generates the final report of results. Figure 3.1 shows a schematic diagram of a 
typical ICP-MS system, from the Perkin Elmer Training Course Manual, (Per99).
3.1.2 Components of the ELAN ICP-MS System 
3.1.2a Sample Introduction System
This sample introduction system consists of a peristaltic pump, nebuliser, spray 
chamber, plasma torch and injector. The peristaltic pump ensures a constant flow rate 
of sample whilst compensating for differences in uptake rate such as the differing 
viscosities of samples, standards and blanks. The nebuliser produces an aerosol by 
interaction of sample liquid with argon. Many types of nebuliser are available each
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with advantages and disadvantages for certain applications. Common nebulisers are 
Cross Flow Nebuliser, Meinhard Nebuliser, (Type A, general purpose. Type C high 
dissolved solids and Type K, reduced gas flow). Ultrasonic Nebuliser (USN), 
Microconcentric Nebuliser (MCN) and Direct Injection Nebuliser (DIN). The Cross 
Flow nebuliser is the one used in this work because of its availability. Trials were 
also made with the Microconcentric nebuliser which is recommended for small 
sample sizes (40-100 uL/min) but clogs with particles >10 microns and we found 
sensitivity to be reduced up to 40%.
The spray chamber separates sample aerosol droplets by size. Large droplets are 
removed by collision with spray chamber walls. The standard ELAN Spray Chamber 
is a Scott Double Pass, made from Ryton and resistant to all commonly used acids, 
even Hydrofluoric acid.
In the Plasma Torch, the main gas flow is 15 L/min, it reacts with the radiofrequency 
(RF) field to form the plasma. The auxilliary gas flow controls the position of the 
plasma relative to torch and the nebuliser gas flow provides the gas flow to nebuliser 
and carries the sample aerosol into plasma.
3.1.2b Excitation Source (ICP source)
The ICP is an excellent ion generator, most elements are 90% ionised under the 
6000°C standard plasma conditions, exceptions are As (52%), Se (33%), S(14%) and 
F (9*104)%. Moreover, the singly charged ions as opposed to the doubly charged ions 
predominate. Only a small number of elements have a low enough ionization 
potential to produce an appreciable amount of doubly charged species. The worst case 
is Ba4^  but the relative percentage of doubly charged ions to singly charged ions is 
about 1-2% and the bulk plasma is still 99% Argon. The energy of the ions is 
approximately between 2 - 1 0  eV, which is optimum for quadrupole mass 
spectrometer.
84
3.1.2c Ion Transport System (Interface and Lens System)
At the plasma spectrometer interface the ions must be transferred from 6000K to 
room temperature and from atmospheric pressure (760 Torr) to 10' 5 Torr. Figure 3.2 
shows the Ion Sampling Process, from the Perkin Elmer Training Course Manual, 
(Per99). The ions are sampled through a 1.1 mm orifice into 1 Torr to 3 Torr Pressure 
Region, the Sampler Cone, most of the argon atoms are removed by the vacuum. The 
ion beam is the further sampled through a second orifice into 10' 5 Torr region, the 
skimmer cone. Matrix particles which depoisit on either of these cones could lead to 
cone blockage and signal instability, (Pru98). Also particulates and neutral species 
passing through the interface may depoisit on the ion lens system, this could affect the 
voltage on the ion optics which could affect their ability to focus ions into the 
quadrupole, (Pru98). Stability has been improved using a shadow stop, (Figure 3.2), 
which stops unwanted matrix substances. The photons are blocked by a photon stop 
located on axis and the E lens is used to focus the ion beam.
3.1.2d Mass Separation Device ( Quadrupole Mass Spectrometer)
! The ELAN uses a classical quadrupole design mass spectrometer operating in a 
vacuum less than 1*10^ to 2*1 O' 5 Torr as the mass separation device.
A quadrupole consist of four independent rods. Each pair of rods has an overall 
positive or negative potential, they are positioned opposite to each other. The electric . 
field in the quadrupole is a combination of RF and DC voltages. The varying electric i 
field controls the trajectory through the quadrupole and separates the ions based on 
their mass to charge ratio. The entire mass range from 1 to 269 atomic mass units 
(amu) may be scanned in milliseconds.
3.1.2e Detector (Discrete Dynode Electron Multiplier) j
| The dual discrete dynode electron multiplier consists of 22 discrete dynodes. The j 
dynamic working range is extended to simultaneously measure both, high and low 
concentrations, from a single mass scan. A negative high voltage is applied to the first 
dynode attracting positive ions to enter the detector and hit the first dynode. Ion 
impact on the first dynode generates negative electrons. A positive high voltage is 
then applied to the base of the detector ( this generates a positive potential difference
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Figure 3.1: ICP-MS Components, (Per99).
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between detector entrance and base) for detection of ion counts at ultra trace to trace 
levels. The analogue current is measured between dynode 10 and 11, analogue 
detection is not very sensitive and is good for detection of high analyte 
concentrations. Analogue signal and pulse counting signal are obtained 
silmultaneously.
3.1.2f Pentium PC with Windows NT and Elan NT software (Spectrometer 
Control and User Interface)
The ELAN 6000 is controlled by a Pentium computer. It controls the ELAN 6000 
hardware (gas flows, plasma, vacuum system, E lens, quadrupole) and quantitative 
analysis. Operations using the autosampler are also controlled via the ELAN software. 
The autosampler used was an AS-91 autosampler fitted with a 152 position (f) tray. 
The ICP-MS ELAN NT software and instrumentation are accredited and follow the 
relevant criteria from ISO 9001/9002. The ELAN 6000 is as other ICP-MS 
instruments sensitive to the room temperature and is therefore installed in a room 
with its own air conditioning system.
3.1.3 Tuning and Optimisation
The Elans Auto tune function permits automated parameter setting to perform a 
mass calibration or adjusts resolution of the mass spectral peaks. Tuning was 
performed at least every two weeks during analysis or whenever there was a change to 
the Elans electronics.
During calibration the ELAN scans the quadrupole and determines the maximum 
intensity of each isotope in a prepared solution and its atomic mass relative to its 
intensity (the measured mass of the isotope). During this measurement, the system 
scans for the peak within a predefined scan width region centered around the exact or 
known mass for that isotope. Since the exact mass of each isotope is known, the 
instrument can then compensate for the differences between the apparent and exact 
mass.
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Resolution of the mass spectral peaks is measured as the peak width at the 10% peak 
height. A resolution control is made to assure that the resolution at each mass of 
interest is within the defined range. This value should be approximately 0.7 amu 
which is the setting providing the best balance between peak separation and signal to 
noise ratio. Resolution should be within +/- 0.10 amu of the expected resolution or an 
adjustment should be made.
3.1.4 Optimisation Procedures
The daily optimisation targets the sample introduction system, the torch and the 
cones. This includes an XY adjustment, nebuliser gas flow optimisation, lens 
optimisation and a check of instrument performance. Typical performance 
specifications (the sensitivity is the minimum number of counts that the ICP-MS 
should be operated at) should be approximately as follows: Background (220): < 30 
cps, 103Rh sensitivity >150000 cps, 24Mg sensitivity > 20000 cps, 208Pb sensitivity >
1 OOOOOcps,156CeO/140Ce < 0.03, 69Ba %^38Ba^< 0.03. A doubly charged ion will cause 
an interference at half the m/z value of the singly charged ion eg 138 B a ^  on 69Ga+.
Complete optimisation involves detector optimisation. When measuring analyte 
concentrations across wide concentration ranges, the si multaneous detection 
approach leads to two calibration curves. Pulse calibration curve from detection limit 
to approximate!^* 106 counts/s. Analog calibration curve from approximately 1 * 105 
counts/sec tol*10%ounts/sec (analog detection is much less sensitive). This is shown 
in Figure 3.3. The two calibration curves per analyte isotope then require a cross 
calibration, this means extending the dynamic range of the detector by normalising 
the analog stage to the pulse stage. The dual detector calibration solution should 
include the analytes that are expected at high concentrations, Na, K, Mg and Ca, 
(Per99).
A dirty lens requires potential range shifts towards higher voltages. Heavy matrices 
require potential range shifts towards higher voltages, especially at low mass. With 
detector age the saturation point moves towards higher voltages. The detector should 
not be operated at voltages far beyond the saturation point because it reduces the
detector lifetime, can cause signal drift and may increase noise level. A dead time 
correction is required when the detector is replaced.
3.1.5 Peak Hopping and Peak Scanning
The ELAN provides two different modes for acquiring mass spectral data during a 
determination; peak hopping and peak scanning.
The most common method and the method used in this work for ELAN data 
acquisition is peak hopping. In peak hop mode, the ELAN measures the signal 
intensity at the top of each peak in the mass range defined for each element of 
interest. The spectrometer spends a specified amount of time known as the dwell 
time, measuring signal intensity at this point. Multiple sweeps may be made to 
increase measurement | precision. The data from each measurement constitutes a 
reading.
To more accurately characterise the mass spectrum peak scanning may be used. 
Scanning acquires data from multiple points in the mass range defined for the element 
being measured. The spectrometer ‘ramps’ that is steps incrementally through the 
mass range, acquiring intensity data for each mass peak (0.7 amu wide). The number 
of data points acquired in the range is determined by the value of the MCA channels 
parameter. The time spent acquiring each individual data point is therefore the dwell 
time (total time spent at each element) divided by the number of MCA channels being 
measured. As in peak hop mode, multiple sweeps per reading can be acquired to 
improve measurement precision.
3.1.6 The ELAN Analytical Techniques
The ELAN ICP-MS spectrometry software provides five different ways of managing 
data acquisition and each of the ELAN analytical techniques vary in the relative 
degree of accuracy and precision they offer. Quantitative analysis is the one used in 
this work and is described below. A description of the other methods may be found in 
the Perkin Elmer Training Course Manual, (Per99).
Figure 3.3: A Cross Calibration is Required for the Pulse and Analog Signals
1e9 128e6
... \  y . , . - .e'-y"mÊtÊKÊtmÆtÊÊWÆk
m&ÆmÆÊBm
n s i
0.1 ng/L 100 mg/L
90
3.1.6a Calibration in Quantative Analysis
The ELAN offers the following methods of calibration in the Quantitative Analysis 
Technique: external standardisation, standard addition, additions calibration as a 
variant of standard addition and internal standard. They are all described below but 
the additions calibration coupled with internal standard is the method used in this 
work, apart from Li which was determined in the human brain samples with no 
internal standard, as described in chapter 7.3.1.
3.1.6b External Standardisation
For samples that are not subject to sample specific matrix interferences that change 
the overall instrument sensitivity between measurement of the standards and samples, 
external standardisation is a simple and effective way to calibrate the ELAN.
External standardisation involves measuring a blank solution followed by a set of 
standard solutions, usually two or three, to create a calibration curve over the 
concentration range of interest.
3.1.6c Method of Standard Additions and Standard Additions Calibration
The method of standards addition involves spiking each sample with known 
concentrations of the analyte measuring a blank solution and creating a calibration 
curve. Although it is time consuming and requires large amounts of the sample, it is 
one of the most accurate calibration methods because calibration is established in the 
sample matrix itself, (Pru98), (Goo93).
Additions calibration is a variant of standard additions. It is used when all samples 
have a similar matrix so only one sample which is representative of the batch is 
spiked, (Pru98). It is much less time consuming than standard additions, requires less 
sample volume and is routinely used in clinical analysis for producing accurate 
results, (Pru98).
3.1.6d Internal Standard
Analysis using internal standard is well established and compensates for matrix 
related interferences, (Nix96). An internal standard is a a  isotope that is
91
added to standards and samples before a determination. Internal standards allow for 
correction of matrix suppression and sample transport interferences.
Elements selected for use as internal standards should not be in the sample or the 
endogeneous content of the sample should be negligible compared to the amount of 
internal standard added, furthermore, an internal standard should not be a likely 
contaminant in the environment. Monoisotopic elements should be selected if 
possible and isotopes free from polyatomic interferences should be selected. Some 
possible isotopes for use as internal standards are 9Be, 45Sc, 89Y, 103Rh, 115In, 193Ir, 
"^Lu/^Re.
Vanhaeke et al., (Van92) suggested that an internal standard with a mass close to that 
of the analyte is preferred for all elements and Thompson, (Tho87) suggested that the 
internal standards should be close in atomic mass and have a similar first ionisation 
potential to the analyte if correction is to be successful. If major matrix elements such 
as Na or Mg have a very low first ionization potential, these elements may withdraw 
a large amount of energy from the plasma. This leads to sensitivity losses for elements 
with a high first ionization potential eg, Zn, As and Se. Use of an internal standard 
with a similar high ionization potential may reduce the problem, (Per99).
If the matrix material causes slight clogging of sampler and or the skimmer, this may 
cause a high ion density behind the skimmer cone causing interactions between ions 
in the ion beam known as ‘space charge effects’This may lead to signal losses at 
lower masses such as Li+ by the presence of heavy ions Pb+. The use of carefully 
selected multiple internal standards across the mass range can eliminate or minimise 
the problems associated with this effect.
3.1.7 Interferences In ICP-MS
The ICP-MS technique offers analytical benefits but interferences of various types 
can occur during routine ICP-MS determinations. An interference causes the signal 
from an analyte to be different from the same signal for the same concentration of 
that analyte in a calibration solution.
92
Interferences which occur from the presence of other isotopes or elements with the 
same atomic weight or mass number as an analyte of interest are termed spectral 
interferences, whereas non spectroscopic interferences are characterised by a 
reduction or increase in analyte signal due to factors exerting an influence on sample 
transport and ionization in the plasma. The type and concentration of the sample 
matrix directly effect this.
3.1.8 Spectral Interferences
Spectral Interferences are the result of chemical species (isotopes or ions) which are 
present at the same atomic mass as the analyte of interest. Since most elements have 
more than one naturally occurring isotope, it is possible for the mass spectrum of an 
isotope of one element to directly overlap that of an isotope of another element. These 
interferences are termed as Isobaric Overlap and may be overcome by using 
alternative isotopes or elemental equations for analysis.
The second category of spectral interferences termed Polyatomic/Molecular Overlap 
are caused by the formation of molecular or polyatomic ions interfering with the 
analyte isotope of interest and these interferences are formed from pre-cursors in the 
plasma gas, entrained atmospheric gases, water, acids used for digestions and the 
sample matrix.
Minor overlaps are corrected automatically by the ELAN 6000 software by measuring 
the intensity of the interfering element at one of its major isotopes. Then using 
published isotope ratios it is possible to subtract the intensity of the interfering isotope 
that is contributing to the analyte signal. In addition most spectral interferences 
caused by molecular overlap may be avoided using alternative isotope masses and 
reduced/eliminated using alternative sample introduction systems, (Van94), (Chu97), 
(Sig74).
When an element is introduced into the plasma the monoatomic singly charged 
analyte ion (M*) are not the only species observed. Elements with a low second 
ionization energy will be partly doubly ionised (M2+), whereas for elements that have
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a high bond strength, oxide (MO+) and hydroxide ions (MOH+) are formed, (Van8 6 ). 
The intensities of these species can be reduced with a low nebuliser gas flow and high 
power.
In addition to these species the following polyatomic ions is also a cause of 
interferences.
3.1.8a Plasma Induced Polyatomic Effects
The presence of atmospheric gases or the argon carrier are sources of potential 
interfering ions as the result of reaction with other analyte or matrix components. 
These interferences occur as polyatomic, molecular ions. Table 3.1, lists the most 
severe, common overlaps which occur.
Table 3.1, Common Interfering Ions which overlap with Analytes
Analyte % Abundance of Isotope Interfering Ions
32 g 95.0 16o 16o
3!,k 93.3 38ArH
40 Ca 96.9 40 Ar
56 Fe 91.7 40Ar16O
80 Se 49.6 40Ar40Ar
In the case of calcium, determinations are generally performed at 44Ca, which is about 
I 2% abundant. This means there is a higher detection limit for calcium determinations. 
Sulphur detection limits are affected both by poor ionization in the ICP (14%), 
resulting in low ion intensity and by overlap of the primary sulphur ion by diatomic 
oxygen. Unless the oxygen entering the plasma can be reduced to trace levels, the 
I overlap forces the use of a less abundant sulphur isotope 34S for determinations.
3.1.8b Matrix Induced Polyatomic Effects
Most biological samples require an acid digestion necessary to precipitate the 
proteins. The solvent or acid in which the sample is dissolved can also be a source of 
interfering polyatomic ions especially chlorine from hydrochloric or perchloric acid
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and sulphur from sulphuric acidflhey all form polyatomic ions with argon and other 
plasma gases. For organic solvents, carbon and oxygen can also form polyatomic ions. 
Information on these spectral interferences are important. The background mass 
spectra for water, 5% solution of HN03 HC104 H2SO4 and have been extensively 
described, (Tan8 6 ). Potential Interferences in 10% HN03 are shown in Table 2.2, The 
use of HNO3 for the digestion of biological samples has been widely favoured 
because it contains only the species H, N and O which are present in the plasma and 
entrained gases anyway, (Van89).
When biological materials are analysed, other matrix elements such as Ca and P also 
give rise to spectral overlap. Evans (Eva93) and Vanhoe (Van94) have given an 
overview of all spectroscopic intereferences as well as those in biological materials. 
Spectral overlap for the elements analysed in this work are described in chapter 4.1.4.
3.1.9 Reducing Spectral Interferences
More recently mixed gas plasmas have been investigated to reduce or eliminate some 
spectral interferences. Se may be determined in several biological materials by the 
addition of methane or N2 to the nebuliser gas. An alternative method is the addition 
of an organic solvent to the sample which is the method used in this thesis for the 
human samples and is described in chapter 7.2, (Del97), (Gam99). This has a cooling 
effect on the plasma and the background spectrum changes from being dominated by 
Ar+, A rif, ArO+ and H20 + to NO+, 0 2+ and or H3O"1". The former are removed due to 
ion molecule reactions.
As described by Hongsen (Hon96), Ar+ comes from neutral Ar; ArH+ and 0 + are 
already present or are formed from reactions between i f  and 0 + and neutral Ar. 
Under ‘cooler’ conditions NO and 0 2 exist, Ar+, i f  and 0 + which have a higher 
ionisation energy extract an electron from NO and 0 2. Protonated water ions are also 
favoured under these conditions. Therefore ions such as NO+, O f  and H30 + replace 
the atomic ions Ar+, i f  and 0 +. Research into the fundamentals of cool plasmas is 
ongoing and is an area which has received much attention over the last five years, 
(Hon96).
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3.1.10 Dissolved Solid Limitations
In ICP-MS the physical design of the ICP mass spectrometer interface limits the 
concentration of dissolved solids to about 0.25%. At higher concentrations the 
sampler cone orifice may become clogged. For most routine analysis the total 
dissolved solids should not exceed 0.1% for A1C13 and 0.3% for NaCl, (Per99). It 
should not however be necessary to run a solution at ‘high enough concentrations’ to 
cross the dissolved solids limit because of the extremely low detection limits of the 
ELAN, (Pru98). In fact, it is normal to dilute the samples 50 -100 X before 
introducing them into the spectrometer, in order not to exceed the signal range of the 
detection system, not to coat the ion optics and also reduce instrument maintenance 
requirements. This dilution also improves the accuracy of the internal standard, 
(Hsi97)
3.1.11 Non Spectroscopic Interferences
3.1.11.a Sample Introduction and Transport Interferences 
Sample introduction effects when using a nebuliser/spray chamber system are 
common in ICP-MS determinations. These interferences are generally the result of 
either sample matrix effects that influence aerosol formation or the formation of ions 
in the plasma through surface tension and viscosity. Futhermore, complex sample 
matrices may interfere with focusing ions into the sample and skimmer cone orifices 
and focusing and transporting ions through the ions lenses and quadrupole.
In addition to influencing nébulisation and transport properties the matrix may have 
an effect on the temperature of the plasma and hence atomization, excitation and 
ionization characteristics of the discharge. The trend of matrix effects is in the order 
of most easily ionised matrix element, (Na>Mg>I>Br>Cl) and since biological 
materials contain large amounts of these elements, this makes sample analysis 
difficult, (Hsi97).
The most commonly observed result of matrix interference is signal suppression. Non 
spectroscopic interferences can be overcome by internal standard and standards 
addition as described previously. This subject is reviewed by Evans, (Eva93).
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Table 3.2: Potential Interferences in a 10% HN03 solution from Perkin Elmer, 
(Per99).
Component Mass % Abund. at 
Component Mass
Potential for 
Interference
Interfered
Element
Percent
Abundance
“ n ' V 28 99.2 high in HN 03 Si 92.23
,4n ' 5n + 29 0 . 8 high in HNOj Si 4.7
14n  14n  ih + 29 99.2 medium Si 4.7
30 0.4 medium Si 3.1
14n 16o 1h + 30 99.4 high in HN0 3 Si 3.1 ~
14n 16o + 30 0.44 medium Si 3.1
14n 16o 1h + 31 99.4 high in HN 03 P 1 0 0
14n 14n 16o + 44 99 medium in
HNOs
Ca 2.09
36Ar15N+ 51 0 . 0 0 1 very low V 99.75
36Ar14N 'H+ 51 0.299 very low V 99.75
38Ar l4N+ 52 0 . 1 very low Cr 83.79
36Ar15N ‘H+ 52 0 . 0 0 1 very low Cr 83.79
38Ar14N 1H+ 53 0 . 1 very low Cr 9.5
36Ar160 1H+ 53 0.299 very low Cr 9.5
4#Arl4N+ 54 99.2 high in HN 03 Fe 5.8
40Ar15N+ 55 0.4 medium in
h n o 3
Mn 1 0 0
4"Ar,4N 1H+ 55 99.2 low Mn 1 0 0
40Ar15N 'iT 56 0.4 low Fe 91.72
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3.2 Electrothermal Atomic Absorption Spectrometry (ETAAS)
3.2.1 Introduction to ETAAS
The principles of AAS were established around 1860 by Kirchoff and Bunsen but it 
was in 1955, that work using AAS for analysis was presented independently by Walsh 
and Alkemade and Milatz, (W694).
ETAAS involves placing the sample usually from a micropipette via the injection 
hole in the centre of the graphite tube and then rapidly heating the tube by a high 
electrical current to a temperature which is high enough to atomise the sample. 
Atomisation occurs within a few milliseconds, resulting in a transient signal. A 
radiation source emits the spectrum of the element being determined and the atomised 
substance absorbs the radiation. The monochromator allows spectral dispersion of the 
radiation and separation of the analytical line of interest from the other lines. This 
signal is then processed via the detector, amplifier and read out system. Figure 
3.shows the SIMAA components.
Figure 3.4 Schematic Components of a basic atomic absorption signal
SAMPLE
CELL
LIGHT SOURCE SPECIFIC LIGHT MEASUREMENT
MONOCHROMATOR ELECTRONICSSOURCE
READOUTFURNACE DETECTORCHOPPER
Atomic Absorption obeys the Beer Lambert Law where absorbance is proportional to 
concentration. In ETAAS, as opposed to Flame Atomic Absorption, (FAA) the 
amount of light absorbed depends on the total amount of analyte in the aliquot and 
not on the concentration of the solution. The relationship between the amount of light 
absorbed and the concentration of analyte present in known standards can be used to 
determine unknown concentrations.
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In ETAAS once the sample is introduced into the graphite furnace, the sample is 
heated in a programmable sequence of temperature and time. The temperature 
increase occurs in a slow controlled rate or ‘ramp’. First the sample is dried at 
approximately 100°C for aqueous solutions. The following stage known as pyrolysis 
is extremely important and here chemical interference and background absorption 
problems from bulk sample constituents can be reduced by volatizing as much as the 
sample matrix as possible (without volatising the analyte element) and these volatised 
sample components may be removed from the atomiser by a stream of argon gas. To 
maximise matrix elimination, a matrix modifier may be added to the sample so the 
matrix becomes more volitile so it may be eliminated at lower temperatures or to 
form a more stable form of the analyte so the maximum temperature can be increased 
to eliminate more of the matrix without loosing the analyte, (Bea78), (Tsa90). After 
pyrolysis the furnace is rapidly heated to a temperature high enough to atomise the 
analyte and produce atomic absorption. To improve sensitivity the argon gas is 
interrupted in the atomisation step. The final step is the cleaning step, in some cases 
not all the sample is volatised during atomisation so the cleaning step removes any 
residuals left in the atomizer tube.
3.2.2 Zeeman Effect Background
Zeeman effect background is required to accurately correct for the background, 
caused by high concentrations of molecular species or smoke which may absorb or 
scatter light from the line emission source. This correction is dependent on the 
absorption profile for an element which splits into several componenents in the 
presence of a strong magnetic field. The central pi components occur at the 
absorption wavelength for the element. The outlying sigma componenets are 
separated from the pi component so that no atomic absorption occurs at these 
wavelengths.
In longitudinal Zeeman systems, the graphite furnace is positioned longitudinally 
relative to the magnetic field. The combined atomic and background absorption is 
measured while the magnetic field is off. The detector measures the background
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absorption only when the magnetic field is on as the pi component is not detected. 
The difference between the two signals is the corrected atomic absorption signal.
| 3.2.3 SIMAA 6000 j
The SIMAA 6000 spectrometer from Perkin Elmer is a high performance atomic 
absorption spectrometer designed for simultaneous multielement graphite furnace 
analyses. Depending on the elements chosen up to six elements may be determined 
simultaneously. The SIMAA 6000 uses a transversely heated graphite furnace and 
Zeeman effect background correction employing a magnetic field orientated 
longitudinally to the optical path. The SIMAA 6000 uses a state-of-the-art Echelle I 
polychromator and solid state detector. The samples are injected from a AS70 
autosampler with a microdispenser capable of delivering 0.1 pi. The spectrometer and , 
atomiser control and display and manipulation of data are all performed through the j 
Perkin Elmer Winlab software version 1.1. The instrument and software are certified 
under the quality requirements ISO 9001.
| The method used was standard additions calibration, described in 3.1.6c.
; 3.2.4 ETAAS 5100 j
| The 5100 atomic absorption spectrometer from Perkin Elmer is designed for single 
elemental graphite furnace analysis and uses transversely heated graphite furnace and j  
| longitudinal Zeeman effect background correction. The samples are injected from a j  
j AS-60 autosampler with a microdispenser capable of delivering 1 pi. The |
| spectrometer and atomiser control and display and manipulation of data are all i 
performed through the Gem software. The instrument and software are certified under j 
the quality requirements ISO 9001.
The method used was standard additions calibration, described in 3.1.6c.
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3.3 Instrumental Neutron Activation Analysis (INAA)
3.3.1 Introduction
The neutron is uncharged, it does not experience the Coulomb forces of electrostatic 
interactions as it approaches the nucleus so neutrons of any energy may interact with 
the nucleus. The interaction between neutrons and nuclei results in compound nucleus 
formation. The neutron adds its kinetic energy and binding energy to the target 
nucleus so the compound nucleus is in an excited state, the lifetime of which is 
(10"14 s). The excited compound nucleus de-excites and is related to the amount of 
energy added to the nucleus.
The nuclear reactions important in Neutron Activation Analysis (NAA) are radiative 
capture, transmutation and inelastic scattering.
3.3.2 Reactions
3.3.2a Radiative Capture
Radiative capture reactions (n, y) are very important in neutron activation analysis and 
occur when a thermal neutron is absorbed. The product compound nucleus decays to 
its ground state by the emission of prompt gamma rays, eqn. 3.1.
, Î X  + l n  [ A+l x ] ' - > A+z' X  + r p,„„pl (3-1)
For thermal neutrons the compound nucleus does not usually have enough energy for 
particle emission to take place although there are exceptions eg. 10B(n,oc).
If the nucleus is unstable the neutron rich nucleus will generally decay by the 
emission of beta negative particles. If the product isotope following beta emission is 
in an excited state then the beta decay may be followed by delayed gamma emission.
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This type of reaction predominates for thermal neutrons because the probability of a 
direct interaction between a neutron and nucleus is generally inversely related to the 
neutron energy and thus to the velocity (1/v law).Thus as the neutrons increase in 
energy the probability of radiative capture decreases.
Although prompt gamma neutron activation analysis (PGNAA) is also used, in this 
work the delayed gamma rays are monitored.
3.3.2b Transmutation
This reaction is the second most common in activation. Neutrons with higher energies 
excite the compound nucleus sufficiently to cause particle emission, most often (n, p) 
and (n,a). Sufficient energy is needed to overcome the threshold value, this energy is 
equal to the Q value for the reaction. Futhermore, according to classical theory, any 
charged particle must have sufficient energy needed to overcome the Coulomb 
potential barrier. In most cases fast neutrons are required to supply this energy to the 
compound nucleus. The lower cross sections and smaller fluxes of fast neutrons make 
it less sensitive than thermal neutrons for analytical purposes.
In this work, fast neutrons cause interferences; Cr is determined via the 50Cr(n,y)51Cr 
reaction, however, 51Cr is also produced with fast neutrons via the following reaction 
54Fe(n,a)51Cr. Thus the determination of Cr in a matrix high in Fe may give 
inaccurate results. Other competing reactions are 41K(n,y)42K and 42Ca(n,p)42K and 
59Co(n,y)60Co and 63Cu(n,a)60Co. The effect of the interference will depend on the 
cross section of each of the target nuclei and the size of the thermal and fast 
components of the neutron flux. These reactions described are examples of Primary 
Interference Reactions.
3.3.2c Inelastic scattering
In inelastic scattering the neutron interacts with a target nucleus which involves 
giving some kinetic energy to the nucleus and then recoiling to conserve momentum. 
The nucleus is left in an excited state and if the energy of the incident neutron is
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higher than the binding energy of the neutron in the nucleus, two neutrons may be 
emitted from the nucleus (n, 2n). The residual nucleus may dexcite emitting a 
positron. This reaction is not so common in NAA because the binding energy of the 
neutron in the nucleus is about 8  MeV and the incident neutron must have an energy 
higher than this.
3.3.3 Neutron Activation Analysis
Georg Hevesy and Hilde Levi in Denmark, were the first to use neutron activation 
analysis for the qualitative detection of the rare earths and published their method in 
1936. Then with the birth of the nuclear reactor in the 50% NAA developed rapidly. 
Nowadays, although ICP-MS and AAS are the techniques used most often, INAA still 
remains an important technique in establishing the ‘normal’ level of several trace 
elements in ‘difficult’ matrices such as blood because not only does this non­
destructive technique yield accurate and precise results but it is generally free of 
matrix effects and the absence of reagent blank problems is also highly important. 
NAA is also the best method for the certification of reference materials in the 
biological field, (Hey94).
There are a large range of sources used to produce particles or photons needed for 
activation analysis, (Ehm91).
(I) Photonuclear sources, eg.88Y with 9Be, 124Sb with 9Be
(II) Alpha emitter (a, n) sources, eg. 239Pu with 9Be, 226Ra with 9Be, 241Am with 9Be.
(III) Spontaneous fission sources, eg. 252Cf
(IV) Cockroft-Walton accelerators, eg. 3H(d,n) 4He
(V) Cyclotrons, eg. 10pA of 30-MeV douterons on Be.
(VI) Nuclear reactor, induced fission.
The neutrons produced by fission events in a reactor vary in energy from very low 
energies (thermal neutrons) to about 20 MeV, consequently activation not only occurs 
with thermal neutrons but with epithermal and fast neutrons. The neutrons produced 
in a reactor (energies of average 2.0 MeV) are reduced to thermal energies by 
collisions with the moderator.
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Thermal neutrons have a most probable energy of 0.025 eV (velocity Vo= 2200 m/s) at 
room temperature (20.5°C) and neutrons with energy between 0.1 eV and up to 2 
MeV are called epithermal neutrons. The neutron cross section for thermal neutrons is 
proportional to E"1/2 or to 1/v. In the epithermal region sharp increases in reaction 
probability are seen for neutrons of discrete energy. These observations are known as 
resonance peaks. Thermal and epithermal neutrons mainly enter into (n,y) reactions.
3.3.4 The Activation Equation
A nuclear reactor is the most intense source of neutrons available for NAA.
If a sample is placed in a nuclear reactor, radiative capture reactions will occur,
The target nucleus ( % X )  containing NA nuclei with a relative atomic mass A w 
capture neutrons to form the radioactive species ( A+z X )  , which then decays to 
y  product|( 2 +jK ).
Assuming the flux § remains constant throughout the target the rate of production of 
radioactive species is given by
#  = (foNj (3.3)
where cr is the reaction cross-section and 
(3-4)
where N0 is Avogadro’s number, f  is the fractional abundance of the target isotope 
and m is the mass of the target element.
The rate of disintegration of unstable nuclei ( A+z X )  is given by
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d  — A+i (3.5)
where t is the time and XA+i is the decay constant, characteristic of the particular 
radioactive species.
The characteristic rate of decay may be given in terms of the half life
^  ^  (36)
1/2
where Ti/2, the half life is the time required for the number of active nuclei to be 
halved.
The silmultaneous events of formation and decay during irradiation are given by
dt ~ ^ (7^ A ^Forma!ion A + \ )  D ecay ( 3  7 )
The activity of { A+z X )  present after time f  is thus given by 
(j)oNj
A4+1
However, after irradiation, the activity will decrease exponentially. The number of 
product nuclei after this decay period is given by
y^l+l
where tw is the waiting time. If tc is the counting time then eqn 3.9 becomes
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- 0  -  (1 -  ) (3.10)
^A+l
since the nuclei decay during counting.
If Iy is the emission probability of the detected gamma ray of interest and 8  is the 
absolute efficiency of the detector for that energy, then the detector response (D) (the 
number of full energy photopeak counts) is given by
g - ^ + l t w
D  = eIr$ o N A(1 - ----- ( l - e ' ^ A )  (3.11)
^A+l
and substituting NA with eqn. 2.4 the detector response is given by
(3.12)
This equation allows calculation of the mass of the element of interest, (Spy93). 
Figure 3.5 shows the growth and decay of the induced activity.
Figure 3.5 : Growth and decay of Radioactivity
ACTIVITY
SATURATION
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IrradiationGrowth During 
Irradiation
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Along with thermal neutrons, epithermal neutrons also contribute to the (n,y) reaction. 
Therefore the flux and cross-section are energy dependent. It is assumed that the 
contribution from fission neutrons are small thus they can be neglected.
Therefore the total neutron flux in terms of thermal and epithermal fluxes may be 
expressed as
<f> =  <f>th +  fa p  P . 1 3 )
where ^  and ^  are the thermal fux up to the Cd cut-off energy and epithermal flux, 
respectively.
However, using eqn. 3.12 to calculate elemental mass and hence concentrations is not 
undertaken in most routine analysis. This is because there are uncertainties in the 
literature for the nuclear parameters involved, such as thermal neutron cross sections, 
branching ratios, neutron flux and decay constants. Also the neutron flux at the
(3-14)
<j is the effective activation cross-section.
Gth is the cross-section for any nuclide obeying the 1 /v law. 
I0 is the resonance integral which is defined below
where ECd is the cadmium cut-off energy
when (/)th = (j)
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irradiation position maybe variable during the period of irradiation. This method is 
therefore, rarely employed, (Ars91). Therefore a comparator method is generally 
used. In this case a multielement standard containing a known amount of the element 
is irradiated along with the samples From the ratio of the induced activities in the 
unknown sample Ax and in the standard As the weight Wx of the element of interest 
can be calculated since Ws, the weight of the standard is known, (eqn. 3.17) on 
condition that all other parameters are identical and there are no interfering reactions. 
However, there may be small variations in flux between the standard and sample 
posistions and thus flux monitors are used to observe any changes in flux.
There are however disadvantages in using multielemetal standards. In NAA, few 
laboratories prepare primary standards and prefer to use certified reference materials. 
Both National Institute of Standards (NIST) and International Atomic Energy Agency 
(IAEA) have stated that reference materials should not be used as primary standards, 
(Bec87). Not only are the uncertainties on recommended values too large to give 
accurate results but also the material is limited and not all elements are certified in 
the reference material. However, in the papers reviewed in this thesis none used
(jfxcep b  X^cxrd)
primary standards/land in this work initially, attempts were made to prepare primary 
standards using AAS standard chemical reagents which were placed on a carrier 
material, quartz and were centrifuged and left to dry in a 30°C oven for three days but 
the results after irradiation were much less reliable than those of the reference 
materials. The process was also extremely time consuming so it was theodecided to 
use CRM’s, which have similar matrix composition and elemental concentrations.
3.3.5 The K* Method
To avoid these problems the single comparator method was developed and introduced 
by Girardi (Gir65) which makes use of a single element as the comparator and 
concentrations calculated relative to it.
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Using eqn. 3.12, keeping irradiation and counting conditions the same as for standard 
and element, the ratio of the detector response for the element of interest x and single 
comparators then:
Therefore from eqn. 3.19, the weight Wx of the element of interest can be calculated 
since the other parameters are known. The problem is that the Kx values are only 
valid for a particular irradiation facility because any change in <)>&%? will change the 
Kx value and therefore the k0 method was developed to correct for this.
The. Ko factors, (Moe77) or standard elements K^td were calculated using a 
comparator element for a reference position in a reactor with a stable thermal to 
epithermal neutron flux ratio. Moens, (Moe77) irradiated and counted a number of 
standard elements and the comparator element under the same conditions and 
calculated the specific activity (Asp) and the ratio is given by Krcf> std.
therefore
(3.19)
where Kx is a constant defined below;
(3.21)
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K.re f,std
( ^ s p ^ s f d
( Z )
(3.22)
s/7 /  com ref
Therefore the K0 std values are given by:
A .
V fiep J
+
K s t d  -  ^ref,std f  . \
A
\fiep  J
riA
f l . '
(3.23)
+
'std
r e f
^ ^ th '  std
where I0 and g0 are taken from the literature and s, the absolute efficiency and the 
flux ratio are determined experimentally.
The K0,std values have been compiled by De Corte, (Cor87) using Au as the 
comparator element and therefore may be used for any irradiation, counting 
conditions and comparator, (except Au), after making modifications, which include 
adding a comparator conversion ratio to eqn. 3.23, (this means along with the samples 
a suitable comparator should be irradiated along with the samples). After determining 
flux ratio, efficiency and specific activities for the comparator and standard, the K0iStd 
values may be modified for the irradiation and counting conditions used for the 
analysis. This has been discussed in more detail by Arshad, (Ars91). The K0 method 
is the method used for analysis of the samples at the IRI, Delft and the comparator 
used was Zr.
3.3.6 Flux Monitors
To correct for neutron flux variations both vertically down and horizontally across a 
container containing samples and reference standards, normally, a foil or a wire is 
used. Flux variations are significant as neutron flux falls off with distance away fron 
the reactor core centre. It is also important to note that any changes in the core 
configuration could cause dramatic changes in the flux. Therefore it is important to 
measure the variations in flux and then correct for them. The choice of material is 
important and should give an accurate measurement of the thermal and epithermal 
flux.
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Zr was chosen because it has isotopes which can measure the thermal flux Zr95 
through 94Zr(n,y)95Zr ti/2=64.02d, 724.20 keV, (isotopic abundance 44.1) and 756.73 
keV, (isotopic abundance 54.5) and the epithermal flux Zr97 through 96Zr(n,y) 97 Zr 
which measures the epithermal neutron flux, t1/2==16.9h, emitting a wide range of 
gammas, table 3.4, (Bla96). Zr wire is also available in high purity form and can be 
cut to the required length.
In initial measurements carried out in this work, the Zr flux monitor was a problem 
because during irradiation, the Zr wire was heated and consequently curled up, so it 
was not possible to use. The only possible solution then was to place the flux monitor 
in thin quartz vial (protecting it from the heat), thus accurately remaining in a fixed 
position and then also having the same geometry for counting on the detector. Quartz 
wool was also used in an initial irradiation to keep the quartz vials and Zr monitor in 
place.
3.3.7 Irradiation and counting times
Long irradiations of 12 hours for the reference materials, samples and flux monitor to 
measure the long lived radionuclides, were carried out at HFR, Petten and IRI, Delft. 
The irradiation facilities are described in chapter 4.
After samples were irradiated at the JRC, Petten, two weeks later, decanning took 
place at Petten and the samples were placed in a clean polyethylene tube and sent to 
Ispra by special courier for counting. Samples were counted immediately, initially for 
three hours and then a week later for five hours and then two weeks later for five 
hours. All samples were counted on the same Ortec HPGe detector. The 
characteristics of this detector are described in chapter 4.
At IRI, Delft, samples were irradiated for 12 hours and samples were unpacked and 
counted four days later for one hour on the Ortec Ge(Li) detector (5cm from the 
sample) and then a week later for two hours on the Canberra Ge well type detector 
and after a waiting period of two weeks, for two hours again on the well type detector.
I l l
In the brain tissue analysed 24Na with (ti/2=14.9h) dominates the spectrum after 
irradiation. After a week, 24Na has decayed then isotopes such as 82Br (ti/2=1.4708d) 
are observed and bremstrahlung radiation from the beta decay of 32P(ti/2=14.28d).
Then after two weeks other elements such as 86Rb (t1/2=18.66d), 59Fe (ti/2=44.496d) 
may be seen and after four weeks, 75Se, (ti/2=119.77d) and 65Zn (ti/2=244.1d) 
Therefore making use of the waiting times maximises the number of elements to be 
determined.
3.3.8 Pile-up and the Puiser Method
Peak pile-up occurs when two consecutive amplifier pulses overlap and generate a 
single output pulse. At high count rates the spectrum is distorted compared to its 
shape at low count rates and it also interferes with measurements based on calculating 
the area under the full energy photopeak, (Deb89).
The most effective way of correcting for errors in the area of the full energy 
photopeak, introduced by pileup is to use the puiser method. The amplitude of pulses 
from a generator create an artificial peak in the spectrum in a location that does not 
interfere with the peaks. Since the number of pulses injected from the generator can 
be accurately determined a measurement of the area under the puiser peak gives the 
number of pulses, so the ratio of expected to measured counts may be calculated and 
this fraction is applied to the signal pulses to allow for correction of the measured 
peak. The puiser method was applied to both the samples counted at the JRC, Ispra, 
Italy and the IRI, Delft, Netherlands.
3.3.9 Computer Analysis of Spectra
The samples irradiated at Petten were sent to Ispra for counting and the program used 
was NED A developed by Ascom1. The NEDA software consists of the main EXE 
program, MAINE The MAINE EXE contains the following programs, ACT (file 
containing weights of standards and samples), LAVACT, (work code given to each 
sample), LIBRERIE, (library which contains the isotopes of interest and the 
concentration of the standards), TARATURE, (files for shaping parameters, energy
1 ASCOM, NEDA, Author, Aurelio Galbersanini, ASCOM, 38, Via Clericetti, 20133, Milan, Italy.
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Table 3.4 : Gamma ray energy and abundance from the 96Zr(n,y)97 Zr reaction,
(Bla96).
Energy of gamma rays from 
9^Zr(n,y)9 7 Zr(keV)
Isotopic Abundance 
%  Abundance
218.90 0.175
254.27 1.25
272.26 0.250
330.49 0 . 1 1 1
355.47 2.27
507.70 5.05
602.56 1.38
690.70 0.250
699.18 0 . 1 2 0
703.76 0.927
804.57 0.649
829.94 0 . 2 2 2
854.95 0.333
909.60 (S)*
958.03 (S)*
971.44 0.287
1021.19 1.35
1147.94 2.64
1276.13 0.974
1362.65 1.35
1402.21 (S)*
1503.41 (S)*
1548.39 (S)*
1750.50 1.35
1851.70 0.352
2105.97 (S)*
(S)* signifies sum peak
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and efficiency calibration), SPETTRI, (files for display and plotting of spectra) and 
LIST (file containing sample description, irradiation and counting parameters), 
TRANSFER allows spectra to be collected from the multichannel analyzer, CHAIN 
and CHAIN 1 carry out the data interpretation and CARICA is the program for loading 
each sample, either for counting or interpretation. Also in addition for this work two 
programs were created CHAJNAN and CHAINAN1, for extracting data to 
characterise the HPGe detector, such as FWHM and errors on peak areas.
The MAIN1 program creates files for each geometry used. In the work here a 152Eu 
point source was used CEA2 The gamma rays produced in its decay are shown in 
Table 3.5.
The peaks are fitted manually and are represented by a Gaussian function on a linear 
background. The values obtained from this fit are used for the determination of the 
polynomials for energy calibration, for the efficiency and for the peak shape. For the 
energy channel calibration, a first or second order polynomial is used for the fit taken 
from 2-10 centroids. The same peaks are also used for expressing the shape and 
efficiency. For the shape a first or second order polynomial is calculated which 
expresses the FWHM as a function of channels with a least squares fit. Both for the 
energy and shape, the coefficients of the polynomial in the calibration file are 
memorized and for the efficiency, the calculated centroid and the coefficients of the 
line that unites two centroids on a semilogarithmic efficiency channel background are 
memorised. In the subsequent calculation of the activity, the values of the local 
efficiency are obtained for interpolation of the line which contains the interval 
belonging to the centroid of the peak.
During measurement it is possible to control and modify the energy channel 
polynomial. It is possible also to subtract the background (the background as 
described by the author is the gamma ray spectrum obtained without a radioactive 
sample). During a series the first measurement is taken with no sample, then when a 
sample is measured the measured background may be subtracted.
2 CEA, Commissariat a L’Energie Atomique, Department des Applications e de la Métrologie des 
Rayonnements Ionisants. DAMRI/LMRI, BP-52, F-91193, Gif-Sur-Yvette, Cedex, Certificate 
D ’Etalonnage, (1993).
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A peak search is made by summing over a number of channels determined by the 
FWHM and searching for minima. Peaks are fitted when the distance between 
centroids is greater than 4 FWHM, these are fitted as singlets on a linear background, 
for peaks closer together they form a single fit where the function is represented by 
the sum of the gaussains on a second order background. The procedure of non linear 
fit consists of a minimization of chi squared with an iterative algorithm, advancing 
along the direction of the steepest descent of the gradient.
The area of the peaks are calculated from the height and FWHM obtained from the 
fit. The errors are obtained from an inverse matrix of curvature in the last phase of 
iteration. Peak areas are finally corrected for efficiency even though in the case of 
comparative analysis an efficiency correction is not necessary. An example of the 
output is shown in figure 3.5.
Figure 3.5. Example of output from a standard Europium Source
"prove tempo cont 13-21.6+1 
" 28"," 4"," 1993"," 12"," 0"
"2133046"
"C"," 5400"," 1"," 1 ","eleeu3+000000000000000000 
" 12.20383"
" .4836052"
"-8.502004E-08"
" 2.379985"
" 8.627044E-04"
" 2.315024E-08"
"  6 "
Channel Polynomial Fun. Polynomial Fun. Decay Area Local Efficiency 
" 226.5837"," 1.148613","-.9474542"," 6412320"," 7395"," 8.263077E-02" 
" 480.5625"," 1.148613","-.9474542"," 6412320"," 2376"," 4.053012E-02" 
" 686.4414","-.2173011","-.4381173"," 6412320"," 8400"," 3.466841E-02" 
" 1585.11"," 1.254804","-.957085"," 6412320"," 4185"," 1.556237E-02"
" 1967.939"," 1.391863","-.999915"," 6412320"," 4800"," .0125352"
" 2885.756"," .593213","-.7574599"," 6412320"," 6800"," 9.38005IE-03" 
"eu4312.tar"
"libeu.lhr"
"no"
"  0"
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NEDA gives no background area counts for the peaks found so difficulties were 
encountered in calculating the Minimum Detection Limit for the peaks found.
Samples irradiated at IRI are analysed using the software, developed by Blaauw 
(Bla93). A description will be given briefly because this work is described extensively 
in Blaauw’s doctorate thesis, (Bla93). Also the Reference Manual (Bla94) describes 
all software developed to form INAA using Apollo computers. Whilst most programs 
are based on the characteristic peak method where one peak from the sample is 
compared with one peak from the comparator, there may be interferences because of 
the presence or absence of other peaks, Blaauw (Bla93), uses a holistic approach 
which means that all peaks are interpreted from a sample at once.
The analysis of gamma ray spectra consists of reduction, standardisation and 
interpretation. Before the gamma spectra may be interpreted, the peak area in the 
spectra must be determined, the spectra must be reduced, Blaauw, (Bla93) defines 
spectral reduction as the final result of the process is a list of peak energies and areas 
which is represented in a much more compact way than the measured spectrum. The 
proportionality factor relating the peak areas to the elemental concentrations must be 
computed for all peaks expected in the spectra and the measured peak and expected 
peaks must be matched. This is the standardisation procedure. Blaauw (Bla93), uses 
the ko method, where the comparator used is gold. Interpretation is when a peak is 
matched to an element taking into consideration the presence or absence of other 
peaks to be expected from the same element. The method used to match the measured 
and expected peaks is the Linear Least Squares Method. A full description of this may 
be found in Blaauw’s thesis, (Bla93).
In the final report, the concentrations, their uncertainties and detection limits are 
listed. The reported error is the estimated accuracy of the concentration at at the 67% 
confidence interval. The estimated accuracy includes the uncertainties of the 
measured peaks, the uncertainty in the neutron flux during irradiation and 
uncertainties in the constants in the nuclear catalogue, (Bla94).
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The IRI laboratory is accredited and follow the relevant criteria from ISO 9001/9002. 
This accreditation covers the quality system of the laboratory as well as the software.
3.4 Conclusions
Three multielemental techniques have been described for the determination of a wide 
range of elemental concentrations
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Table 3.5 : Gamma ray energy and abundance from the decay o f 152 Eu (ti/2=T3 .3 3 y) 
(Bla96)
Energy of gamma rays 
emitted from 152 Eu (keV)
Isotopic Abundance 
% Abundance
121.78 213
147.96 0.0395
244.69 7.50
25E61 0.0625
269.83 8.13E-3
270.53 1.95E-3
270.78 (E r
271.13 0.0729
295.93 0.441
315.17 0.0504
324.81 0.0750
329.42 0 . 1 2 2
340.46 0.0275
344.29 260
357.12 4.79E-3
366.47 (S)*
367.80 0.858
386.00 (E r
411.12 2 . 2 2
416.05 0.0974
417.71 (S)*
44189 2.79
443.98 0.285
488.61 0.408
493.51 0.0266
503.41 0.152
511.00 0.0520
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Table 3.5 cont.
520.24 0.0537
534.26 0.0429
564.01 0.458
565.67 (S)*
566.42 0.129
586.30 0.461
615.42 (S)*
656.48 0.145
674.70 0.168
678.59 0.469
688.67 0.865
712.09 (S)*
712.86 0.0958
719.33 0.0594
719.42 0.266
755.41 (S)*
759.42 (S)*
764.90 0.180
768.95 0.0729
778.92 13.0
810.45 0.333
841.58 0.165
867.38 4.20
919.39 0.438
926.31 0.264
930.59 0.0753
964.11 14.5
989.16 (S)*
1005:26 0.658
1 0 2 2 . 0 0 (S)*
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Table 3.5 cont.
1 0 2 2 . 8 8 (S)*
1041.17 (S)*
1085.89 9.92
1089.71 1.70
1109.19 0.183
1112.07 13.6
1123.21 (S)*
1163.31 (S)*
1171.00 0.0356
1212.93 1.41
1233.85 (S)*
1249.95 0.186
1292.78 0 . 1 0 2
1299.16 162
1334.50 (S)*
1334.71 (S)*
1363.75 0 . 0 2 2 2
1408.00 2 0 . 8
1434.00 (S)*
1457.62 0.495
1528.12 0.291
1529.78 (S)*
1579.40 (S)*
1605.63 7.38E-3
1608.44 4.03E-3
1635.24 1.45E-4
1643.45 (S)*
1649.90 (S)*
1769.07 4.38E-3
(S)* signifies sum peak and (E)A signifies escape peak
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CHAPTER 4
Experimental Arrangement and Operating Conditions
Inductively Coupled Plasma Mass Spectrometry
4.1.1 Introduction
To obtain the maximum signal intensity across the mass range it is necessary to 
maximise the instrumental parameters. Details of the operating conditions for the 
Perkin Elmer SCIEX ELAN 6000, with a cross flow nebuliser for sample introduction 
and peristaltic pump are described below.
4.1.2 Influence of Instrument Parameters on ICP-MS Analysis
Sampling position, power and nebuliser gas flow affect analyte ion, polyatomic ion 
and doubly charged ion intensity. They interact together so for each RF power the 
optimum analytical conditions were obtained for the selected power.
The sampling position was identical for all analyses. Moving the torch towards the 
sampling orifice reduces first increases then decreases M+ and increases MO+. 
Increasing the RF power dissociates oxide ions more efficiently. For MO+ the oxide 
level drops and for M+ the analyte signal increases however increasing power leads to 
an increase of doubly charged ions, so it is important to find the optimum. See 
Figures 4.1 from the Perkin Elmer Training Course Manual, (Per99).
Increasing the nebuliser argon flow, increases then decreases M*. The increased 
nebuliser flow reduces the plasma temperature thus decreasing M ^ and increases 
MO+, see Figure 4.2, from the Perkin Elmer Training Course Manual, (Per99). 
However, the best comprimise for sensitivity, noise, oxide and doubly charged ion 
levels is achieved within a small RF power range. For normal sample types the RF 
power should be within 1000W to 1150W. Higher powers from 1200-1300W are 
recommended, (Per99) for use with organic solvents; since nebuliser gas flow 
decreases with increasing amount of alcohol, the rf power may be increased. 
Gammelgaard, (Gam99) used an rf power of 1300W because any higher causes 
unnecessary wear of the sampler and skimmer cones.
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Figure 4.1: Influence of Increasing RF Power on Ions, (Per99)
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Figure 4.2: Influence of Increasing Nebuliser Gas Flow on Ions, (Per99)
++
Intensitv
Increasing Nebulizer Argon Flow
127
4.1.3 Optimisation Solutions ;
For the ELAN 6000, there is only one ion lens to optimise, simplifying instrument j 
optimisation and this was optimised across the entire mass range using the autolens j 
procedure. The autolens was calibrated using 3 analytes. Be, Co and In. These | 
elements, represent the mass range and also have well defined lens mountains. Perkin 
Elmer recommends a lens calibration in a typical sample matrix, thus a brain sample 
was spiked with Be, Co and In. The lens voltage increases, after each optimisation, 
due to particle accumulation on the lens from the matrix. The lens was removed and 
cleaned every two weeks.
A 10 pg/L multielement solution containing (Ba, Ce, Mg, Rh, Pb) was used for 
optimising the nebuliser gas flow and then checking the instrument performance. This 
was carried out each time the plasma was switched on. Ba was used to make sure that 
ratio of Ba^/Ba4" was <0.03 and Ce was used so that the ratio of CeO/Ce <0.03. The 
maximum sensitivity of the nebuliser flow rate was achieved and then to achieve a 
low oxide ratio, the maximum sensitivity was compromised. Table 4.1 shows the net 
intensity mean (cps) for 24Mg, 103Rh and 208Pb over a period of five months (one per 
month, taken from between the 1 0 th and 2 0 th of each month), when a large part of the 
human brain analysis took place. As can be seen the values are much greater than the 
performance specifications given by Perkin Elmer, given in chapter 3.1.4
Table 4.1 shows the net intensity mean (cps) for Mg, Rh and Pb over a period of five 
months, one per month, taken from between the 1 0 th and 2 0 th of each month.
Month, 1999. Average Mean Intensity ± SD (cps)
"4Mg 103 Rh 20Spb
May 100680 ±612 464497 ±1540 570899 ± 3745
June 88535 ± 8 6 8 406719 ±2650 977387 ± 6963
July 86336 ± 225 373731± 1409 730803 ±1130
August 68387 ±1016 207491 ±1103 308411 ±1673
September 112481 ±717 740268 ±5154 702399 ±5157
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4.1.4 Selected Elements
The following elements were analysed as internal standards to determine the 
endogeneous content of these elements in the porcine brain tissue 9Be, 45Sc, 69Ga , 
89Y, 93Nb, 103Rh, 193Ir, 232Th, 209Bi. It was found that the porcine brain sample 
contained the lowest amounts of the following elements 9Be, 89Y, 193Ir, so these 
elements were selected. 115In was also later analysed and selected for use with inCd. 
115In and 193Ir have some potential interferences, shown below in Table 4.2.
Table 4.2 Potential Interferences for 115In and 193Ir used as internal standards in this 
work
Analyte Mass Corrections Potential Interferences
In 114.904 Sn, MoO
Ir 192.963 -0.014032*Sn 118 HfO, LuO
The chosen isotopes of the elements were as follows; 7Li with 9Be as internal 
standard, 55Mn, 57Fe, 65Cu, 67Zn and 82Se with internal standard 89Y, n iCd with 
internal standard 115In and 202Hg, 208Pb with internal standard 193Ir.
Most of the important elements for biological samples are between 40 and 80 in mass 
where many polyatomic species containing Ar, H and O or tissue major elements 
overlap. These spectral interferences are a problem when there is no isotope free from 
intereferences and it is difficult to apply a mathematical correction method using the 
natural abundance of the isotope, (Goo94).
For the elements determined in this work, the possible interferences are shown below 
in Table 4.3.
82Se was corrected for from the 83Kr interference using the equation intensity mass
82-1.008696* 83Kr. The doubly charged ions are all in low concentrations and should
not introduce errors.
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Table 4.3 Potential Interferences for all the isotopes of the elements relevant to this 
work, (Per99), (Hse99)J
Analyte Mass %  Abund. 
(Iup91)
Corrections Potential Interferences
Li 6 Li (7.5) - -
Li 7 Li (92.5) - -
Mn 55 Mn (100) 4"Ar15NH+, 40Ar15N+, 37C1180 +,
39k 16o +
Fe 54 Fe(5.28)
Cr(2.38)
-0.028226 * Cr 52 54Cr+, 37C1160H+, 40At14N+
Fe 56 Fe (91.72) - 40Ai16O+, 40Ca16O+
Fe 57 Fe(2.19) - 40Ca17O+, 40Arl6OH+, 40Ca16OH+
Fe 58 Fe (0.33) 
Ni (67.84)
-2.596080* Ni 60 5SNi+ 40Cal(fo + 40^18(3+ 23Na35c l+
Cu 63 Cu (69.09) - 40Ar23Na+, 47Ti,60 +, 31P160 2+
Cu 65 Cu (30.91) 31P170 2+, 48Ca16OH+, 48Ca170 +,
33s 16o 2+, 32s 16o 17o +, 32s 33s+,
130Ba ++, 49Ti160 +,
Zn 64 Zn (48.89) 
Ni (1.08)
-0.035313 * Ni 60 64Ni+, 49Ti,60 +, 48Cal60 +,
3 IP160 170 +, 32s 16o 2+, 32s 32s+
Zn 6 6 Zn (27.81) 50Ti16O+, 34S160 2+, 33S160 2H+, 
33S160 I80 +, 32S34S+, 132B a++
Zn 67 Zn(4.11) 34s 16o 16o h +, 32s 16o 18o h +, 51v 16o +,
40Ar17P+, 35C1160 2+, ""Ba^
Zn 6 8 Zn (18.56) 36s  16o 2+, 34S 160 1S0 +, 32s 36s+,
36A r32S+, 136B a++, '“ C e-34’
Zn 70 Zn (0.6) - 34S36S+, l38B a++, i38Ce **
Se 74 Se (0.89) 37C12+, 4ùAr34S+, 74Ge+, 148Sm++,
l48Nd++
Se 76 Se (9.36) 36Ar40Ar+, 38Ar38Ar+, 40Ar36Ar+, 
31P2 14N+, 152Sm4+, 152Gd++
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Table 4.3 cont. Potential Interferences
Se 77 Se (7.63) 40Ar37Cl+, 40Ar36ArH+, 1MSm++, 
154Gd4+
Se 78 Se (23.78) 38Ar40Ar+, 3 IP2 160 +, 156Dy++, 
l56Gd++
Se 80 Se (49.61) - 40Ai2+, "BrH+. '“ Dy-n-, '“ G tT
Se 82 Se (9.19) 
Kr (11.56)
-1.008696 *Kr 83 82Kr+, 4t,Ar2H+, slBrH+, V W  
’“ E r", '“ Dy44"
Cd 106 Cd(1.25) 
Pd (27.33)
106Pd+, 88Sr 180 +,
Cd 108 Cd(0.89) 
Pd (26.46)
108Pd+, 92Mo160 +,
Cd 1 1 0 Cd (12.49) 
Pd (11.72)
noPd+, 94Mo160 +,
Cd 1 1 1 Cd(12.8) - 95Mo160 +
Cd 1 1 2 Cd(24.13)
Sn(0.97)
n2Sn+, 96MoI60 +
Cd 113 Cd (12.22) 
In (4.3)
113In+, 9 /Mo160 +
Cd 114 Cd (28.73) 
Sn(0.65)
114Sn+, 98Mo160 +
Cd 116 Cd(7.49) 
Sn (14.53)
""Sn4  m"Mo160 4
Hg 196 Hg(0.15)
Pt(29.3)
i96pt+ i»i\vl60 4, 
180Ta16O4
Hg 198 Hg(9.97)
Pt(7.2)
198Pt4, 182W160 4
Hg 199 Hg (16.87) - l83w 16o +
Hg 2 0 0 Hg(23.1) - l84w 16o 4
Hg 2 0 1 Hg (13.18) -
Hg 2 0 2 Hg (29.86) - 186W!60 4
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Table 4.3 cont. Potential Interferences
Hg 204 Hg(6.87) 
Pb (1.4)
l86W180 +
Pb 204 Pb (1.4) 
Hg(6.87)
Pb 206 Pb(24.1) -
Pb 207 Pb(22.1) -
Pb 208 Pb (52.4) -
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The 81BrH interference may be a problem and the results from the Certified Reference 
Material for Se are discussed in chapter 5. The correction for Kr made very little 
difference and results with and without the equation were almost identical.
The extent of the interferences, (Table 4.4) on Fe, Cu and Zn, on a porcine brain 
sample from S and Cl were checked by addition of approximately 1% ultrapure 
H2 SO4 and HC1.
Table 4.4 The extent of the interferences on Fe, Cu and Zn, on a porcine brain sample 
from S and Cl by addition of approximately 1% ultrapure H2SO4 and HC1.
Analyte Reduction of S 
signal (%)
Reduction of Cl 
signal (%)
54Fe No signal No signal
y/Fe 15% 0 %
58Fe 19% 0 %
63Cu 19% 4%
64Zn No signal 1 1 %
65Cu 29% 3%
66Zn 6 8 % 1 1 %
67Zn 64% 18%
68Zn 6 6 % 1 2 %
From these results it can be seen that S interferences may be a problem in determining 
Cu and Zn in brain tissue and increases in S from sample to sample may significantly 
reduce the signal, so the choice of calibration and internal standard for determining 
these elements is extremely important.
It is also important that when the sample is completely digested it is free from fat and 
that no organic interferences or nébulisation effects can be present, so accuarate 
results may be obtained. Thompsen, (Tho98) found that a full fat sample weight of 
less than 300 mg digested in a microwave oven resulted in less than 0.1% residual 
content. In this work all sample weights were below 180 mg.
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The delay time was 40 seconds with a pump speed of 24 rpm requiring approximately 
3 minutes per analysis using 4.5 mL sample. A wash solution of 2% HNO3 was used 
between analysis of samples. The wash time between each sample was three minutes 
at a pump speed of 48 rpm.
4.1.5 Calibration Method
The calibration methods have been previously described in chapter 3. In this work, 
the additions calibration coupled with internal standard has been used. The internal 
standard alone does not always appropriately correct for interferences, (Moe94), eg 
Ejima et al., (Eji97) found in their measurements of Central Nervous Fluid, As, Cd, 
Hg, Se and Zn could not be corrected for with internal standard. Additions calibration 
is a derivative of the method of standards addition, (Pru98) and is used for batches 
having the same composition, where standard spikes are added to a single 
representative sample thus eliminating the need to spike every sample. It is a method 
routinely used in clinical chemistry, (Pru98).
4.2 Atomic Absorption
A Perkin Elmer SIMAA 6000 (Norwalk, USA) was used for determining Cu, Mn, Cd 
and Pb. Hollow cathode lamps were used for all element measurements except 
cadmium for which an electrodeless discharge lamp was used. The furnace system of 
the SIMAA 6000 is a Transverse Heated Graphite Atomiser, (THGA), this allows a 
uniform temperature profile over the entire tube length. Transverse heating ensures 
that the tube ends reach the same temperature as the tube centre. The THGA graphite 
tube also includes an integrated L’vov platform. The L’vov platform is heated 
indirectly by radiation from the tube walls, this delays the vaporization and 
atomization of the sample until the furnace atmosphere has reached equilibrium 
conditions. The parameters for determining the elements Cu, Mn, Pb and Cd are 
shown in Table 4.4.
A Perkin Elmer 5100 Atomic Absorption Spectrometer (Norwalk, USA) was used for 
determining Se and Li with transversely heated graphite furnace with a tube with a 
L’vov platform. A hollow cathode lamp was used for Li determination and an
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electrodeless discharge lamp was used for Se. The parameters are shown below in 
Table 4.5. - |
! ■ ; 
! The following parameter which were common for all elements were peak area and j
j argon gas was used to protect the graphite tubes with an internal flow rate of 250
| mL/min and a gas stop in atomisation step.
i
For Li, the atomisation temperature is important and was selected as low as possible 
to minimise emission from the hot graphite tube.
For Li, Cd and Pb the sample was injected five times to increase pre-atomisation 
sensitivity. i
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Table 4.4: Instrumental Parameters for Determining Cu, Mn Pb and Cd in Digested
Porcine Brain Tissue.
Element Cu Cd Pb Mn
Instrument SIMAA 6000 SIMAA 6000 SIMAA 6000 SIMAA 6000
Wavelength 324.8 nm 228.8 nm 283.3 nm 279.5 nm
Background Zeeman Zeeman Zeeman Zeeman
Correction
Measurement Peak area Peak area Peak area Peak area
Read Time 3.0s 4.0s 4.0s 2.5s
Delay Time 0 .0 s 0.5s 0.5s 0 .0 s
Diluent 0 .2 % HNOg , 0 .2 % HNOg , 0 .2 % HNO3 , 0 .2 % HNO3 ,
0.05% Triton 0.05% Triton 
X -lO O
0.05% Triton 
X--IOC)
0.05% Triton
x - \ o o
Sample vol 5 jaL 30 pL 30 p i 1 0  pL
Diluent vol lOjaL 1 0  pL 1 0  p i 1 0  p i
Matrix mod. None None None None
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Table 4.5 Instrumental Parameters for Determining Se and Li in Digested Porcine
Brain Tissue.
Element Li Se
Instrument 5100 5100
Wavelength 670.8 nm 196.0 nm
Background
Correction
Zeeman Zeeman
Read Time 5.0s 5.0s
Delay Time Os 0s
Diluent 0.2%HNO3 0.2% HNOg
Sample vol 30 pL 15 jliL
Diluent vol 1 0  pL 15 pL
Matrix mod 
volume
5 pL 1 0  pL
Matrix Modifier 1000 ug/mL Palladium 50 ul 1000 ug/mL MgN 
500 ul 1000 ug/mL Pd 
450 ul 1000 ug/mL Ni
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Table 4.6 Furnace programmes for elements Cu, Cd, Pb, Mn, Li, Se.
Element Cu Cd/Pb Mn Li Se
Step 1 (°C) 130 1 1 0 1 1 0 90 130
Ramp (s) 40 30 1 0 1 30
Hold (s) 2 0 30 2 0 1 1 0
Step 2 (°C) 700 250 130 1 2 0 130
Ramp (s) 2 0 30 15 30 30
Hold (s) 1 0 2 0 2 0 30 1 0
Step 3 (°C) 2 0 0 0 1600 800 900 1 1 0 0
Ramp (s) 0 0 2 0 5 2 0
Hold (s) 5 4 5 30 2 0
Step 4 (°C) 2450 2500 1300 2 0 2 0
Ramp (s) 1 1 1 0 1 2
Hold (s) 3 8 15 4 3
Step 5 (°C) 2 0 2300 2 1 0 0 1900
Ramp (s) 2 0 0 0
Hold (s) 5 4 5 5
Step 6  (°C) 2400 2400 2700
Ramp (s) 1 1 1
Hold (s) 3 5 5
Step 7 (°C) 2 0
Ramp (s) 2
Hold (s) 8
Read step Step 4 Step 3 Step 5 Step 5 Step 5
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4.3 Neutron Activation Analysis
4.3.1 Irradiation Facilities of HER, Petten
Samples were irradiated at the High Flux Reactor (HFR) Petten, The Netherlands. The 
HFR reactor is a tank, pool type, light water cooled and moderated and operated at 45 
MW. The reactor uses highly enriched uranium as fuel. The most important locations 
for placing experimental facilities to irradiate material samples are the 19 in-core 
positions, the 12 positions in the large pool side facility (PSF I) and the 10 positions 
in the small, low flux, pool side facility, Table 4.7. Most of the material irradiations 
are carried out in the in-core positions and PSF I. Figure 4.3 shows the standard core 
configuration with nuclear values and permanently installed experimental reactor 
facilities, (Ahl93).
Table 4.7 The fluxes of the most important experimental facilities.
Irradiation Position Maximum fluxes available for 
experiments (lO^cm'V1)
Thermal fast (E>0.1 MeV)
Core central 1.5 4.6
Core reflector 1.4 2.7
Pool PSF I 2.7 0 . 6
Pool PSF n 0.32 0 . 0 2
Taking into account the nature of the irradiations, two possibilities were available the 
HFPIF, (High Flux Pool Side Isotope Facility) and HIP, (High Flux Isotope 
Production), both having thermal flux 2.5*1014 cm'V 1 and fast flux (E>0.IMeV) 
0.35* 1 0 14 cm'V 1 (data measured using Ir wires), (Tar97).
There are four positions on the pool side facility in which the rig HFPIF may be 
installed and in the rig there are five positions for placing the cans. The thermal fluxes 
are shown in the Table 4.8. HIP is always placed in PSF9.
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Figure 4.3: Standard Core Configuration with Nuclear Values, (Eur93).
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Table 4.8: Thermal Fluxes in Row 2 of HFPIF positioned on rails 5, 7, 8 , 9 of the Pool 
Side Facility
PSF
Position
No.
2 -1 *
Thermal
Flux
(cm'V1)
2 -2 *
Thermal
Flux
(cm'V1)
*2-3
Thermal
Flux
(cm'V1)
*2-4
Thermal
Flux
(cm'V1)
*2-5
Thermal
Flux
(cm'V1)
5 1.57E+14 1.80E+14 1.84E+14 1.62E+14 1.32E+14
7 1.95E+14 2.02E+14 1.92E+14 1.63E+14 1.24E+14
8 1.72E+14 1.90E+14 1.84E+14 1.65E+14 1.34E+14
9 1.62E+14 1.79E+14 1.73E+14 1.51E+14 1.28E+14
* Position 2-5 means row 2 capsule 5.
Values given are for the centre of the capsules
For the irradiations carried out in this work, the HFPIF was used.
For long lived irradiations Suprapure quartz (Hereaus) was chosen as it not activated 
to a great extent and can withstand any radiation damage or heating effects. Also 
Heydom (Hey82) found that with polyethylene containers selenium and mercury were 
lost through the walls and thus used quartz.
The quartz vials were wrapped in A1 foil and a piece of Zr wire was placed in each A1 
can for neutron flux measurements. Figure 4.4 shows the arrangement.
At Petten, A1 containers are used for the irradiation of long lived radionuclides which 
require activation with a high neutron flux as they activate to produce only a short 
lived radionuclide and do not need to be unloaded immediately after irradiation. Also 
A1 is added to the cans to bring them to sinking weight before irradiation (»40g).
After irradiation the samples were washed in 10% Nitric acid and then rinsed in 
Millipore (18 Mfl) water to remove any contaminants on the outside of the quartz 
that may have been activated.
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Figure 4.4: Schematic Arrangement of the Samples.
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4.3.2 Characterisation of GeLi and HPGe Detectors at Ispra
In all the methods described in chapter 3, in partciular for the absolute method, proper 
calibration of the detector is required.
The characterisation of detectors involves energy calibration of the gamma-ray 
spectroscopy system, measurements of the detector energy resolution and detection 
efficiency and investigation of its effective interaction depth.
4.3.2a Calibration of Channel Number Versus Energy
The counting room until the end of 1996, consisted of four germanium detectors, one, 
'two', 'three' and 'four'. ‘One’ was then replaced with the new 'five'. However, because 
only one puiser was available it was only possible to use one detector at a time. So 
‘three’ was chosen on the basis that it was a HPGe detector and had higher efficiency, j 
Each of the detectors were coupled to a 4000 channel analyzer equipped with an i 
automatic sampler changer equipped with a mechanical stopping mechanism accurate 
to 1mm. The spectra was analyzed with the NED A software described in chapter 3 . j 
The detectors were in lead castle which shields against environmental background 
radiation. The characteristics of HPGe for determining elemental concentrations in 
biological samples is shown below with GeLi as a comparison.
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The values of resolution and efficiency as measured for this work are quoted later and 
the data given in tables 4.9 and 4.10 are the manufacturers values.
Table 4.9: GeLi Dectector Specifications
Coaxial GeLi detector
Date of Shipment 11/83
Model Number 8111-25200E
Serial Number 18-7391
Bias Voltage + 4000 V
Detector diameter and length respectively 52.0 mm and 61.0 mm
Absorbing layers and thickness Aluminium 0.5 mm. 
Teflon 1mm
Endcap to crystal distance 5 mm
Measured efficiency %: Ratio of area under photopeak to 
that of 3"*3" Nal(Tl). Measured at 1.333 MeV, source to 
detector distance of 25 cm, at 3 ps amplifier time 
constant
26.0%
Measured total resolution, FWHM using 1.333 MeV 
photons, at 3 ps amplifier time constant
1.84keV
Measured Peak/Compton: Ratio of peak height to 
Compton plateau height, at 3 ps amplifier time constant
51/1
Warranted efficiency %: Ratio of area under photopeak to 
that of 3"*3" Nal, measured at 1.333 MeV, source to 
detector distance of 25cm
25%
Warranted system resolution, using 1.333 MeV photons 2.0keV
Warranteed Peak/Compton: Ratio of peak height to 
Compton plateau height
48/1
Total active volume cm3 -
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Table 4.10: HPGe Detector Specifications
LABEN 3 HPGe Coaxial detector
Date of Shipment 7/16/84
Model Number GMX-25200
Serial Number 24-N-96V
Bias Voltage -2500V
Detector diameter and length respectively 54.1mm and 68.3mm
Absorbing layers and thickness Beryllium 0.5 mm
Endcap to crystal distance 3mm
Measured efficiency %: Ratio of area under photopeak to 
that of 3"*3" Nal(Tl). Measured at 1.333 MeV, source to 
detector distance of 25 cm, at 3 ps amplifier time 
constant
32.4%
Measured total resolution, FWHM using 1.333 MeV 
photons, at 3 ps amplifier time constant
1.84keV
Measured Peak/Compton: Ratio of peak height to 
Compton plateau height, at 3 ps amplifier time constant
59.7/1
Warranted efficiency %: Ratio of area under photopeak to 
that of 3"*3" Nal, measured at 1.333 MeV, source to 
detector distance of 25cm
25%
Warranted system resolution, using 1.333 MeV photons 2.0keV
Warranteed Peak/Compton: Ratio of peak height to 
Compton plateau height
46/1
Total active volume cm3 -
The experimental arrangement is shown in Figure 4.5. A source holder was 
constructed to hold the source in a reproducible position along the axis of the 
detector. The maximum variation in distance between the detector window and 
source was 22.6cm +/- 0.1 cm. This was the maximum height possible, due to the lead 
castle surrounding the detector.
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Figure 4.5: Frontal View of geometrical Settings for GeLi and HPGe Detectors
height of ’stand
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.+/- 0.1 cm
thickness
0.3 cm  +/- 0.1 cm  
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1cm  +/- 0,1 cm  lor 
1/  labens 3 and 4
7 2 cm  +/- 0.1 cm  for
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(Not drawn to scale)
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The calibration of the gamma-ray counting system was performed by using a set of 
standard sources. Four point sources 2 4 1  Am, 1 3 7Cs, 80Co and 1 3 3Ba, (sources from 
Amersham, where the activity was measured on 1/12/1984 at time 12:00, GMT), 
Table 4.11, were placed at the highest distance possible from the detector along its 
axis which was 23.6 cm for GeLi and 22.6 cm for HPGe .
Table 4.11: The Activity (pCi), Half Life (years). Gamma Ray Energies (keV) and 
Gamma Ray yield per disintegration (%) of the set of sources used for calibration of 
the gamma ray counting system.
Source Activity
(pCi)
Accuracy
(%)
Half Life 
(years)
Gamma-ray 
Energies (keV)
Gamma-ray 
yield per 
disintegration 
(%)
24'A m 11.18 5.0 432.7 ±0.5 59.537 ± 0.002 35.9 ± 0.3
'33Ba 10.87 4.8 10.5 ±0.1 80.998 ± 0.005 34.1 ± 0.5
10.5± 0.1 302.853 ± 0.001 18.32 ± 0.07
1 0 .5± 0 . 1 356.017 ± 0.002 62.0 ± 0.3
^Co 12.14 1.9 5.27± 0.02 1173.231 ± 0.030 99.88
5.27 ± 0.02 1332.508 ± 0.015 99.98
'37Cs 11.91 3.7 30.15 ±0.06 661.660 ± 0.003 84.7 ± 0.3
The spectrum was collected for a period of 30 minutes . At this distance this is long 
enough to produce a good pulse height spectrum and to determine the peak position 
reasonably accurately. A print out of all the channels with the corresponding counts 
was produced.
The settings of the amplifier gain were not altered whilst performing the above, so as 
not to alter the position of the photopeak. The settings of the amplifier gain are shown 
in Tables 4.12 and 4.13.
146
Table 4.12: The settings of the amplifier gain for GeLi
GeLi 2
AMPLIFIER ORTEC 572
Amplifier fine gain 7.50 ±0.01
Coarse gain 2 0 . 0
Shaping time 3 jus
Table 4.13: The settings of the amplifier gain for HPGe
HPGe 3
AMPLIFIER ORTEC 572
Amplifier fine gain 9.70 ±0.01
Coarse gain 2 0 . 0
Shaping time 2  p.s
The dead time for each source is shown in Table 4.14.
Table 4.14: The dead time (%) of GeLi and HPGe for the set of standard sources.
Source Dead Time 
Ge(Li) at
23.6 cm (%)
Dead Time 
HPGe at 
2 2 . 6  cm (%)
" 'A m 1 0
1 3 3 Ba 4 3 .
6 0  Co 4 1
1 37 Cs 4 2
Figures 4.6 and 4.7 show a linear relationship between the gamma ray energy and the 
channel number.
The uncertainties reflect the inaccuracies in the energy and channel locations of the 
energy calibration peaks, expected drifts in the detector system and errors in the 
energy determination itself.
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Figure 4.6: GeLi Detector
0 0
Y = A + B * X
0 0 Par. Value Err.
A 19.29 0.05 
B 0.59 3.92E-50 0
Regression R = 0.9990 0
0 0
0 0
0 0
0 0
0 0
0
C h a n n e l  N u m  b e r
Figure 4.7: HPGe Detector
Y = A + B * X
Par. Value Err.
A 12.18 0.003 
B 0.48 2.2E-6
Regression R = 0.999
Figures 4.6 and 4.7 Showing A Linear Relationship Between the 
Gamma Ray Energy and the Channel Number for the GeLi and 
HPGe Detectors
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4.3.2b Energy Resolution
The energy resolution of the detector (FWHM) was measured for different energies 
using different standard sources at the distances mentioned previously. For this 
measurement 1 5 2Eu, Table 4.15 was also used with the previous mentioned standard 
sources. The 152Eu source was from CEA, where the activity was measured 19/7/1993 
at time 12:00, GMT.
Table 4.15: The Activity (kBq), Half Life (years). Gamma Ray Energies (keV) and 
Gamma Ray yield per disintegration (%) of the 152Eu source used for calibration of
the gamma ray counting system.
Source Activity 
(kBq) ± 
(%)
Half Life 
(years)
Gamma-ray 
Energies (keV)
Gamma-ray yield 
per disintegration
(%)
1 5 2 Eu 62.19 + 5 13.53 + 0.03 121.78 ±0.0004 0.284+ 0.0015
244.70 + 0.0010 0.075 + 0.0005
344.28 + 0.002 0.265+ 0.0018
443.98+ 0.007 0.031 ±0.0002
778.90+ 0.006 0.129+ 0.0007
964.13+ 0.009 0.146 ± 0.0008
1085.91 + 0.013 0.101 ±0.0004
1 1 1 2 . 1 2  ± 0.017 0.136 ± 0.0006
1408.01+0.015 0.208 ± 0 . 0 0 1 2
The energy resolution R is defined as FWHM divided by the location of the peak 
centroid.
E
The resolution of both detectors usually quoted for the 1332 keV peak of the 60Co at 
this energy was found to be for GeLi2, 3.28 ± 5.1E-8 keV and for HPGe3, 1.81+ 1.3E-
149
8  keV. These values, compared with the typical values (1.8-2.0 keV) are higher than 
expected for GeLi , according to manufacturers specifications.
Practically, resolution loss is due mainly to the statistical broadening of the peak, so 
in this case, assuming Poisson statistics, the variation of resolution with gamma ray 
energy is simply the FWHM of the peak and is proportional to the square root of the 
gamma ray photon energy.
Figures 4.8 and 4.9 shows the variation of the FWHM2  versus the gamma energy 
which is the relationship in the number of charge carriers. Using the gradient, the 
detector Fano factor was found to be GeLi' , 0.29 ± 0.02 and for HPGe 0.17± 0.01 
where the Fano factor is used to quantify the difference of observed statistical 
fluctuations in the number of charge carriers from pure Poisson statistics. Alamin 
(Ala95), in his work, found a Fano factor of 0.14 ± 0.02 for their GeLi detector.
4.3.2c Absolute Efficiency
The detector efficiency is important since not all the gamma energy emitted may be 
detected. To determine the activity of a sample it is necessary to have an efficiency 
which relates the number of pulses counted to the number of photons incident on the 
detector, (Kno89). It is convenient to subdivide counting efficiencies into two classes, 
absolute and intrinsic.
Absolute Efficiency = Counts in full energy photopeak per unit time/Activity of the 
source in terms of full energy photopeak efficiencies (Bq)
Intrinsic Efficiency = Counts in full energy photopeak per unit Time/ Number of 
gamma rays of energy of interest incident on the detector crystal
Knowing the activity of a source on a particular date and its half life, tables and 
enables the present activity to be worked out using the formula below:
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Figure 4.8: GeLi Detector
Y = A + B * X
Par. Value Err.
A 1.23 0.22
B 0.005 3.0E-4
Regression R = 0.989
u_
Figure 4.9: HPGe Detector
Y = A + B * X6
Par. Value Err.
5 0.003 1.14E-4
Regression R = 0.996
4
3
2
1
E n e r g y  ( k e  V )
Figures 4.8 and 4.9 showing the variation of FWHM2
with incident gamma ray energy for the GeLi and HPGe detectors
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A =A oe-°'693t/T (4.2)
where A is the activity at time t in kBq,
A0  is the activity at time 0 
t is the time of decay in days 
T is the half life in days
The absolute efficiency was then calculated by using the relationship
where C/s are the counts recorded under the full energy photopeak divided by the 
time of counting
I is the branching ratio of the gamma, ray energy and A is the present source activity. 
In order to calculate the intrinsic efficiency, the total number of gamma rays which 
fall on the crystal must be calculated, using the solid angle technique as shown below
where S = source
Q = solid angle in steradians 
d = source detector distance 
a = diameter of the crystal 
1 = length of the crystal 
A = area of the crystal Ttr2
But for d » a ,  the solid angle reduces to the ratio of the detector plane frontal area A, 
visible to the source, to the square of the distance.
(4.4)
L / 2  „ 2y j d2 - a
(4.5)
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The intrinsic efficiencies can then be calculated using the following equation.
S ’\ n X  — S a b s
An
v a (4.6)
All the calculated efficiencies are illustrated in the following Tables 4.17 and 4.18.
Table 4.17: Calculated absolute and intrinsic efficiencies for the isotopes for the 
detector
GeLi
GeLi
Isotope Energy (keV) Absolute Efficiency Intrinsic Efficiency
2 4 1  Am 59.6 4.77E-4 +/- 2.38E-5 0.157+/-0.008
^  Ba 81.03 8.46E-4 +/- 4.14E-5 0.279+/-0.014
302.99 8.76E-4 +/- 4.29E-4 0.289+/-0.014
356.16 7.71E-4 +/- 3.77E-5 0.254+/-0.012
137 Cs 661.7 4.48E-4 +/- 1.66E-5 0.147+/-0.006
60 Co 1173.13 2.94E-4 +/- 5.69E-6 0.053 +/- 0.001
1332.3 2.67E-4 +/- 5.17E-6 0.046 +/- 0.001
1 5 2 Eu 121.93 1.21E-3 +/- 6.06E-5 0.399 +/- 0.020
244.87 1.02E-3 +/- 5.09E-5 0.335 +/- 0.017
344.48 7.78E-4 +/- 3.89E-5 0.256+/-0.013
444.18 6.73E-4 +/- 3.40E-5 0 . 2 2 2  + /- 0 . 0 1 1
779.06 4.20E-4 +/- 2.1 IE-5 0.138+/-0.007
964.12 3.47E-4 +/- 1.75E-5 0.114+/-0.006
1085.95 3.11E-4 +/- 1.56E-5 0.102+/-0.005
1112.05 3.12E-4 +/- 1.56E-5 0.103 +/- 0.005
1407.85 2.58E-4 +/- 1.29E-5 0.085 +/- 0.004
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Table 4.18: Calculated absolute and intrinsic efficiencies for the isotopes for the 
HPGe detector
HPGe
Isotope Energy (keV) Absolute Efficiency Intrinsic Efficiency
2 4 1  Am 59.74 2.22E-3 +/- 1.11E-4 0.620 +/- 0.031
1 3 3 Ba 81.1 2.28E-3 +/- 1.12E-4 0.637+/-0.031
302.99 1.27E-3 +/- 6.20E-5 0.354 +/- 0.017
356.18 1.11E-3 +/- 5.42E-5 0.309 +/- 0.015
137 Cs 661.97 6.54E-4+A 1.97E-5 0.183 +/- 0.006
60 Co 1173.7 4.26E-4+/- 8.25E-6 0.119+/-0.002
1332.97 6.80E-4+/- 1.32E-5 0.108+/-0.002
152 Eu 122.16 1.84E-3 +/- 9.21E-5 0.514+/-0.026
245.06 1.30E-3 +/-6.51E-5 0.363 +/-0.018
344.64 1.01E-3 +/- 5.08E-5 0.283 +/- 0.014
444.37 8.5E-4 +/- 4.26E-5 0.237 +/- 0.012
779.34 5.52E-4 +/- 2.77E-5 0.154 +/- 0.008
964.51 4.68E-4 +/- 2.35E-5 0.131+/-0.007
1086.28 4.35E-4 +/-2.18E-5 0.121+/-0.006
1112.55 4.31E-4 +/-2.16E-5 0 . 1 2 0  +/- 0.006
1408.4 3.57E-4 +/- 1.79E-5 0.100 +/- 0.005
As can be seen from the results above the efficiency of the HPGe detector is greater 
than the GeLi detector so for analysis of the samples it was decided to use the HPGe 
detector.
The variation of absolute efficiency versus energy was plotted for HPGe only and are 
shown in Figures 4.10 and 4.11, where Figure 4.10 uses only 152Eu and Figure 4.11 
I uses ^'A m , Ba, " 'C s, % o  and '^Eu.
Many papers have summarised semi-empirical formulae and functions to represent 
these full energy peak efficiency curves, (Mcn73), (Sin76).
The formula used here is the one most popular and is the one described by East, 
(Eas71).
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Figure 4.10
0 0 2 0 Fitting Equation
y=P1*exp(-P2*x)+P3*exp(-P4*x) 
Chi2 = 5.8437E-11
0 0 1 5 P1 = 0.00203 
P3 = 0.00074
P2=0.0047 
P4=0.00051
0 0 1 0
0 0 0 5
0 0 0 0
8 0 0 1 0  0 0 1 2  0 0 1 4  0  0 1 6  0 02 0 0 4 0 0 6 0 00
Figure 4.11
Fitting Equation
y=P1 *exp(-P2*x)+P3*exp(-P4*x) 
Chi2 = 3.966E-9
0 0 2 5
P1 = 0.00205 
P3 = 0.00074
P2=0.00434 
P4=0.000520 0 2 0
0 0 1 5
0 0 1 0
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Figure 4 .1 0  show in g  the variation of ab so lu te  effic iency with g a m m a
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ray en ergy  for Eu for the H P G e detector
Figure 4.11 show in g  the variation of ab so lu te  effic iency  with g a m m a
ray en ergy  for 152Eu and 241Am, 13oBa, 1o7C s  and 60C o  
for the H P G e detector
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e f  = a1 exp(-a2£) + <23 QX^{-aAE )  (4.7)
This equation is accurate for energies above 200 keV, the problem is below 
approximately! 00 keV where the efficiency begins to decrease because of attenuation 
in the window material of the detector.
Few functions have accurately described the full energy range above 50 keV , Owens, 
(Owe89), compared several formulae and found that the most precise, over the largest 
possible range was obtained using the semi-empirical formula of Hasnal and Klusek, 
(Owe89).
The intrinsic efficiency versus energy using 2 4 1 Am , 1 3 3 Ba, 1 3 7Cs, 60Co and 152Eu is also 
illustrated in Figure 4.12.
4.3.2d Effective Interaction Depth
The effective interaction depth is defined as the distance below the surface of the 
detector window at which a gamma ray of a particular energy appears to interact or 
give up all its energy . The effective interaction depth may be employed to calculate 
any detector efficiency for any source detector distance, if the efficiency has been 
measured at one known distance.
It has been possible to calculate this depth since it is known that the efficiency at a 
distance r^  divided by the efficiency at a distance r2  did not equal the inverse ratio of 
the squares of the distances, ie.
4n) ^
4) ri2
where e(ri) = efficiency of detector at rh e(r2) = efficiency of detector at r2  and r2  and 
ri are distances measured from the surface of detector to the source. Hence if dcff is 
the effective interaction depth of the gamma ray then
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( 4 8 )
Thus at different distances the effective interaction depth can be calculated ie
Thus it can be seen with increase in gamma ray energy, the effective interaction depth 
increases, this is expected with increasing energy the gamma rays will interact at a
The variation of the effective interaction depth with the gamma ray energy for 
HPGe3 is illustrated in Figure 4.13.
4.3.3 Irradiation Facilities of BRI, Delft
The remaining samples were irradiated at the IRI, Delft, The Netherlands. The reactor 
is a light swimming pool type using 93 percent enriched 235U for fuel. It runs at 2 
MW. The present peak thermal neutron flux is approximately 2*1013 cm s . There 
are six radial beam tubes and one tangential beam tube, three slow and two fast rabbit 
systems for irradiation near to the core and one wet and three dry irradiation tubes. 
The quartz vials were irradiated in the befa position, (one of the radial beam tubes) of 
the BRI, Delft, 2.1*1013 neutrons cm "2  s’ 1 for 12 hours. The reactor is operated 
continuously from Monday noon until Friday 22.00 hr. The counting facilities which 
consisted of a Ge(Li) detector and a Ge well type detector used automatic sampler 
changes, (Cor94). The detector systems and absolute efficiency have been described
by Bode, (Bod93).
(4.9)
greater depth within the crystal.
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Figure 4,12
Fitting Equation
y= P 1 *exp(-P2*x)+P3*exp(-P4*x) 
Chi2 = 0.00032
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Figure 4.13
Fitting Equation 
y=A+B1*x+B2*x2
A = 2.66466 
B1 = 0.00303 
B2 = -1 .5077E"
Regression R = 0.838
Figure 4 .1 2  show in g  the variation of intrinsic effic iency with g a m m a
ray en ergy  for 152Eu and 241Am, 133Ba, 137C s  and 60C o  
for the H P G e detector
Figure 4 .1 3  show in g  the variation of effective  interaction depth with 
g a m m a  ray en erg y
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C H A P T E R  5
Porcine B rains
5.1 Introduction to Porcine Brains
This preliminaiy work using porcine brains was undertaken to develop methods using 
INAA, ICP-MS and ETAAS, which would then be applied in the analysis of human 
brain tissue, when these arrived.
The pig is the animal of choice for many physiological and nutritional studies. The 
pig is similar to humans in dental characteristics, renal morphology and physiology. 
The greatest use of the pig is in nutrition because the digestive physiology and 
nutrient requirements of newborn pigs and human infants are remarkably similar thus 
diets adequate for neonatal pigs should be adequate for neonatal humans. (Sch6 6 ), 
(Pon78).
The pigs chosen were from Northern Italy. The males were castrated and slaughtered 
at ten months. The female is the fertile Dutch Landra Polasoid and the male the 
healthy, robust Durok which mate to produce a pig with lean meat and very little fat. 
The pigs are given supplements of 175 mg/kg per day Cu up to sixteen weeks and 
then from the seventeenth week up to the six month they are given 1 0 0  mg/kg Cu; 
from the sixth month to slaughter they are given 35 mg/kg. Cu is given in the form of 
copper sulphate for fattening. Other elements supplemented are 60 mg/kg Fe, 60 
mg/kg Zn, 16 mg/kg Mn, 0.22 mg/kg Co, 0.6 mg/kg I and 0.01 mg/kg Se.
Dietary mineral interrelationships are of extreme importance. Iron deficiency is 
significant in the newborn pig, since the placental transfer of this element is low. The 
result is limited stores of iron in the newborn pig and unless this is supplemented, 
severe iron deficiency results within 2-3 weeks. Iron deficiency causes microcytic 
hypochromic aneamia. The copper requirement of pigs is small (<10mg/kg) but 
Barber, (Bar61) found that concentrations of copper above the metabolic rate result in 
growth acceleration. Kirrchgesser et al, (Mer87) demonstrated that copper stimulates 
growth by improving the digestibility of proteins and cupric ions activate pepsin and
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raise peptic hydrolysis. These findings were valid under certain conditions which are 
copper may stimulate a growth effect if the zinc and iron content in the pigs diet was 
adequate, (Mer87). It has been found that pigs fed high concentrations of copper 
develop anemia due to iron deficiency, unless their diet are supplemented with iron 
levels, (Hed73). The competitive antagonism between copper and iron and copper and i 
zinc is important in the field of trace elements and copper supplementation in the diet 
is a complex matter, (Mer87).
Hartmann et al., (Har94) studied the physiological effects of a marginal copper and 
iron supply on pigs and found there was no interaction between copper deficiency and 
iron metabolism. The protein metabolism was unchanged. They found low copper and 
iron intake reduced the copper and iron concentrations respectively in serum, liver 
and muscle. A marginal copper and iron supply had no relevant effect on either food 
intake and growth performance or carcass characteristics or meat quality.
The manganese requirements for pigs for satisfactory reproduction are higher than 
those for body growth. Manganese depletion results in skeletal abnormalities and 
impaired reproduction, (Mer87).
5.2 Pre-analytical Factors
At the JRC, Ispra, all work surfaces and cabinets were constructed from high density 
plastic, (Tema, srl , Faenza, Italy). The laboratories were supplied with filtered air 
and all sample preparation stages were performed under a laminar flow hood or in a 
laminar cabinet. The importance of working under cleanroom conditions is reported 
by Nakahara, (Nak79). Lievens, (Lie77) found in a typical laboratory environment, 
contaminants such as Al, V, Mn, Fe, Co, Cu, As, Br and Sb. White, (Whi98) checked 
airborne contamination in the instrument room of the JRC, Ispra and found only for 
Ni there was a risk, however to minimise this risk, samples were only transferred to 
the instrument room immediately prior to analysis. Suprapure double sub-boiling 
distilled HN0 3 was obtained from Romil Chemicals (Loughborough) England. All 
dilutions were made using MilliQ ultra pure water resistivity of 18 MQ cm. Pipette 
tips were rinsed with 10% acid and then MilliQ water. Sample containers were made
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of polypropylene, suitable for storing samples, without causing contamination. All 
sample containers, quartz vials, test tubes and tops were acid washed before use. All 
stock solutions and washing solutions were kept in polytetrafluoroethylene (PTFE) 
(Nalgene, USA). Gloves without powder were used.
Three tissue samples were taken from the frontal, temporal and parietal lobes (grey 
and white matter) in both hemispheres of porcine brains. The brains were collected 
two hours after slaughter from Ceriani di Uboldo, Milan. Transport took 1 hour in a 
polyethylene container kept cool at approximately -4°C. They were dissected not 
more than ten hours after collection on a polyethylene plate. The cerebral volumes for 
human brain according to Blinkov, (Bli6 8 ) are 31.3% frontal lobe, 16% occipital 
lobe, 2 1 .4 % frontal lobe and 31.3% temporal lobe and these proportions were used in 
dissecting the porcine brain, which was a difficult process.
Iyengar et al., (Iye81) studied the implication of post mortem changes such as cell 
swelling, inhibition and autolysis on the elemental composition of rats. Iyengar found 
that retaining the liver inside the intact dead body for different periods of time at 
ambient temperature induced significant changes in its weight due to post mortem 
degeneration. Livers from animals that were frozen at -15°C also showed significant 
decrease in weight after being thawed on the third day. The total concentration 
content of K+ was reduced by 40% and for Na differences ranged from +20 to -40%. 
The loss observed in the total content of the liver for Cu, Fe, Mn Rb and Zn were 
found to be about 20-40%. Summarising, Iyengar indicated the need for standardising 
the sampling time and once removed from the body careful freezing permits 
prolonged storage.
To reduce the risk of metal contamination during the collection of biological samples 
titanium nitride coated scalpels and pincers were used for dissection. These tools 
were available in the laboratory. Pietra et al., (Pie90) looked at Fe, Cr and Ni released 
in human serum from TiN- or T i02- coated AISI 316 materials as determined by 
INAA. The authors found that the release of the three elements from the T i02- coated 
materials is lower than from the uncoated stainless steel. However, the release from
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Ti02- coated material are higher than the corresponding values found for the TiN- 
coated materials. They also found that the release of the 23 elements from the TiN- 
coated materials is lower than that from the uncoated AISI 316 blades, particularly for 
Co, Cr, Cu, La, Mn, Ni, Sb, Ti, V and Zn. Also, Zaichick, (Zai96) found the content 
of all elements studied, Ag, Co, Cr, Fe, Hg, Rb, Sb, Se and Zn in thyroid samples 
taken with a stainless steel blade were higher than in samples taken with a titanium 
knife but were only statistically reliable for Co and Cr. The problem was that no 
article discussed a cleaning process for regular use of the titanium instruments.
The meninges were removed with any blood vessels and any surface blood. The 
samples were placed in acid cleaned 30ml propylene vials and were frozen at -80C for 
at least 12 hours. Freezing is an important way of preserving samples, if freeze-drying 
cannot take place immediately after sampling. For long term storage it is important to 
freeze at < -15°C, but irreversible processes take place such as dénaturation of 
proteins and redistribution of elements due to rupture of cell walls by ice crystals. 
Samples should be stored without dividing them into smaller parts. The larger the 
sample in the container the less important will be the influence of the sample 
container, (San84).
In the case of the porcine brains preparation and analysis could be carried out 
immediately but in the case of the human brains it was not possible and storage before 
freeze drying could last 3 weeks. Much research has been carried out into storage of 
samples. Subramanian, (Sub83) observed whole blood samples stored in 
polycarbonate containers at -10°C up to 60 days and found no changes in the 
concentrations of Cd and Pb. Also duplicate samples stored at -20°C in polyethylene 
containers, were analysed for manganese, arsenic and selenium after five years and no 
differences were found. Minoa, (Min92) found losses >1% for Bi, Hg (both 
chemical forms), "M o, 124Sb and 113Sn from in vivo radiolabelled rat and rabbit blood
stored at -20°C for 1 month in polyethylene vials.
The samples were then freeze dried until constant mass and weighed, this was for 
approximately 78 hours. Once freeze dried any surface blood may be peeled away.
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this is preferred to blotting the samples which may lead to contamination. However it 
is difficult to remove residual blood and this leads to widespread variations in 
reported results such as Fe, (Iae80). Drying the sample is necessary to repress any 
microbial decomposition during storage and to acquire a constant reference value for 
determining the dry weight rather than the fresh weight which is difficult to assess, 
(Mak95). Freeze drying is considered the only acceptable method for drying. Oven 
drying results in a loss of volatile elements and oven ashing leads to uncontrolled 
losses of both trace elements and some major minerals. Lyophilization or freeze 
drying involves freezing the sample at -80°C before putting it under vacuum in the 
freeze dryer to remove water by sublimation, (Sei94). Zaichick, (Zai97) looked at the 
possible losses of seven chemical elements in biological tissues during freeze drying 
and found that before and after lyophilisation there was evidence of no loss of Br, Ca, 
Cl, I, K, Mg and Na. Also De Goeij, (Goe79) determined Cr, Fe, Co, Cu, Zn, As, Se, 
Br, Mo, Cd, Sb and Hg in freeze dried and non freeze dried human liver using INAA 
and found no significant losses. However, losses in Hg have been reported for the 
pons (brain), (Pil71).
The samples were then pulverised using a pestle and mortar made of agate. Grinding 
materials are made from several materials, Agate from Brazil or Uruguay, Hard 
Porcelain, sintered alumina I and sintered alumina II, carbon steel, zirconium oxide, 
boron carbide, tungsten carbide, titanium, chromium steel and stainless steel, 
(Mak95).
The composition of agate and titanium from which the usual types of grinding 
material are made are shown in Tables 5.1 and 5.2. The lowest concentrations of 
metals are in the agate.
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Table 5.1: Composition of agate, (Mak95)
AGATE % COMPOSITION
SiOz 99.91%
AI2 O3 0 .0 2 %
NazO 0 .0 2 %
FezOg 0 .0 1 %
K2 O3 0 .0 1 %
MnO 0 .0 1 %
CaO 0 .0 1 %
MgO 0 .0 1 %
Table 5.2: Composition of titanium, (Mak95)
TITANIUM % COMPOSITION
Ti 99.437%
Fe 0 .1 %
0 2 0.3%
Nz 0.07%
C 0.08%
H2 0.013%
The samples were placed in tightly closed acid cleaned vials to prevent water 
absorption and stored at room temperature. However, Zaichick, (Zai97) found that 
even in a tightly closed polyethylene container after one year or more there mass can 
be 1 0  % higher.
5.3 Freeze Dried Certified Reference M aterial (CRM)
Samples from the CRM were freeze dried and the results are shown below. It was 
found that the samples contained between approximately 5 and 9% water content. In 
the case of the Bovine Liver b and the Oyster Tissue a, the bottles were sealed, so the 
endogeneous content of water is approximately 5-6%. Therefore CRM’s should be 
freeze dried before being used or a correction should be made. In this work the CRM 
was freeze dried before use.
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Table 5.3: Water Content of Certified Reference Material, (e x p e rv re A to x l dcJscx)
CRM Water Content as % of CRM Sample 
Before Freeze Drying
Pine Needles 7.0%
Bovine Liver a 8.5%
Bovine Liver b 5.9%
Oyster Tissue 7.4%
Oyster Tissue a 5.4%
Peach Leaves 8.3%
5.4 Sample Preparation for ICP-MS and ETAAS
Dried samples of 150 mg were weighed in teflon PFA microwave digestion vessels. 
The teflon vessels were washed in de-ionised water in an ultrasonic bath Bramsomc 
5200 E4 (Branson, USA) for 30 minutes, rinsed in MilliQ water, left overnight in 
10% ultrapure HN03, rinsed again in MilliQ water and left to dry at room temperaure 
in an ultraclean room For the ETAAS 3 mL of ultrapure HN0 3 was added to each of 
the digestion vessels with the pig’s samples and mineralised in a microwave oven 
(MDS-2000, CEM, USA) at 80% power for 40 minutes,, in this case 250mg of NIST 
certified reference material was used. Bovine Liver a and b. Oyster Tissue and Peach 
Leaves arid IAEA Animal Blood. For ICP-MS, the samples were digested using 2 mL 
of HN0 3 to reduce interferences caused by HN0 3 and therefore only 150mg of 
certified reference material could be used, NIST Bovine Liver a and b and IAEA 
Animal Blood. The vessels were cooled down to room temperature and opened in a 
laminar flow box (Cleansphere CA 100, Safety, Limited, USA) to avoid 
contamination. The contents were transferred to acid cleaned polypropylene tubes and 
diluted to a volume of 10 mL with MilliQ water. For the ICP-MS all samples were 
düuted (1 mL+4 mL). For ETAAS the PI), Cd, Mn and Li were diluted (200 pL+SOO 
pL) whilst the Cu was diluted (50 pL +950 pL)
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5.4.1 Calibration
For determination by ICP-MS a standard additions calibration coupled with internal 
standards was used and for ETAAS standard addition calibrations were prepared as 
described in chapter 3.1.6c. A small number of porcine brains were analysed by
INAA using the comparator method, this is described below.
The accuracy of all methods was determined using NIST and IAEA Certified 
Reference Materials.
For ETAAS the calibration was linear for the points shown below in Table 5.4. 
and ICP-MS calibrations are shown in Table 5.5.
Table 5.4: The calibrations prepared using ETAAS
Element Calibration 
Point 1
Calibration 
Point 2
Calibration 
Point 3
Calibration 
Point 4
Cu 8 16 24 32
Pb 1 2  1 18 24 30
Cd 0 . 2 0.3 0.4 0.5
Mn 5 1 0 15 2 0
Li 0 . 2 0.4 0 . 8 1 . 0
In AAS, according to the Beer Lambert Law, the absorbance - concentration
relationship should be linear but in practice, there is some curvature which as 
described by Barnett is due to stray light, non-homogeneties of temperature and space 
in the absorbing cell, causing gradients of atoms in the light beam and for Zeeman 
correction incomplete separation of the pi and sigma in the magnetic field, (Lim78), 
(Bar84). It is important that the additions remain in the linear range of the curve. 
Beaty states that experimentally it has been shown that accurate calibration can be 
achieved with three standards and a blank, (Bea78).
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Table 5.5: The calibrations prepared using ICP-MS
Element Calibration Point 1 
(pg/L)
Calibration Point 2 
(pg/L)
Calibration Point 3 
(pg/L)
7Li 0.4 1 . 0 2.4
55Mn 8 40 80 .
57Fe 2 0 0 500 1 0 0 0
65Cu 2 0 1 0 0 2 0 0
68Zn 2 0 0 500 1 0 0 0
82Se : 2 5 1 0
luCd : 0.4 1 . 0 2.4
202Hg ! 0 . 8 2 . 0 4.8
1 208Pb j
1
0 . 8 2 . 0
4.8
The calibration curve used for ICP-MS is simply linear, using standard linear 
regression for curve calculation, where a minimum of two calibration points is 
sufficient for accurate calibration.
Wash trials were also made to control the problems of memory for all the elements 
determined. For Hg, the memory effects after 360 s wash times were acceptable.
For ICP-MS, standards were prepared manually, for ETAAS standards were prepared 
automatically by the instrument.
5.5 Sample Preparation for Neutron Activation Analysis
A small proportion of samples were analyzed by neutron activation analysis, 150 mg 
of standard, 15mg of sample and one blank were placed in pre-cleaned quartz vials 
for irradiation. Quartz vials were irradiated in the PIP position of the High Flux 
Reactor at Petten, flux, 2*1014cm "2 s' 1 for 12 hours. Trials were made on small 
amounts of whole porcine brain to determine which elements could be measured.
The samples were counted directly after a waiting time of 10 days on the HPGe3 
detector at the JRC, Ispra. The spectra were analysed using the package NEDA. The 
samples were counted for five hours after 10 days, (“ t o  and 5 1 Cr) after 18 days (5 9 Fe, 
4 6 Sc, 85Sr and 1 2 4 Sb) and after 28 days, ( 1 3 4 Cs, 60Co and 6 5 Zn) to maximise the number
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of elements detected. An example of the spectra from the porcine brain is shown in 
Figure 5.1.
Figure 5.1: Porcine brain spectrum counted after 18 days
Number Of
Counts Puiser Peak
Zn
Se Rb
Sb
Cs
Channel Number
High purity zirconium wire was used. The wire was cut into 2 cm sections, sealed in 
pre washed quartz vials and then three were placed vertically along both the right and 
left sides of the aluminium can. They were held in place by aluminium foil. Then two 
pieces were cut 1 cm each and were placed horizontally along the bottom of the 
aluminium can, held in position with aluminium foil. It was found that the maximum 
variation in thermal flux along the vertical and horizontal axis was 1.2%, which is 
considered to be negligible. Unfortunately because the samples arrived after one 
week, it was found that the gamma line used for calculating the epithermal neutron 
(^Zr-^Zr) flux had already decayed ('^Zr, 16.9 hours) so only the thermal neutron 
flux could be calculated for these samples.
After irradiation the quartz vials were placed in 10 mL polyethylene bottles, the 
bottles were made to fit the autosampler and were originally used for Radiochemical 
Neutron Activation Analysis, (RNAA). To ensure the same geometry for each sample.
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a hole was made in the lid of the bottle and alOO ul pipette tip inserted and soldered 
to the bottom. The quartz vial was then inserted in the fixed pipette tip.
For method evaluation particular attention was paid to quality control. This included 
the use of commercial certified reference materials and spiked samples. The 
following reference materials were selected NIST, 1547 Peach Leaves, 1577a and b 
! Bovine Liver, 1566 and 1566a Oyster Tissue and A13 Animal Blood. For ICP- 
I  MSZETAAS reference materials were diluted to be within the range of the calibration, 
j  They were treated as normal samples.
5.6 Homogeneity
The homogeneity of a material is related to several factors such as the type of
material, the sample size for the analysis, the kind of species and the requirements of 
the user and the applied analytical technique. Homogeneity is achieved when 
replicate subsamples of the size required by the trace analytical techniques do not 
show significant differences within the precision limits of the method, (Zei98). 
Homogeneity has been defined by the ASTM Commttee E-2 on Emission 
Spectroscopy, (Des85), and is defined as statistically acceptable differences among 
means of specimens in the test and has been used by Panayi et al., (Pan99) to 
determine homogeneity of porcine brains.
Homogenisation is important for two reasons: To obtain a uniform source of material 
representative of the material and the sample to be irradiated and counted is uniform 
throughout. In ICP-MS and AAS the sample is liquid form and thus uniform by
nature, (Par91).
5.7 Results
5.7.1 Dry to Fresh Weight Conversion Ratios (DFW)
The average dry to fresh weight conversion factors (DFW) with standard deviation for 
the various sections of the four brains were as follows; left temporal lobe 0.192 ± 
0.005, right temporal lobe 0.191 ± 0.005, left parietal lobe 0.208 ± 0.002, right 
parietal lobe 0.211 ± 0.005, left frontal lobe 0.206 ± 0.007 and right frontal lobe
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0.202 ± 0.004. Using the students t-tests there was no significant difference between 
the right and left hemispheres but there was a significant difference between the j 
temporal and parietal lobe (p<0.0002) and between the temporal and frontal lobe 
(p<0.005), between the parietal and frontal lobe there was less difference but it was 
still significant (p<0.05).
The average DFW conversion factors with standard deviation for the whole brain is 
0.202 ± 0,009. This value is higher than that found by Stedman, (Ste96), this could be 
due to the proportions of grey and white matter used because Duflou (Duf87) found a 
mean value of 0.169 ± 0.008 for 12 grey matter regions and a mean value 0.247 ± 
0.045 for 10 white matter regions.
5.7.2 Results
For ICP-MS, three Certified Reference Materials, (CRM) have been used which have 
a similar matrix to porcine brain, NIST Bovine Liver b and a and IAEA Animal 
Blood. The values determined compare well with the certified values as shown in 
Tables 5.6, 5.7 and 5.8, respectively. There is good agreement for Mn, Fe Cu, Zn and 
Cd in Bovine Liver b and Cu, Zn and Pb in Animal Blood. It is surprising that Fe 
agrees well with the Certified Reference Value, (CRV) given for Bovine Liver b, 
since ^Fe is interfered by ^Ar "0+ and ^Ar '"O W  in ICP-MS analysis. The 
acceptable results are probably due to the high concentrations of Fe in the Bovine 
Liver whereas Fe in Animal Blood gives low values, this is probably due to the low 
concentration of Fe in Animal Blood and also because Ça as 40Ca 160  is a significant 
interfèrent in the blood matrix. Se is also too high but addition of organics as 
described in chapter 7.2 corrects for interferences from 40Ar2 W  and 81Br lï f  .
For ETAAS determinations the concentration of the sample and standard must be 
similar. Unfortunately, the concentrations of the elements of interest in Bovine Liver 
and Oyster Tissue CRM are much higher than the values of the porcine brain tissue 
and could only be used for Mn. The Bovine Liver and Oyster Tissue used for 
determining Mn were diluted (1+19). The results are shown, in Table 5.9
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A recovery study was also performed for all elements using ICP-MS and ETAAS. The 
added spikes were at the same concentration levels as the elements in the sample and 
the results are shown in Tables 5.10 and 5.11.
The precision of the analytical method using ICP-MS and ETAAS was controlled by 
measuring five aliquots from the same mineralised brain sample and the results are 
shown in Tables 5.12 and 5.13, respectively.
The homogeneity of the 150 mg porcine brain tissue using ICP-MS and ETAAS was 
determined by measuring five different digested aliquots from the same original 
freeze dried sample. Tables 5.12 and 5.13 respectively. In these samples Cd could be 
detected but due to a very low concentration, a high RSD was obtained.
The Limit of Detection was defined for ICP-MS and ETAAS, as 3 * standard 
deviation of the blank (n=S) for the procedure. The LCD has also been estimated for 
a 150 mg brain sample, (ng/g), Tables 5.12 and 5.13, respectively.
Using INAA, Table 5.14, the elements Co, Cr, Cs, Fe, Rb, Sb, Sc, Se and Zn were 
detected in the brain samples. The MDL for each element has been calculated 
theoretically using the error on the peak and the peak area to calculate the background 
and therefore may only be used as an approximation. In INAA for Co, Fe, Rb, Se and 
Zn, the concentrations of these elements are well within the detection limits thus 
probably explaining why the results for homogeneity are acceptable for most 
elements.
Converting the porcine brain dry weight concentrations to wet weight concentrations 
for the three areas, frontal, parietal and temporal lobe in the left hemisphere. Table 
5.15 and 5.16 shows the results for the left and right hemispheres, respectively, using 
the techniques ICP-MS and ETAAS. Tables 5.15 and 5.16 show the results for the left 
and right hemispheres, respectively using ICP-MS and ETAAS.
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The elemental concentrations are found to be in general, highest in the temporal lobe, 
then the frontal lobe and lowest in the parietal lobe. Using t tests there were no 
significant differences between the right and left hemispheres apart from Fe which 
was found to be significantly higher in the left lobe compared to the right (p<0.02). 
Between lobes Mn was found to significantly higher in the parietal lobe compared to 
the temporal lobe (p<0.1). This agrees with the work of Stedman, (Ste96). Fe i 
concentrations were found to be significantly lower in the temporal lobe compared to 
the parietal and frontal lobe at significance (p<0.05) and (p<0.02), respectively.
Comparing techniques ETAAS and ICP-MS Mn was found to be significantly higher 
using ICP-MS compared to ETAAS, at significance (p<0.001) and Cu and Cd were 
found to be significantly higher using ETAAS compared to ICP-MS (p<0.001). For 
Mn the differences found between the two techniques could be due to the low 
concentrations of Mn found in the porcine brain. The NIST Bovine Liver a and b Cu 
concentrations are equivalent to those in the porcine brain. The NIST CRM’s gave 
excellent accuracy with ICP-MS, therefore it was probably the high dilution factor for 
the samples analysed by ETAAS, which gave higher results than for the ICP-MS. The 
results for Li, Cd, Hg even though quoted are close to or below the limits of detection.
Converting the porcine brain dry weight concentrations to wet weight concentrations 
for the whole brain. Table 5.17 using the technique INAA shows the fresh weight i 
concentrations in whole brain.
Even though Fe, Se and Zn were determined by ICP-MS, a method comparison was 
not undertaken because of the small number of samples and because by INAA whole 
brain was determined as opposed to the frontal, temporal and parietal lobes 1 
determined by ICP-MS. However, in chapter 8, an intermethod comparison has been 
undertaken for the two techniques, ICP-MS and INAA.
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' Table 5.6: Determined concentrations (ng/g), sd and rsd (%) of NIST Bovine Liver (b)
using ICP-MS. Five digested samples were analysed
Bovine Liver (B) Determined Concentration (pg/g) Certified Value (pgfg)
Mean SD RSD (%)
7Li 0.15 0.02 12.7
55Mn 10.3 0.27 2.6 10.5 ± 1.7
s?Fe 180.2 5.5 3.0 184 ± 15
63Cu 159.4 6.2 3.9 160 ± 8
68Zn 133.2 6.5 4.9 127 ± 1 6
8'Se 1.3 0.32 32.0 0.73 ± 0.06
inCd 0.5 0.01 1.8 0.50 ± 0.03
202Hg 0.007 0.003 44.1 (0.003)
208Pb 0.10
. . .
0.019 18.4 0.129 ± 0.004
Table 5.7: Determined concentrations, (jag/g) sd and rsd (%) of NIST Bovine Liver (a) 
using ICP-MS. Five digested samples were analysed
Bovine Liver (A) Determined Concentration (fxg/g) Certified Value (pgjg)
Mean SD RSD (%)
7Li 0.14 0.02 14.0
55Mn 9.5 0.59 6.20 9.9 ± 0.8
7^Fe 170.4 20.0 25.9 194 ± 20
3^Cu 148.1 12.7 8.6 158 ±7
68Zn 128.9 13.2 10.3 123 ± 8
82Se 0.9 0.14 15.2 0.71 ± 0.07
111Cd 0.42 0.03 6.0 0.44 ± 0.06
2"2Hg 0.008 0.006 74.4 0.004 ± 0.002
208Pb 0.120 0.018 15.6 0.123 ± 0.008
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Table 5.8: Determined concentrations, (jug/g), sd and rsd (%) of IAEA Animal Blood
A l3 using ICP-MS. Five digested samples were analysed
IAEA Animal 
Blood
Determined Concentration ^ug/g) Certified Value
W g )
Mean SD RSD (%)
7Li 0.056 0.006 10.7
55Mn 0.062 0.016 25.9
7^Fe 1137.5 66.6 5.9 2.4 (2.2-Z.5)
63Cu 3.9 0.13 3.4 4.3 (3.7-4.S)
68Zn 13.4 13.7 27.5 13(12-14)
^Se 0.55 0.038 6.9 0.24 (0.15-0.31)
n lCd <lod
202Hg 0.007 0.006 85.7
208Pb 0.173 0.034 19.9 0.18 (0.14-0.300)
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Table 5.9: Determined concentrations, (jig/g), sd and rsd (%) of IAEA CRM using
ETAAS. Five digested samples were analysed
Element Certified Reference 
Material
Determined
Concentration <pg/g)
Certified Value 
(Mg/g)
Mean SD RSD(%)
Cu NIST Peach Leaves 3.5 0.3 8.8 3.7 ± 0.4
IAEA Animal Blood 3.8 0.3 7.1 4.3 (3.7-4.8)
Pb NIST Peach Leaves 1.3 0.19 14.5 0.87 ±  0.03
IAEA Animal Blood 0.12 0.04 29.2 0.18 (0.14-0.30)
Cd NIST Peach Leaves 20.6 5.6 27.0 26 ±3
(ng/g) IAEA Animal Blood 2.4 1.4 56.0 -
Li NIST Bovine Liver b
Se NIST Bovine Liver b
Mn NIST Bovine Liver a 11.8 0.8 6.8 9.9 ± 0.8
NIST Bovine Liver b 12.6 0.5 3.9 10.5 ± 1.7
NIST Oyster Tissue 17.8 0.7 4.1 17.5 ± 1.2
NIST Oyster Tissue a 13.5 0.4 3.0 12.3 ± 1.5
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Table 5.10: Recovery of spiked samples using ICP-MS. Five digested samples were
analysed.
Ele. Added spike (ug/L1) Recovery (%) RSD (<Vo)
I 2 3 1 2 3 1 2 3
Li 0.4 1 2.4 94 93 93 3.0 3.8 4.1
Mn 8 40 80 101 101 101 4.5 1.6 2.0
Fe 200 500 1000 101 99 100 2.3 1.9 2.0
Cu 20 100 200 99 100 100 7.1 0.9 1.0
Zn 200 500 1000 103 ^ 103 102 1.5 2.0 1.5
Se 2 5 10 101 100 100 6.9 4.9 2.2
Cd 0.4 • 1 2.4 99 100 101 2.5 1.5 1.0
Hg 0.8 2 4.8 98 100 99 4.0 2.1
1.8
Pb 0.8 2 4.8 97 99 99 9.1 3.1 3.7
Table 5.11 Recovery of spiked samples using AAS. Five digested samples were 
analysed.
Element Added spike (ug/L1) Recovery (%) RSD (:%)
1 2 3 1 2 3 1 2 3
Cu 5 10 12 71 89 94 24.9 16.8 10.0
Pb 9 18 22.5 94 88 111 11.0 9.3 5.2
Cd 0.15 0.3 0.75 88 80 101 16.2 11.5 9.0
Mn 2 5 10 111 101 96 11.5 3.3 3.8
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Table 5.12: showing the Precision, (RSD in %), Homogeneity, (RSD in %) and LOD 
(ug/L"1) and LOD for 0.150 mg sample in (ng/g"1) of methods using the ICP-MS. Five
digested samples were analysed.
Element Precision Homogeneity LOD LOD
RSD (%) RSD (%) (ug/L"1) (ng/g1)
Li 8.2 14.8 0.004 1.3
Mn 2.3 2.5 0.130 43.3
Fe 2.3 2.3 7.921 2640
Cu 1.1 2.6 0.919 306
Zn 18.3 19.4 27.7 9238
Se 1.7 6.7 0.128 43
Cd - 59.4 0.004 1.3
Hg 24.7 48.0 0.035 11.7
Pb 40.3 68.1 0.301 100
Table 5.13 showing the Precision, (RSD in %), Homogeneity, (RSD in %) and LOD 
(ug/L"1) and LOD for 0.150 mg sample in (ng/g"1) of methods using the ETAAS. Five
digested samples were analysed.
Element Precision Homogeneity LOD LOD
RSD (%) RSD (%) (ug/L-1)
Cu 4.5 5.5 0.218 291
Pb 30.9 39.6 0.100 33
Cd i 9.3 8.6 I 0.005 1.7
Mn 3.2 6.3 0.026 8.7
Se - -
Li - - 0.039 13
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Table 5.14 showing the homogeneity (RSD in %) and MDL using INAA in whole 
brain. The mass of the sample is 0.015g.
Element No. of 
Samples
Homogeneity (ng/g) 
RSD (%)
MDL
Co n=4 11.1 2.4
Cr n=2 121.4 106
Cs n=2 46.7 15.4
Fe n=5 9.8 58800
Rb n=6 11.1 4400
Sb n=2 57.6 160
Sc n=3 15.7 2.4
Se n=2 4.2 410
Zn n=2 9.3 14960
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Table 5.15: Fresh weight Concentrations in Left Hemisphere of Brain Tissue (ng/g).
(n=4) by ICP-MS and ETAAS
Element Left
Temporal Lobe
Left
Parietal Lobe
Left
Frontal Lobe
Li 0.77 ±0.18 0.87+0.33 1.92±1.84
Li* <LOD CLOD CLOD
Mn 269 + 71 293 ± 43 293 + 48
Mn* 212 + 14 233 ± 26 224 ±23
Fe 13073 + 964 14354 ±1056 14271+ 760
Cu 4871 +781 5041 +760 4965 ± 729
Cu* 5522± 876 5535± 970 5663 ±731
Zn 12151 + 1764 11989 ± 1063 14115 ±3694
Se 171 + 18 191+21 193 ±34
Se* <LOD cLOD cLOD
Cd 0.18 + 0.14 0.33 ±0.47 0.24 + 0.19
Cd* 0.64 ±0.21 0.44 ±0.32 0.59 ±0.41
Hg 1.22 ±0.72 0.44 ±0.50 0.52 ± 0.42
Pb <LOD cLOD cLOD
Pb* cLOD cLOD CLOD
* determined by ETAAS
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Table 5.16: Fresh weight Concentrations in Right Hemisphere of Brain Tissue (ng/g).
(n=4) by ICP-MS and ETAAS
Element Right Temporal 
Lobe
Right Parietal 
Lobe
Right Frontal 
Lobe
Li 1.26 + 0.74 1.00 ±0.40 1.03 ±0.44
Li* <LOD cLOD cLOD
Mn 255 + 30 292 ± 56 327 ± 96
Mn* 195 ±31 234 ± 19 219 ±16
Fe 12960 ± 1901 13988 ±1199 13382 ±956
Cu 4789 ± 973 4923 ±1199 4848 ± 956
Cu* 5307± 1013 5717 ±730 5316 ±944
Zn 12082 + 853 11422 ±963 11912 ±1400
Se 169 ± 14 153 + 91 184 ±32
Se* <LOD cLOD cLOD
Cd 0.12 + 0.15 0.32 + 0.38 0.26 + 0.20
Cd* 1.18± 1.55 0.91 ±0.54 0.54 ±0.36
Hg 1.19 ±0.94 0.43 ± 0.45 0.89 ±0.18
Pb clod clod clod
Pb* clod clod clod
* determined by ETAAS
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Table 5.17: Fresh weight Concentrations in Porcine Whole Brain (ng/g) by INAA.
The mass of the sample is 0.015g.
Element No. of 
Samples
Whole Brain (ng/g) SD
Co n=4 4.5 0.5
Cr n=2 12.7 15.0
Cs n=2 2.5 1.2
Fe n=5 16319 1758
Rb n=6 3563 425
Sb n=2 13.3 5.8
Sc n=3 0.099 0.016
Se n=2 129 8
Zn n=2 13883 1427
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5.8 Correlation Coefficients
Correlation coefficients were made for the ICP-MS and ETAAS results for all six 
areas, both hemispheres, for the elements Fe, Mn, Se, Zn and Cu. A positive 
correlation between Fe-Cu (p<0.005) was the only significant correlation found. Fe 
and Cu positively correlated with DFW conversion ratios (p<0.01) and (p<0.01) 
respectively. The Fe-Cu correlation is expected because of competitive antagonism 
between these two elements as described in section 5.1.
5.9 Discussion
It is interesting to note that these results reflect the eating habits of the pigs in 
Northern Italy. The concentrations of Cu in the brain are high because 175 ug/g per 
day is fed to the piglets when they are young to promote quick growth. This is 
reduced to 35 ug/g when they are older. There are very small amounts of Pb, Cd and 
Hg in their diets and no external contamination. The values of Se are also low as the 
pigs are fed only 0.01 ug/g of Se per day as a dietary supplement. Cadmium and lead 
accumulate in the brain with time, (Mer93) and because pigs are slaughtered early on 
life, the concentrations of these elements are low.
5.10 Comparison with Literature
It was relatively difficult to find publications on porcine brain, wheras on rat brain 
there are several publications, (Gel92) but comparing with Stedman, (Ste96), who 
determined Zn and Rb with INAA and Fe, Mn and Cu with Proton Induced X Ray 
Emission in four areas of the cortex and the cerebellum. The concentrations of Zn 
(ICP-MS) in this work are slightly higher than Stedman’s (Ste96), the Mn values are 
similar and the results for Fe (ICP-MS) in this work are about three times lower than 
Stedman’s (Ste96) and Cu (ICP-MS) in this work was also lower than Stedman’s 
(Ste96). The results for Rb (INAA) in this work for whole brain were also slightly 
higher than Stedman’s (Ste96) results for Rb. Stedman, (Ste96) however, didn’t state 
at which age the pig’s were slaughtered. Comparing with Wong, (Won69), who used 
Radiochemical Neutron Activation Analysis, the dry weight concentrations for Cu, 
Mn and Zn were lower than this work but that is maybe because the pigs in this work
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were slaughtered at ten months whereas the pigs in Wongs work were slaughtered at 
three months old.
5.11 Conclusions
Using t tests on the ICP-MS results, there were no significant differences between the 
right and left hemispheres, apart from Fe which was found to be significantly higher 
in the left lobe compared to the right (p<0.02).
Between lobes Mn was found to significantly higher in the parietal lobe compared to 
the temporal lobe (p<0.1).
Determination of trace element concentrations at very low levels is difficult. It 
requires great care under clean conditions to keep the blank values low and 
reproducible.
Other problems for all techniques are the small sample size of biological material 
available, which may be inhomogeneous for certain elements and traces of blood in 
these samples which may cause high concentrations of elements such as Fe.
INAA avoids most problems of sample contamination because no mineralisation is 
necessary and it is relatively free of matrix interferences but the complete time period 
from sample preparation to the final collection of data may take two months. Also 
costs of irradiation and transport are high when the reactor is at a distance, so under 
these circumstances it is difficult to use INAA as a technique for routine analysis. 
ICP-MS and ETAAS are techniques which are used for routine clinical analysis and 
sample preparation and rapid analysis of samples may take place in one day. There 
are however problems with sample contamination during preparation and also the 
costs of argon gas for the ICP-MS are high, where one argon bomb lasts up to 
approximately 6 hours.
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CHAPTER 6
Titanium Tools and Dry to Fresh Weight (DFW) Conversion Ratios
6.1 Titianium Tools Used For Collection
Ti and quartz are used for the collection of human samples but the pathologists are 
reluctant to use these instruments because surgical blades made of pure Ti are too 
elastic while quartz instruments are brittle and have no convenient edges, (Pie90). For 
this reason it is better to use stainless steel surgical instruments coated with Ti based
materials, (Pie90).
The tools used by the Netherlands brain bank were stainless steel and coated in 
titanium using a Physical Vapour Deposition (PVD), coating. The tools were 
scrupulously cleaned, this involved placing the instruments in NAOH, in HN03 and 
in deionised water and the tools were then loaded into the vacuum chamber. When all 
the air was pumped out, the titanium was evaporated into the chamber and pure 
nitrogen was leaked in. This vapour reacted with the nitrogen to form a hard nitride 
compound. A high voltage applied to the tools attracted the metal vapour which 
adhered to the surface. The coating is between 2-10 microns thick. PVD is carried 
out at low temperature (200°C and 500°C), this temperature is selected to prevent 
distortion of the tools, (Tec99).
The tools used by the Netherlands Brain Bank, after each dissection, were sterilised in 
the autoclave for 6 minutes at 134 °C and pressure 4 bar. It is important that the water 
used in the sterilisation of the instruments should contain a low salt level or the 
choice of stainless steel (should be AISI 316) should offer a high enough level of 
corrosion resistance. Titanium nitride as depoisited is a totally inert coating but 
because of micropores in the surface of coatings produced by the (PVD), technology, 
they are totally reliant on the base material offering equal corrosion resistance, 
(Tec99), so the choice of stainless steel surgical instruments is critical.
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6.2 Lillifors Probabilities
Lillifors probabilities will be used later on so a brief explanation will be given here. In 
a Kolmogorov Smirnov test for normality when the mean and standard deviation of 
the normal hypothesized normal distribution are not known, (ie they are estimated 
from the sample data) the probability values tabulated by Massey, (Mas52), (Con80), 
are not valid. Instead the Lillifors probabilities should be used in determining whether 
the Kolmogorov Smirnov difference statistic is significant.
The distribution of data may be checked with Lillifors probabilités. If the Lillifors 
probabilties are greater than the tabulated values given by Lillifors, (Lil67), at the 
level of significance calculated, one may reject the hypothesis that these observations 
are from a normal population. STATISTICA was used for determining the Lillifors 
probabilités
6.3 Dry to Fresh Weight Conversion Ratios
Tissue samples rapidly loose their mass as a result of moisture evaporation, especially 
when the sample mass is only several milligrams, (Zai97). Ideally the samples should 
be weighed immediately after they have been removed from the autopsy but under the 
circumstances for the samples from the Netherlands Brain Bank, this was not 
possible. On removal the samples from the Netherlands Brain Bank were immediately 
frozen at -70°C and after arrival, at the HSL laboratories in UK, under dry ice, the 
samples were weighed. To ensure conditions were identical for all samples thus 
avoiding any differences between samples, all samples were weighed in the same way 
at the same time, ie if there was evaporation loss from the samples it was assumed to 
be equal among all samples.
The complete subject details have been given in Table 2.9, Chapter 2. A summary is 
shown in Table 6.1
The DFW conversion ratios in the Normals, the Alzheimer’s Subjects and the 
Subjects with Senile Involutive Cortical Changes (SICC) in both sexes, in both
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hemispheres, in all areas and the total are shown in Table 6.2. A comparison to 
determine significant differences is made later on in this chapter.
Table 6.1: A Summary of Subject Details; Total Number, Sex and Ages for the 
‘Normal’ and Alzheimer’s Disease Subjects and Subjects with Senile Involutive 
Cortical Changes (SICC).
Subjects Normals Alzheimer’s
Disease
SICC
Total No. 10 11 7
No. of Males 7 1 4
Ages of Males 
(years)
38, 48, 50, 56, 69, 
78,87
62 85,79,88,85
No of Females 3 10 3
Females
(years)
77,82,83 62, 67, 75, 82, 83, 
87,90,90,90,92
64,69,94
Also, there was one Multiple Sclerosis Subject with Senile Involutive Cortical 
Changes subject with a DFW ratio of 0.202 +/- 0.014 (n=10). These results have been 
included in the DFW statistical analysis because these samples were analysed by ICP- 
MS and the results are discussed in chapter 7.
In addition to the subjects described in Table 6.1 there was one Hippocampal 
Sclerosis subject DFW ratio of 0.190 +/- 0.018 (n=10), one Dementia Subject with 
Senile Involutive Cortical Changes, DFW ratio of 0187 +/- 0.01 (n=T0) and one 
Multiple Sclerosis Subject with Alzheimer’s Disease, DFW ratio of 0.199 +/- 0.024 
(n=10).
6.3.1 DFW Conversion Ratios for ‘Normal’ Subjects
A histogram was then plotted for the Normal subjects. Figure 6.1 and this was found 
to follow a normal distribution (Lillifors test p>0.2), therefore T tests were used for 
comparisons between groups where the level of significance was (p<0.1).
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Table 6.2: Mean Dry to Fresh Weight Conversion Ratio ± Standard Deviation
Code* Normals Alzheimer’s Disease Senile Involutive 
Cortical 
Changes (SICC)
Females 0.191 ± 0.019 (n=29) 0.202 + 0.088 (n=94) 0.189 ± 0.017 (n=30)
Males 0.199 ± 0.018 (n=66) 0.188 + 0.023 (n=8) 0.186 ± 0.012 (n=40)
Left (1) 0.200 ± 0.019 (n=49) 0.194 ± 0.021 (n=51) 0.187 ± 0.013 (n=35)
Right (2) 0.194 ± 0.019 (n=46) 0.190 ± 0.025 (n=50) 0.188 ± 0.016 (n=35)
A1 0.198+ 0.020 (n=10) 0.199 ± 0.021 (n=10) 0.184 + 0.009 (n=7)
A2 0.193 ± 0.019 (n=10) 0.187 ± 0.021 (n=ll) 0.189 ± 0.008 (n=8)
A1+A2 0.195 ± 0.019 (n=20) 0.192 ± 0.021 (n=21) 0.187 ± 0.009 (n=15)
B1 0.197 ± 0.015 (n=10) 0.198 + 0.016 (n=ll) 0.183+ 0.012 (n=7)
B2 0.193 ± 0.018 (n=10) 0.189 ± 0.030 (n=12) 0.185 ± 0.013 (n=7)
B1+B2 0.195 ± 0.015 (n=20) 0.193 ± 0.028 (n=23) 0.184 ± 0.012 (n=14)
Cl 0.198 ± 0.015 (n=10) 0.181 ± 0.030 (n=ll) 0.182 ± 0.013 (n=7)
C2 0.192 ± 0.016 (n=8) 0.183 ± 0.030 (n=9) 0.185 ± 0.015 (n=6)
C1+C2 0.196 ± 0.015 (n=18) 0.182 ± 0.024 (n=20) 0.183 ± 0.014 (n=13)
D1 0.199 ± 0.015 (n=10) 0.186 ± 0.018 (n=10) 0.195 ± 0.006 (n=7)
D2 0.197 ± 0.012 (n=9) 0.190 ± 0.015 (n=9) 0.190 + 0.005 (n=7)
D1+D2 0.198 ± 0.013 (n=19) 0.188 ± 0.016 (n=19) 0.192 ± 0.006 (n=14)
E l 0.208 + 0.028 (n=9) 0.212 ± 0.017 (n=8) 0.193 ± 0.018 (n=7)
E2 0.193+ 0.028 (n=9) 0.206 + 0.028 (n=9) 0.189 + 0.030 (n=7)
E1+E2 0.200 ± 0.028 (n=l 8) 0.207 + 0.022 (n=19) 0.191 ± 0.024 (n=14)
TOTAL TOTAL TOTAL 
0.197±0.019 (n=95) 0.193 + 0.023 (n=102) 0.187 ± 0.014 (n=70)
where 1 and 2 are the left and right hemispheres, respectively.
A, B, C, D, E are the superior frontal gyrus, superior parietal gyrus, medial 
temporal gyrus, hippocampus and thalamus, respectively.
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No significant differences were found between any regions or between the left and 
right hemispheres but from Table 6.2 it can be seen that the thalamus has the highest 
DFW ratio. This agrees with the work of Stedman, (Ste96), who found the thalamus 
was found to have the highest DFW ratio because it contains a large amount of white 
matter.
In this study the hippocampus also was found a higher DFW ratio than the cortex and 
this is mainly grey matter, the reason being unknown but the value does agree with 
that of Thompson’s et al., (Tho88) 0.194 ± 0.004. Also DFW values were found to be 
consistently higher in the left hemisphere compared to the right, Andrasi et al., 
(And90) also found the higher DFW ratios in the left side compared to the right.
In this study, DFW ratios were found to be significantly higher in males compared to 
females (p<0.1), however because the ages were not matched, all the male subjects 
less than 65 years were excluded and there was found to be no significant difference 
for the DFW ratios between males and females, the average DFW ratio for the age 
matched males being 0.198 +/- 0.020.
The scatter plot, Figure 6.2, illustrates that the dry to fresh weight ratios are 
dependent on age in ‘normal’ subjects, where Figure 6.3a shows more clearly an 
increase of DFW ratio up to 65 years, (in males only), at significance (p<0.02) and 
Figure 6.3b shows after 65 years a general a negative correlation with DFW ratios in 
both females and males at significance (p<0.001). Markesbery et al., (Mar82), have 
shown water increases in older subjects therefore decreasing the conversion ratio.
Stedman, (Ste96) found in dividing the samples into females and males, the decrease 
in DFW conversion ratios with age was due to the male subjects with no correlation 
seen for females. Even though in this work, there was a small number of samples a 
decrease of DFW ratio was seen for both females, (pO.OOl), (Figure 6.3a) and males 
over 65 years, (Figure 6.3b), (pO.OOl).
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DFW versus age distributions have also been plotted for each separate area of the 
brain and for both hemispheres and for all age groups. Figures 6.4a-6.4e. Before the 
age of 65 there is a positive correlation of age and DFW ratio in the frontal lobe, at 
significance (p<0.05), the hippocampus at significance (p<0.05), and the thalamus at 
significance (p<0.05), in DFW ratio after 65 years old, there is a negative correlation 
with age in the frontal lobe at significance, (p<0.05), the parietal lobe at significance, 
(p<0.02), in the hippocampus at significance, (p<0.01) and in the thalamus at 
significance at (p<0.05).
Distributions were also plotted to illustrate Brain Weight Versus DFW ratio, Figure 
6.5a, Brain Weight Versus Age, Figure 6.5b, pH (of Cerobrospinal Fluid) Versus 
DFW, figure 6.5c and Post Mortem Interval Versus DFW value, figure 6.5d.
Figure 6.5a shows an increase of DFW ratio with brain weight until about 1300 g and 
then a gradual decrease of DFW ratio with brain weight, there is no significant 
correlation, whereas from Figure 6.5b, brain weight decreases with increasing age 
(pO.OOl). So even though brain weight decreases with increasing age, after 65 years, 
the DFW generally decreases, which suggests during the ageing process, as brain 
weight decreases, the water content increases. There is also a correlation for pH with 
DFW ratio, Figures 6.4c, pH decreases with increasing DFW ratio, (pO.OOl), so the 
thalamus has the lowest pH, the reason why is not clear and there no significant 
correlation for pH with age. Also in Figure 6.5d, there is a decrease in DFW ratio with 
post mortem interval, (pO.OOl) when the samples taken within the longest length of 
time were removed, the level of signifance remained the same but when samples 
taken within the shortest length of time were removed, (2.4 hours), the level of 
significance decreased, (pO.Ol), so it is important that samples are removed within a 
similar time scale. Stedman, (Ste96) found no correlation for ‘normal’ or Alzheimer’s 
subjects from the London Institute of Psychiatry, UK, even though intervals ranged 
from 12-91 hours.
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Figure 6.4a: DFW Ratio of Sam ples taken from Frontal Lobe of 
Left and Right Hem ispheres of 'Normal' Subjects, versus Age 
Figure 6.4b: DFW Ratio of Sam ples taken from Parietal Lobe of 
Left and Right Hem ispheres of 'Normal' Subjects, versus Age
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Figure 6.4c: DFW Ratio of Sam ples taken from Temporal Lobe of 
Left and Right Hemispheres of 'Normal' Subjects, versus Age 
Figure 6.4d: DFW Ratio of Sam ples taken from Hippocampus of 
Left and Right Hem ispheres of 'Normal' Subjects, versus Age
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Figure 6.4e: DFW Ratio of Sam ples Taken from Thalamus of 
Left and Right Hemispheres of 'Normal' Subjects, versus Age
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6.3.2 DFW Conversion Ratios for Alzheimer’s Subjects
A histogram. Figure 6.6, was plotted for the Alzheimer’s Subjects and this was found 
approximately to follow a normal distribution (Lillifors test p>0.2), therefore T tests 
were used for comparisons between groups where the level of significance was p<0.1.
No significant differences were found between males and females or between the left 
and right hemispheres but the DFW ratio in the thalamus, (0.207 ± 0.022) was 
significantly higher; at (p<0.05) than the frontal area, (0.192 ± 0.021), at (p<0.05) 
than the parietal area, (0.193 ± 0.028), at (p<0.002) than the temporal area (0.182 ± 
0.024) and at (p<0,005) than the hippocampus (0.188 ± 0.016). These DFW values 
agree with those given by Thompson et al., (Tho88) for the hippocampus, 0.194 ± 
0,004 and those given by Stedman, (Ste97b) for the frontal, temporal and parietal 
lobes, 0.185 ± 0.027, 0.196 ±0.019 and 0.185 ± 0,020, respectively.
The scatter plot, Figure 6.7, illustrates that the dry to fresh weight ratios do not be 
seem to be dependent on age in Alzheimer’s Disease subjects, where Figure 6.8a 
shows more clearly the DFW ratio up to 65 years and Figure 6.8b shows after 65 
years DFW ratios, there was no significant correlation.
The DFW ratio was also compared with disease duration Figure 6.9 and was found to 
decrease with disease duration at significance (pO.OOl).
DFW versus age distributions have also been plotted for each separate area of the 
brain and for both hemispheres for all age groups, Figures 6.10a-6.10e. There is in the 
Alzheimer’s Disease Subjects after 65 years, no significant correlations with age, 
apart from the thalamus which increases positively with age at significance, (pO.l).
Graphs, (Figures 6.11a and 6.11b) were plotted to illustrate the significant 
correlations of brain weight versus DFW value and brain weight versus age, 
respectively, there is no correlation for pH with age and DFW ratio, also there is no 
significant correlation in DFW ratio with post mortem interval, this is because all 
samples were taken before 6.5 hours.
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Figure 6.11a shows an increase of DFW ratio with brain weight until about 1050 g 
and then it is relatively constant, whereas from Figure 6.11b, brain weight decreases 
with increasing age at significance, (pO.OOl).
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6.3.3 DFW Conversion Ratios for Subjects with Senile Involutive Cortical 
Changes, (SICC)
A histogram was then plotted Figure 6.12a for the Subjects with SICC and figure 
6.12b which also includes the SICC subject with MS. Using the Lillifors tests for all 
subjects including the subject with MS, the normal distribution was rejected at 
significance (p<0.1) and without the MS subject at sigificance (p<0.05), so the data 
was logarithmically transformed and the data followed a lognormal fit better, at 
significance (p<0.15) and (p<0.1), respectively. All data was logarithmically 
transformed and t tests were used for comparisons between groups where the level of 
significance was p<0 .1 .
The DFW ratio of the samples from the SICC subject with MS are significantly higher 
(pO.Ol) than the samples from the subject with SICC alone.
For the SICC subjects alone no significant differences were found between the left 
and right hemispheres but there were significant differences between the frontal 
region and hippocampus, (p<0.05), between the parietal region and hippocampus 
(p<0.05) and between the temporal area and hippocampus (p<0.05), where DFW 
ratios in the hippocampus were higher in all cases and there were significant 
differences between the males and females (p<0.1), where the DFW ratios were 
higher in the females.
When the SICC subject with MS was included no significant difference was found 
between hemispheres, sex and regions, apart for the hippocampus which was found to 
have higher DFW ratios than the temporal lobe at significance, (p<0.1).
The scatter plot, Figure 6.13, illustrates that the dry to fresh weight ratios seem to be 
dependent on age in the subjects with SICC only at significance (p<0.1) and without 
the MS SICC subject, at significance (p<0.02), however, figure 6.14a shows more 
clearly the DFW ratio up to 65 years in females and Figure 6.14b shows after 65 
years DFW ratios in females and Figure 6.15 DFW ratio versus age in males. For the
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subjects >65 years old there was a negative correlation (p<0.002) of DFW ratio with 
age, for the SICC subjects only and (pO.OOl) when the SICC subject with MS was 
included. For the SICC subjects greater than 65 years, there was a negative 
correlation with age for the female subjects at significance (pO.OOl) and for the 
male subjects at significance (pO.05). These levels of significance were the same 
when the SICC subject with MS was included.
Distributions have also been plotted for each separate area of the brain and for both 
hemispheres, Figures 6.16a-6.16e for the SICC subjects only. For the subjects older 
than 65 years old, for both hemispheres of the parietal lobe. Figure 6.16b and 
thalamus Figure 6.16e, there is a negative correlation with age at significance 
(p0.005), when the SICC subject was included, this significance (pO.OOl) and for 
the thafihus, in both cases, (pO.02).
Results were plotted to illustrate Brain Weight Versus DFW value, figure 6.17a Brain 
Weight Versus Age, Figure 6.17b, Age Versus Fh, (of the Cerebrospinal Fluid), PW 
(of Cerobrospinal Fluid) Versus FDW, Figure 6.17c and Post Mortem Interval Versus 
DFW value. Figure 6.17d.
Figure 6.17a shows the brain weight of females, without the SICC subject is lower 
than those of males, (pO .00001) but the differences in DFW ratios are not 
significant, the SICC subject with MS also shows a very small brain weight. In Figure 
6.17b, excluding the MS subject with SICC, brain weight generally increases with 
increasing age (p<0.05) and with the MS subject at a lower level of significance, 
(p<0.02). This is unexpected because for both the ‘normal’ and Alzheimer’s cases 
brain weight generally decreases with increasing age. There is no significant 
correlation for DFW ratio with age but there is a negative correlation, Figure 6.17c for 
age versus pH (p<0.01) for the SICC subjects only and (p<0.05) when the MS subject 
is included. There is a decrease in DFW ratio with post mortem interval, (p<0.002). 
Figure 6.17d, but when two samples taken after 9 hours were removed the correlation 
was no longer significant.
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6.4 Comparing the three subject groups
The average age for the ‘normals’ was 6 6 . 8  ± 17.8 (n=T0) but all samples <65 year 
were ignored so the average age was 79.3 ± 6.2 (n=6 ), the average age for the 
Alzheimer’s subjects was 80.0 ±11.6 (n=ll) and when the sample < 65 years was 
removed this became 84.0 ± 8.3 (n=10) and for the SICC 80.6 +/- 10.7 (n=7) but 
when the sample < 65 years was removed this became 83.3 ± 8.5. The SICC subject 
with MS has been excluded from this comparison. The DFW conversion ratios for the 
reduced group of ‘normal’ subjects are given in Table 6.3.
Table 6.3: The DFW conversion ratios for the reduced group of ‘normal’ subjects
‘Normals’ ‘Normals’
Total 0.195+/-0.023 (n=57) C2 0.195+/-0.015 (n=5)
A1 0.195 +/-0.023 (n=6 ) C1+C2 0.196 +/- 0.017 (n=10)
A2 0.193 +/-0.023 (n=6 ) D1 0.199+/-0.016 (n=6 )
A1+A2 0.194 +/- 0.022 (n=12) D2 0.196+/-0.015 (n=6 )
B1 0.195 +/-0.019 (n=6 ) D1+D2 0.198+/-0.015 (n=12)
B2 0.193+/-0.023 (n=6 ) El 0.213 +/- 0.047 (n=6 )
B1+B2 0.194 +/- 0.020 (n=12) E2 0.180 +/- 0.018 (n=5)
Cl 0.196 +/- 0.021 (n=5) E1+E2 0.204 +/- 0.036 (n=ll)
where A, B, C, D, E are the superior frontal gyrus, superior parietal gyrus, medial 
temporal gyrus, hippocampus and thalamus, respectively, 
and 1 and 2  are the left and right hemispheres, respectively.
Parametric t tests were used to compare groups. Using the DFW values for the 
‘normal’ subjects given above, for both hemispheres and comparing with the 
Alzheimer’s and SICC subjects, the only significant difference between the normals 
and the Alzheimer’s was between the temporal regions (p<0.1) and the hippocampal 
areas (p<0.1) and between the normals and the SICC subjects the temporal regions 
(p<0.1), where the DFW ratio was found to be higher in the temporal area of the 
‘normal’ subjects in all cases. When the data was logarithmically transformed, again
214
using t tests the level of significance remained the same in all cases apart for the 
temporal area of the normals and SICC subjects which changed to (p<0.05). This is 
interesting because in Alzheimer’s Disease pathologic studies, there is a predominant 
presence of lesions of neurons in the hippocampal system and temporal area, (Kay97), 
whereas temporal lobe, (especially medial temporal lobe) volume loss occurs at the 
beginnning of the disease process, (Kay97) and in this work, the water content of the 
temporol and hippocampal regions was found to be lower in the ‘normal’ subjects 
compared to the other groups. There was also a significant difference between the 
Alzheimer’s and SICC subjects where the DFW ratio of the thalamus was found to be 
higher in the Alzheimer’s at significance (p<0.01), therefore showing a lower water 
content.
6.5 Discussion
The DFW ratios of all samples from subjects sent from the Netherlands Brain Bank 
have been examined.
In the ‘normal’ subjects no significant differences in DFW ratio were found between 
the left and right hemispheres or any of the regions. When samples were age matched 
no significant differences between sex were found. In the Alzheimer’s subjects no 
significant differences were found between males and females or between the left and 
right hemispheres, but the DFW ratio in the thalamus is significantly higher than the 
frontal, parietal and temporal regions and the hippocampus. For all the SICC subjects 
no significant differences were found between the left and right hemispheres but 
significant higher DFW ratios were found in the hippocampus compared to the 
frontal, parietal and temporal regions. Also higher DFW ratios were found in females. 
When the MS subject was removed no significant differences were found between 
hemispheres, sex and regions, apart from the hippocampus which was found to have 
higher DFW ratios than the temporal region.
Using combined hemispheres, all regions and both sexes, in the ‘normal’ subjects 
DFW ratios up to 65 years increased positively with age and after 65 correlated 
negatively with age. In Alzheimer’s Disease no significant correlation was seen with
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age and for the SICC subjects > 65 years there was a negative correlation of DFW 
ratio with age.
In the ‘normal’ subjects, DFW ratio was found to be dependent on post mortem 
interval, so short and fixed time scales may be important.
When comparing groups, significant differences were seen between the ‘normals’ and 
Alzheimer’s Disease temporal region and the hippocampal region. Between the 
‘normal’ and SICC groups, differences were seen between the temporal region.
The DFW ratio in the thalamus of the Alzheimer’s was significantly higher than in the 
SICC group, showing a significant water reduction in the thalamus of Alzheimer’s 
subjects.
To conclude, in general from these results, no significant differences in DFW ratio 
was found between hemispheres in any of the groups, so combined hemispheres may 
be discussed. DFW ratio depends on age, so for comparison of groups, age matched 
samples must be used. When making comparisons between groups, samples must 
come from the same brain region and different sexes may show differences but 
further studies need to made over a specific age range.
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CHAPTER 7
Elemental Concentrations Determined by ICP-MS
7.1 Methods
The methods, calibration and internal standards used were as described in chapter 5, 
as described for the porcine brains, for Mn, Zn, Cd and Hg.
For the human samples, 57Fe and 65Cu were diluted 100 times because of the high 
concentrations, this decision was taken rather than working in analogue mode or 
changing the resolution of these peaks at the 50 times dilution level. 6Li and 7Li were 
added together to increase the number of counts and determined without Be as the 
internal standard and 206Pb, 207Pb and 20SPb were also added together to increase the 
number of counts.
7.2 Determination of Selenium
Selenium in biological samples is difficult to determine because selenium has a high 
ionisation potential, so only approximately 30% is ionised, thus poor sensitivity and 
because of the argon type and other molecular interferences, i.e. C C2 , S O3 , 
82Kr+, 40Ar2H2+ and 1H81Br+. These interferences depend on plasma conditions and 
sample matrix, so a blank correction may not be used, (Gam99). The sample was 
diluted with <1% butanol, with standard operating conditions, (Del97). As a trial to 
determine the amount of butanol to add, the counts from the masses 78 and 82 (with 
and without correction equations) were determined in the bovine liver for an increase 
of concentration of butanol up to 0.8%. Table 7.1 shows the counts obtained and it 
was decided to add 0.7% butanol.
7.3 Determination of Lithium
Difficulties were encountered in determining Li with ICP-MS because of the 
extremely low mass of Li. The first problem was the very low concentrations in the 
brain tissue close to the limit of detection as shown in Table 7.2. So 6Li and 7Li were 
added together thus increasing the number of counts obtained. Also because there is 
no certified reference value for Li in Bovine Liver b, it was necessary to use NIST
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Table 7.1 : Increase of counts of Se 82, with and without correction equation and Se 
7  8  with increase of concentration of butanol.
% butanol Se 82 with 
correction equation
Se 82 without 
correction equation
Se 78
0 5237 6134 2 1 2 2 0
0.05 6281 7135 23627
0 . 1 9332 10114 30940
0 . 2 10413 1 1 1 0 0 33379
0.4 11298 11905 35380
0 . 6 14232 14749 41807
0 . 8 14946 15405 43348
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1643c, Trace Elements in Water; because the NIST water contained Be, the Be 
internal standard could not be used. Furthermore after two or three series it became 
apparent that there was a loss in Li. The reason being as the lens becomes less clean, 
the accumulated impurities held onto the charge so the lens voltage didn’t return to 
the required value quickly enough for the first element in the sweep, (Per99). Also 
any charge on the lens deflected the lighter elements to a greater extent than the heavy 
ones. The latter also deflected the heavy elements, these are known as space charge 
effects, (Tyl95). It was found that putting a low mass element such as mass 5 allowed 
long analytical runs, i.e., greater than ten series.
The Limit of Detection for each of the elements determined by ICP-MS are shown in 
Table 7.2. As described in chapter 4, the detection limits (jag/L) were established by 
analysis of >50 blank solutions, (LOD 3a). The detection limits (jag/g) are also given 
for a 50 mg and 150 mg sample. These detection limits are sensitive for determination 
of all elements in ‘normal’ human brain tissue apart from Li and Pb where over 50% 
of the samples were below the limit of detection.
Table 7.2: Limit of Detection (LOD) for all elements determined in this work.
Isotope (s) Used For 
Determination
LOD (jag/L) LOD (ng/g)
50 mg sample
LOD (ng/g)
150 mg sample
^Li + 7Li 0.148 0.06 0.02
^Se 1.6 1.6 0.52
55Mn 0.6 0.6 0.2
% n 32 32.3 10.7
57Fe 120 240 80
^Cu 2.6 5.2 17.3
m Cd 0.017 0.02 0.006
^ H g 0.007 0.007 0.002
208Pb+207Pb+206Pb 0.076 0.076 0.025
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7.4 Recovery, Precision, Accuracy and Homogeneity
As described in chapter 4, recovery was performed by spiking samples with known 
concentrations of the element of interest The analytical recovery is shown in Table
7.3 and was found to be satisfactory for all elements.
The accuracy of the methods was assessed by analysing NIST Bovine Liver b, (Table 
7.4), IAEA Animal Blood, (Table 7.5), Bovine Liver a, (Table 7.6) and NIST Trace 
Elements in water, (Table 7.7). The consensus values for NIST biological materials 
by Roelandts, (Roe98) are shown in bold. All reference materials were within the 
range of the certified reference values except for Hg, which however, is not certified.
The precision of the samples and standards are shown in Table 7.8, precision is 
defined in Chapter 5.7.2. Precision was found to be acceptable for all elements. 
Homogeneity shown in Table 7.8, as defined in Chapter 5.7.2, was measured in one 
‘normal’ sample and one Alzheimer’s Disease sample was also found to be 
acceptable apart from Zn where the RSD was found to be slightly high. Also the 
samples chosen to determine homogeneity had concentrations close or below the limit 
of detection for Li and Pb so no conclusions are available for these two elements.
222
Table 7.3: Analytical recovery for all determined elements.
Isotope (s) used for 
determination
Spike added 
(Mg/1)
Spike
determined 
(jLig/1) n>20
Recovery ( Percentage 
+ Standard Deviation)
6Li + 'Li 0.2 0.21 +/-0.02 106 +/- 9
6Li + 7Li 0.8 0.83 +/- 0.05 104 +/- 6
55Mn 0.3 0.33 +/- 0.07 103 +/- 24
55Mn 3.0 3.04 +/- 0.56 102 +/-19
57Fe 200 206 +/- 16 103 +/- 8
57Fe 400 305 +/- 107 92+/-24
67Zn 40 45 +/-13 111+/-30
67Zn 200 196 +/- 25 99 +/-12
65Cu 40 40 +/- 3 100 +/- 6
65Cu 100 95 +/- 7 95 +/- 7
teSe 2.0 1.93 +/-0.16 97 +/- 8
82Se 50 4.48 +/- 0.22 90 +/- 4
11'Cd 0.2 0.21+/-0.01 102 +/- 7
"'Cd 1.0 1.02 +/-0.03 102 +/- 3
202Hg 0.2 0.19+/-0.03 96+/-13
202Hg 1.0 1.02 +/-0.13 102 +/-13
2l)8Pb+207Pb+206Pb 0.4 0.40 +/- 0.03 101 +/- 7
208Pb+207Pb+206Pb 2.0 1.99 +/-0.11 101 +/- 2
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Table 7.4: Results determined by ICP-MS for NIST Bovine Liver b (BLb) in (p,g/g).
Isotope (s) Used 
for Determination
BLb (n>50) 
(Pg/g)
NIST CRY 
(Hg/g)
Roelandts (Roe98)
(ng/g)
6Li + 7Li 0.172 ±0.038 - -
55Mn 10.5 ±0.5 10.5 ± 1.7 10.5 ± 0.9
y/Fe 172 ±16 184 ± 15 173 ± 19
67Zn 131 ± 9 127 ± 16 125 ±8
"Cu 153 ±9 160 ± 8 157 ± 8
^Se 0.73 ±0.075 0.73 ± 0.06 0.73
^^Cd 0.497 ±0.024 0.50 ±0.03 0.50 ± 0.05
'"'Hg 0.0046 ±0.0017 (0.003) 0.003 ±0.001
2ti8Pb+207Pb+206Pb 0.125 ±0.021 0.129 ± 0.004 -
Table 7.5: Results determined by ICP-MS for IAEA Animal Blood in (jag/g).
Isotope (s) Used 
for Determination
AB (n>30)
(ng/g)
IAEA CRY
(ng/g)
6Li + 7Li 0.064 ± 0.014 -
55Mn - -
y'Fe - -
6>Zn 13.5 ± 6 13 (12-14)
65Cu 3.7 ±0.5 4.3 (3.7-4.S)
82Se 0.28 ±0.035 0.24 (0.15-0.31)
' “ Cd - -
i02Hg - -
2,J8Pb+2(l7Pb+2(J5Pb 0.16 ±0.05 0.18 (0.14-0.3)
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Table 7.6: Results determined by ICP-MS for NIST Bovine Liver a (BLa) in (jug/g).
Isotope (s) Used 
for Determination
Bla (n>12) 
W g )
NIST CRM 
W g )
Roelandts (Roe98) 
(lig/g)
6Li + 7Li - - 0.25 ± 0.027
55Mn 10.0 ±0.6 9.9 ± 0.8 9.9 ± 0.6
5/Fe 183 ±29 194 ±20 181 ± 19
67Zn 124 ± 6 123 ± 8 122 ± 5
65Cu 161 ±10 158 ±7 153 ± 11
82Se - - -
11‘Cd 0.425 ±0.03 0.440 ± 0.06 0.430 ± 0.04
2”2Hg 0.0046 ±0.0028 0.004 ± 0.002 0.004 ± 0.001
208Pb+207Pb+2('6Pb 0.134 ±0.038 0.123 ± 0.008 0.136 ±0.018
Table 7.7: Results determined by ICP-MS for NIST Trace Elements in Water in 
W L ).
Isotope (s) Used 
for Determination
NIST Trace 
Elements in Water 
(Pg/L)
CRY
(Pg/L)
Roelandts
(Roe98)(pg/L)
6Li + 7Li 16.1 ± 1.4 (n=32) 16.5 ±1.0 16.8 ±0.9
55Mn 38.9 ±7.10 (n=30) 35.1 ±2.2 35.6 ± 1.6
57Fe - 106.9 ±3.0 107 ±3
67Zn - 73.9 ±0.9 74 ± 3
65Cu 27.4 ±5.8 (n=6) 22.3 ±2.8 22.2 ± 2
82Se 12.1 ± 0.9 (n=9) 12.7 ± 0.7 12.5 ± 1.2
luCd 12.6 ± 0.9 (n=31) 12.2 ± 1.0 12.2 ± 0.7
202Hg - - <0.6
2(,8Pb+207Pb+2(l6Pb 33.8 ± 3.2 (n=31) 35.3 ± 1.7 35.3 ± 1.7
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Table 7.8: Precision (RSD (%)) of the sample and Bovine Liver b (BLb) standard and 
the homogeneity (RSD (%)) of one ‘normal’ sample and one Alzheimer’s Disease 
sample.
Isotope used for Precision Precision BLb Homogeneity Homogeneity
determination sample (n=5) ‘normal’ ‘AD’
(n=5) (n=5) (n=5)
RSD (%) RSD (%) RSD (%) RSD (%)
"Li + 7Li 1.8 0.8 <LOD cLOD
55Mn 1.3 0.3 8.7 4.9
)7Fe 0.3 1.8 14.6 9.5
67Zn 2.1 10.7 22.8 16.3
65Cu 4.9 2.0 2.6 7.7
82Se 2.9 1.3 13.6 4.3
luCd 1.3 0.8 6.6 4.2
202Hg 5.8 5.0 7.4 7.2
208Pb+207Pb+206Pb 1.7 2.2 <LOD CLOD
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7.5 Elemental Concentrations
The elemental concentrations for Fe, Mn, Zn, Cu, Se, Cd, Hg, Pb and Li and standard 
deviation determined by ICP-MS are shown in Table 7.9, with the number of samples 
below the limit of detection. Also stated are the range, arithmetic mean and standard 
deviation, geometric mean and standard deviation, the median. For Li and Pb where 
more than 50% of the samples, were below the limit of detection, statistics were 
applied on both hemispheres and all areas. Of interest is the concentration of Fe in the 
SICC subjects; the range is high, especially in the thalamus because of the MS 
subject. The high concentration of Fe, may be caused by oxidative stress. It may be 
important in further work to control with spéciation studies if this is Fe(HI). Also Hg 
concentrations were found to be 10 times lower than those given by Ehmann et al., 
(Ehm86), using INAA.
F r e q u e n c y  distributions were plotted for all elements, for all groups, Fe in Figures 
7.1(a, b and c), Zn in Figures 7.2 (a,b and c), Cu in Figures 7.3 (a,b and c), Mn in 
Figures 7.4 (a,b and c), Cd in Figures 7.5 (a, b and c), Hg in Figures 7.6 (a,b and c), 
and Se in Figures 7.7 (a, b and c), Li in Figures 7.8 (a, b and c) and Pb in Figures 7.9 
(a, b and c) because the distribution of the element, normal or lognormal as described 
by Liebscher, (Lie67) may give information about the essentiality of the element.
Each distribution is for both hemispheres and all areas. For samples containing Li and 
Hg distributions were plotted for sample concentrations greater than the LOD.
Visually, either a normal or lognormal curve may be fitted to the distribution, 
however, the distribution of the data was checked by the Lillefors probabilités, (as 
described in chapter 6.2) for normality as shown below in Tables 7.10, for the 
‘normal’ subjects, Table 7.11 for the Alzheimer’s subjects and Table 7.12 for the 
subjects with Senile Involutive Cortical Changes. The statistical analysis were 
performed with the STATISTICA software package. The lognormal test was only 
fitted if the normal had to be rejected, (p<0.2). For the ‘normal’ subjects Mn, Zn and 
Se did not follow either distribution, for the Alzheimer’s cases, Mn, Se and Cd did not 
follow either distribution so by using the frequency distributions, outliers were 
identified (>3ct) and removed and the results are shown in each of the respective 
tables. For the ‘SICC’ subjects, Mn and Pb did not follow either distribution and this
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remained, even when the outliers were removed. In Table 7.12, the calculations in 
italics are without the SICC subject with Multiple Sclerosis. Since MS is an immune 
disorder of the CNS, it must also be excluded.
For the ‘normal’ subjects, Fe and Li follow normal distributions and Cu, Cd, Hg and 
Pb clearly follow lognormal distributions, this is expected for Cd, Hg and Pb because 
of their probable non essential roles in the brain, however this is not expected for Cu 
which also follows a lognormal distribution. Cu is extracellular and cytoplasmic and 
is found in oxidases and superoxide dimutase, however, free Cu may increase the 
number of free radicals. (PraOO). Fe is important in the brain because of it enzymatic 
role in energy metabolism. No essential role for Li has been found in the literature. It 
has been suggested that Li may compete for magnesium and calcium binding sites on 
biological ligands, (Bir76). Using the Lillifors probabilities, Mn, Zn and Se do not fit 
either distribution but when the outliers were removed and Mn was found to follow a 
lognormal distribution and Zn and Se normal distributions indicating their 
essentiality. In the Alzheimer’s subjects Li, Fe, Cu and Zn follow a normal 
distribution. For Zn this is expected as more than 300 reactions are oxidised by Zn 
containing enzymes. Mn, Se and Cd don’t seem to follow either distribution but when 
the extreme values were removed Se followed normal distribution and Mn and Cd 
still didn’t follow either distribution. In the subjects with senile involutive cortical 
changes, Li, Fe, Cu, Zn, Se and Hg follow a lognormal distribution. When the MS 
subject with SICC was excluded, Fe followed a normal distribution and Cd followed 
a lognormal distribution. Mn and Pb as explained above, did not follow either 
distribution.
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Table 7.9: Fresh Weight Concentrations in ‘Normal’ Subjects (NORM), Alzheimer s 
Disease (AD), Subjects and Subjects with Senile Involutive Cortical Changes (SICC) 
determined by ICP-MS. The arithmetic mean and standard deviation, the geometric 
mean and standard deviation, the median, range and number of samples are presented.
Fe (us/e) ________________________ _
Brain Group Arithmetic Geometric Median Range N
SDMean SD Mean
A1 NORM 51 9.4 50 1.2 51 33-63 9
AD 49 7.8 49 1.2 53 34-57 10
SICC 46 7.1 46 1.2 47 36-50 6
A2 NORM 53 4.9 53 1.1 54 43-56 9
AD 52 11.2 51 1.3 55 37-70 11
SICC 47 7.2 46 1.2 48 33-54 6
B1 NORM 50 12.0 49 1.3 48 32-65 9
AD 56 11.1 55 1.2 54 42-75 10
SICC 46 11.7 45 1.3 45 34-61 6
B2 NORM 53 11.9 52 1.3 58 29-64
10
AD 64 20.7 61 1.3 63 39-116 11
SICC 46 8.3 45 1.2 47 35-56 6
Cl NORM 50 8.5 49 1.2 50 38-61
9
AD 63 19.1 61 1.4 62 31-110 11
SICC ^ 46 I 12.5 1 44 1.3 49 30-62 ^ 6
C2 NORM 54 14.4 53 1.3 49 42-87
8
AD 58 13.5 56 1.3 59 31-78 11
SICC 44 9.3 43 1.2 43 35-60 6
D1 NORM 43 7.2 42 1.2 40 35-53
9
AD 46 7.0 46 1.2 45 38-61 9
SICC 40 8.4 39 1.2 41 30-52 6
D2 NORM 44 6.6 43 1.2 43 34-49
10
AD 46 12.7 45 1.3 47 33-71 10
SICC 45 18.4 42 1.5 43 23-79 6
El NORM 56 17.1 54 1.4 52 43-87
9
AD 47 12.4 46 ....1.3 49 31-65 8
SICC 53 33.4 45 1.8 40 26-112 6
E2 NORM 63 19.4 60 1.4 60 43-109
10
AD 51 15.9 48 1.4 55 30-76 8
SICC 54 27.4 49 1.6 49 25-103 6
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Table 7.9 cont: Fresh Weight Concentrations
Mn (ng/g)
Brain Group Arithmetic 
Mean SD
Geometric 
Mean SD
Media Range 
n
N
Al NORM 257 126 238 1.5 204 172-569 9
AD 210 46 206 1.2 213 136-220 10
SICC 214 19 213 1.1 210 190-240 6
A2 NORM 219 61 213 1.3 208 171-372 10
AD 196 63 175 1.9 204 167-275 11 .
SICC 209 15 208 1.1 212 188-223 6
B1 NORM 224 37 228 1.2 235 187-280 10
AD 212 51 207 1.3 204 159-327 10
SICC 218 11.2 218 1.1 217 205-232 6
B2 NORM 211 36 209 1.6 199 175-294 10
AD 224 29 222 1.2 216 189-293 11
SICC 218 20 218 1.1 222 188-240 6
Cl NORM 195 43 191 1.2 186 147-288 9
AD 222 30 220 1.2 230 172-263 11
SICC 206 22 205 1.1 203 191-236 6
C2 NORM 260 78 252 1.3 240 187-433 8
AD 231 65 225 1.3 240 148-393 11
SICC 215 20 214 1.1 213 205-243 6
D1 NORM 274 42 271 1.2 260 239-355 10
AD 278 51 274 1.2 284 223-354 8
SICC 256 27 255 1.1 258 226-286 6
D2 NORM 246 84 224 1.7 224 173-366 10
AD 305 48 301 1.3 318 245-376 10
SICC 291 51 287 1.2 292 231-350 6
El NORM 427 164 407 1.4 407 266-838 9
AD 396 51 393 1.1 378 343-481 8
SICC 411 100 402 1.3 391 308-428 6
E2 NORM 481 271 422 1.7 370 155-834 10
AD 385 33 383 1.1 393 328-407 8
SICC 411 62 407 1.2 402 322-488 6
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Table 7.9 cont: Fresh Weight Concentrations
Zn (ng/g)
Brain Group Arithmetic 
Mean SD
Geometric 
Mean SD
Median Range N
Al NORM 13.4 2.9 13.1 1.2 12.6 10.4-19.4 9
AD 13.2 2.1 13.1 1.2 12.9 9.7-16.3 10
SICC 15.1 5.4 14.4 1.4 13.6 9.9-24.6 6
A2 NORM 13.0 2.9 12.8 1.2 12.7 10.3-19.5 10
AD 13.3 2.8 13.0 1.2 13.1 8.3-19.4 11
SICC 14.5 4.5 13.4 1.3 14.0 10.9-22.2 6
B1 NORM 14.7 5.6 13.9 1.4 13.5 9.5-27.7 10
AD 12.7 3.1 12.4 1.3 12.5 8.3-18.7 10
SICC 16.2 5.5 15.4 1.4 16.4 9.8-24.3 6
B2 NORM 12.2 1.9 12.1 1.2 12.4 9.4-14.8 10
AD 13.4 3.1 13.1 1.3 14.8 9.2-16.7 11
SICC 15.7 2.8 15.5 1.2 16.1 12.2-19.3 6
Cl NORM 13.1 2.2 12.9 1.2 13.8 10.3-16.1 9
AD 14.6 2.5 14.4 1.2 14.3 11.0-18.5 11
SICC 15.5 2.3 14.9 1.2 15.4 13.7-19.8 6
C2 NORM 15.2 3.5 14.8 1.3 15.7 10.3-20.7 8
AD 14.7 2.2 14.4 1.2 15.2 10.5-18.0 11
SICC 17.9 5.0 17.4 1.3 17.0 13.3-26.1 12
D1 NORM 15.2 2.4 15.0 1.2 15.3 12.4-17.7 10
AD 14.8 3.2 14.4 1.3 16.3 7.1-17.1 9
SICC 17.8 5.0 18.2 1.3 17.2 12.6-25.0 6
D2 NORM 14.1 4.0 13.4 1.3 13.6 8.6-21.4 10
AD 14.3 3.5 13.9 1.3 13.6 8.5-19.3 10
SICC 19.0 6.5 18.1 1.4 18.6 12.3-26.0 6
El NORM 12.5 3.7 12.0 1.3 11.9 8.0-19.9 9
AD 12.8 3.0 12.5 1.2 12.3 9.8-19.4 8
SICC 22.9 10.9 20.5 1.7 20.0 8.5-37.8 6
E2 NORM 14.3 7.8 12.7 1.7 10.7 6.4-29.3 10
AD 14.2 1.1 14.1 1.1 13.9 13.1-15.7 7
SICC 16.9 5.2 16.2 1.4 16.0 11.9-23.2 6
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Table 7.9 cont: Fresh Weight Concentrations
Cu (jig/g)
Brain Group Arithmetic 
Mean SD
Geometric 
Mean SD
Median Range N
Al NORM 4.4 1.5 4.1 1.5 4.3 1.5-7.4 9
AD 3.0 1.0 2.9 1.4 3.1 1.4-5.0 10
SICC 4.6 1.1 4.5 1.3 4.3 3.3-6.3 6
A2 NORM 3.5 1.5 3.1 1.8 3.7 1.0-5.5 9
AD 3.6 1.4 3.4 1.5 3.5 1.6-6.2 10
SICC 4.8 1.3 4.6 1.3 4.8 3.2-6.0 6
B1 NORM 3.5 1.2 3.3 1.6 3.8 0.9-5.1 9
AD 3.6 1.4 3.4 1.5 3.5 1.6-6.2 10
SICC 4.7 0.9 4.6 1.2 4.6 3.5-6.1 6
B2 NORM 3.9 1.2 3.8 1.4 3.8 1.7-5.5 10
AD 3.7 0.8 3.6 1.3 3.7 2.8-4.6 11
SICC 4.6 1.1 4.5 1.3 4.3 3.4-6.1 6
Cl NORM 3.6 1.2 3.3 1.5 4.0 1.8-4.8 10
AD 3.1 1.0 2.9 1.4 3.3 1.3-5.1 11
SICC 4.4 1.1 4.2 1.3 3.9 3.4-5.8 6
C2 NORM 3.8 1.3 3.6 1.6 3.8 1.4-5.0 8
AD 3.3 1.0 3.2 1.4 3.4 1.4-5.4 11
SICC 4.5 0.8 4.5 1.2 4.4 3.5-6.0 6
D1 NORM 3.6 1.0 3.4 1.4 3.5 1.7-5.2 9
AD 2.9 1.1 2.7 1.5 3.2 1.8-4.7 9
SICC 4.1 1.3 4.0 1.3 3.7 3.0-6.6 6
D2 NORM 3.6 0.9 3.4 1.4 3.9 1.3-4.3 10
AD 2.6 1.1 2.4 1.5 2.4 1.2-4.6 10
SICC 3.7 1.2 3.5 1.4 3.3 3.2-5.Ô 6
El NORM 3.2 1.1 2.9 1.5 3.3 1.3-4.9 9
AD 2.7 1.0 2.5 1.4 2.3 1.7-4.8 8
SICC 4.2 1.7 3.9 1.5 3.7 Z2-6.9 6
E2 NORM 3.6 0.9 3.5 1.4 3.7 1.4-4.7 10
AD 3.1 1.2 3.0 1.5 3.1 1.8-5.3 8
SICC 3.7 0.9 3.6 1.3 3.9 2.3-4.6 6
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Table 7.9 cont: Fresh Weight Concentration
Se (ng/g)
Brain Group Arithmetic 
Mean SD
Geometric 
Mean SD
Median Range N
Al NORM 155 31 152 1.2 159 114-198 5
AD 129 19 128 1.2 133 96-147 7
SICC 133 25 132 1.2 133 102-174 6
A2 NORM 130 30 127 1.2 130 102-178 5
AD 124 40 114 1.7 135 29-156 9
SICC 145 35 142 1.3 131 122-211 12
B1 NORM 189 170 153 1.9 132 79-571 6
AD 146 21 146 1.2 148 118-180 7
SICC 122 40 116 1.5 121 59-183 6
B2 NORM 141 24 39 1.2 142 106-166 6
AD 167 55 160 1.3 148 127-299 15
SICC 115 31 111 1.3 114 98-161 6
Cl NORM 136 21 135 1.2 123 122-172 5
AD 127 21 125 1.2 129 95-163 7
SICC 129 22 128 1.2 133 93-147 6
C2 NORM 143 38 138 1.4 136 86-183 6
AD 136 19 135 1.2 138 119-162 8
SICC 157 61 150 1.4 128 93-260 11
D1 NORM 131 30 128 1.3 132 87-194 10
AD 130 15 129 1.1 134 110-148 8
SICC 139 52 133 1.3 137 105-148 5
D2 NORM 106 32 100 1.4 112 46.8-144 10
AD 132 37 129 1.3 123 108-223 9
SICC 136 34 133 1.3 137 105-148 5
El NORM 161 64 153 1.4 140 144-312 9
AD 163 37 159 1.2 158 120-231 7
SICC 155 45 149 1.3 150 107-218 6
E2 NORM 178 86 162 1.6 160 72.4-364 9
AD 173 48 169 1.3 160 130-265 7
SICC 137 13 136 1.1 133 121-153 5
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Table 7.9 cont: Fresh Weight Concentrations.....
Cd (ng/g)
Brain Group Arithmetic 
Mean SD
Geometric 
Mean SD
Median Range N
Al NORM 36 44 23 2.6 20 5-145 9
AD 24 11 21 1.7 24 8-47 10
SICC 25 5 25 1.2 24 20-34 6
A2 NORM 22 13 18 1.9 21 5-52 10
AD 26 14 26 2.0 26 4-56 11
SICC 25 6 25 1.2 24 20-35 6
B1 NORM 33 27 24 2.3 25 5-100 10
AD 26 19 25 1.7 25 12-80 10
SICC 24 7 24 1.3 22 18-36 6
B2 NORM 19 9 17 1.8 19 5-35 10
AD 28 10 27 1.4 28 14-54 11
SICC 26 6 25 1.3 24 22-38 6
Cl NORM 22 14 19 1.7 19 9-53 8
AD 30 13 27 1.6 29 11-54 11
SICC 25 7 24 1.3 22 21-37 6
C2 NORM 20 9 18 1.7 21 8-35 9
AD 25 10 23 1.6 24 10-36 11
SICC 27 6 27 1.2 24 24-39 6
D1 NORM 20 12 17 1.7 20 8-50 10
AD 30 12 28 1.5 27 12-51 9
SICC 24 7 23 1.3 21 21-38 6
D2 NORM 21 14 17 2.0 20 5-54 10
AD 32 16 29 1.5 27 11-67 10
SICC 26 8 26 1.4 26 17-38 6
El NORM 41 29 32 2.1 31 9-98 9
AD 58 34 52 1.6 45 33-136 8
SICC 56 20 54 1.4 51 35-63 6
E2 NORM 35 22 29 2.0 29 9-72 10
AD 51 24 47 1.5 48 23-104 8
SICC 57 21 55 1.4 49 41-95 6
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Table 7.9 cont: Fresh Weight Concentrations
Hg (ng/g)
Brain Group Arithmetic 
Mean SD
Geometric 
Mean SD
Median Range N
Al NORM 3.7 3.0 2.9 2.2 2.5 0.9-10.5 9
AD 2.2 1.4 1.9 1.7 2.0 0.9-5.8 10(1)*
SICC 3.1 2.5 2.6 1.8 2.2 1.7-8.1 6
A2 NORM 4.3 3.0 3.4 2.2 3.6 0.7-11.0 10
AD 2.1 1.3 1.6 2.3 2.2 0.6-4.5 11
SICC 2.8 2.3 2.3 1.9 2.0 1.4-7.2 6
B1 NORM 5.5 3.9 4.2 2.4 5.1 0.6-14.2 10
AD 2.8 1.6 2.3 2.0 1.9 0.6-4.7 9
SICC 3.2 2.1 2.6 2.1 2.7 0.9-6.5 6
B2 NORM 4.2 2.9 2.9 2.9 3.5 0.3-7.7 10
AD 2.3 1.4 1.8 2.8 2.2 0.1-4.5 10
SICC 3.2 1.8 2.9 1.7 2.6 1.7-6.5 6
Cl NORM 2.7 1.6 2.4 1.8 2.5 0.9-5.8 8
AD 4.4 3.9 3.1 2.5 4.1 0.7-14.1 10
SICC 3.3 2.6 2.7 1.9 2.5 1.3-8.3 6
C2 NORM 4.8 4.2 3.7 2.1 3.5 0.6-4.5 10
AD 4.9 4.5 3.3 2.5 2.8 0.9-14.2 11
SICC 3.1 2.2 2.5 1.9 2.7 1.1-7.3 5
D1 NORM 4.9 3.7 4.0 2.0 3.8 0.6-5.2 8
AD 3.1 0.8 3.0 1.3 3.1 2.0-4.7 8(1)*
SICC 3.7 2.6 2.9 3.5 2.4 0.7-8.2 6
D2 NORM 5.1 3.6 4.1 2.0 3.9 0.1-4.5 9
AD 3.8 2.3 3.3 1.8 3.3 1.1-8.9 10
SICC 3.4 3.1 2.1 3.5 2.2 0.2-8.7 5
El NORM 6.7 4.5 5.6 1.9 4.6 0.7-14.0 9(2)*
AD 3.7 1.5 3.2 1.8 4.3 1.2-5.2 8
SICC 6.3 2.8 5.7 1.7 6.8 2.9-10.1 6
E2 NORM 6.7 3.8 5.6 2.3 6.4 0.9-14.2 10(1)*
AD 3.5 1.3 3.3 1.5 3.8 1.6-5.5 9(1)*
SICC 5.1 3.1 4.5 1.8 3.7 2.6-9.6 6
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Table 7.9 cont: Fresh Weight Concentrations..........
(For Li and Pb, 50% of the samples were below the LOD, so for these samples 
statistics have been made on both hemispheres and all areas).
Pb (ng/g)
Group Arithmetic 
Mean SD
Geometric 
Mean SD
Median Range N
NORM 15 16 11 2.1 10 2-85 62
AD 11 7 9 2.2 10 0.8-39 41
SICC 13 9.9 9 2.2 10 0.4-45 30
Li (ng/g)
Group Arithmetic 
Mean SD
Geometric 
Mean SD
Median Range N
NORM 11 15 5.3 5.4 5.4 0.02-74 30
AD 5 4 3.0 4.9 4.9 0.01-12.8 24
SICC 4 3 3.3 1.2 1.2 0.4-11.4 21
where A = Superior Frontal Gyrus, 1 = Left Hemisphere and 2 = Right Hemisphere 
B = Superior Parietal Gyrus, 1 = Left Hemisphere and 2 = Right Hemisphere 
C = Medial Temporal Gyrus, 1 = Left Hemisphere and 2 = Right Hemisphere 
D = Hippocampus, 1= Left Hemisphere and 2 = Right Hemisphere 
E = Thalmus, 1 = Left Hemisphere and 2 = Right Hemisphere 
(N)* is the number of samples below the Limit of Detection
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Table 7.10: Lillifors Probabilités for Normality for ‘Normal’ Subjects
Element ‘Normal’ Subjects
Normal Lognormal Distribution
Lillifors (p) Lillifors (p)
Li <0.1 <0.01 Normal
Mn <0.01 <0.01 -
Mn (outliers removed) <0.01 <0.05 Lognormal
Fe >0.20 - Normal
Cu <0.01 >0.20 Lognormal
Zn <0.01 <0.01 -
Zn (outliers removed) >0.20 Normal
Se <0.01 <0.01 -
Se (outliers removed) <0.05 Normal
Cd <0.01 <0.05 Lognormal
Hg <0.01 >0.20 Lognormal
Pb <0.01 >0.20 Lognormal
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Table 7.11: Lillifors Probabilités for Normality for Alzheimer’s Disease Subjects
Element Alzheimer’s Subjects
Normal Lognormal Distribution
Lillifors (p) Lillifors (p)
Li >0.20 - Normal
Mn <0.01 <0.01 -
Fe >0.20 - Normal
Cu >0.20 - Normal
Zn >0.20 - Normal
Se <0.01 <0.01 -
Se (outliers removed) >0.20 - Normal
Cd <0.01 <0.01 -
Cd (outliers removed) - - -
Hg <0.01 >0.20 Lognormal
Pb <0.01 <0.05 Lognormal
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Table 7.12: Lillifors Probabilités for Normality for Subjects with Senile Involutive 
Cortical Changes (SICC).
Element Subjects with ‘SICC’
Normal Lognormal Distribution
Lillifors (p) Lillifors (p)
Li <0.05 >0.20 Lognormal
Mn <0.01 <0.01 -
<0.07 <0.07 -
Fe <0.01 >0.20 Lognormal
>0.20 - Normal
Cu <0.15 >0.20 Lognormal
<0.75 >0.20 Lognormal
Zn <0.05 >0.20 Lognormal
<0.05 >0.20 Lognormal
Se <0.01 >0.20 Lognormal
<0.05 <0.15 Lognormal
Cd <0.01 <0.01 -
<0.07 <0.05 Lognormal
Hg <0.01 >0.20 Lognormal
<0.01 >0.20 Lognormal
Pb <0.01 <0.01 -
<0.01 <0.01 -
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Figure 7.1a (Fe 'Normals')
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Figures 7.1 (a,b and c): Frequency  Distribution of F e  C oncentrations  
(pg/g) in S a m p le s  taken from 'Normal', A lzheim er's  D i s e a s e  S u b jec ts  
and S u b jec ts  with S e n i le  Involutive Cortical C h a n g e s  (SICC).
F igures 7 .2  (a,b and c): F requency  Distribution of Zn C oncentrations  
(pg/g) in S a m p le s  taken from 'Normal', A lzheim er's  D i s e a s e  S u b jec ts  
and S u b jec ts  with S e n i le  Involutive Cortical C h a n g e s  (SICC).
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Figure 7.3a (Cu ’Normals')
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Figure 7.4b (Mn Alzheimer's)
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Figures 7 .3  (a,b  and c): Frequency  Distribution of Cu C on cen tration s  
(jjg/g) in S a m p le s  taken from 'Normal', A lzheim er's  D i s e a s e  S u b jec ts  
and S u b jec ts  with S e n i le  Involutive Cortical C h a n g e s  (SICC).
F igures 7 .4  (a,b and c): Frequency  Distribution of Mn C on cen tration s  
(ng/g) in S a m p le s  taken from 'Normal', A lzheim er's  D i s e a s e  S u b jec ts  
and S u b jec ts  with S e n i le  Involutive Cortical C h a n g e s  (SICC).
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Figure 7.5a (Cd ’Normals')
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Figures 7 .5  (a,b and c): F requency  Distribution of Cd C oncentrations  
(ng/g) in S a m p le s  taken from 'Normal', A lzheim er's D is e a s e  S u b jec ts  
and S u b jec ts  with S en ile  Involutive Cortical C h a n g e s  (SICC).
F igures 7 .6  (a,b and c): F requency  Distribution of Hg C on cen tration s  
(ng/g) in S a m p le s  taken from 'Normal', A lzheim er's D i s e a s e  S u b jec ts  
and S u b jec ts  with S e n ile  Involutive Cortical C h a n g e s  (SICC).
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Figure 7.7a (Se 'Normals')
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Figures 7 .7  (a,b and c): Frequency Distribution of S e  C on cen tration s  
(ng/g) in S a m p le s  taken from 'Normal’, A lzheim er's  D is e a s e  S u b jec ts  
and S u b jec ts  with S en ile  Involutive Cortical C h a n g e s  (SICC).
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Figure 7.8a (Li ’Normals')
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Figures 7 .8  (a,b and c): F requency  Distribution of Li C on cen tration s  
(ng/g) in S a m p le s  taken from 'Normal', A lzheim er's D i s e a s e  S u b jec ts  
and S u b jec ts  with S e n i le  Involutive Cortical C h a n g e s  (SICC).
F igures 7 .9  (a,b and c): F requency  Distribution of Pb C oncen tration s  
(ng/g) in S a m p le s  taken from 'Normal', A lzheim er's D i s e a s e  S u b jec ts  
and S u b jec ts  with S e n i le  Involutive Cortical C h a n g e s  (SICC).
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7.6 Variations in Concentrations between Hemispheres
As described by Stedman, (Ste96) because the two hemispheres perform different 
functions it may also be expected that elemental concentrations vary between 
hemispheres. T tests were used to identify significant differences between 
hemispheres, (p<0.1). Considering each element, the only differences seen were for 
Mn at (p<0.1) in the right hemisphere lower than the left hemisphere of the temporal 
gyrus in the ‘normal’ subjects and Pb was found to be lower at significance, (p<0.1) 
in the right hemisphere compared to the left. These differences were less significant 
than samples from the cortex with MAA, (Pan99) but the latter was a much smaller 
sample size than above so it is more difficult to prove differences between groups. 
Also for Pb the sample size was quite small so it was difficult to prove differences.
7.7 Variations in Concentrations between Regions of the Brain
A summary of t tests used between all areas are shown in Tables 7.13, 7.14 and 7.15. 
Because there was no significant difference between hemispheres or the level of 
significance was (p>0.05) the combined values found for both hemispheres were used
for each region.
For the ‘normal’ subjects Se and Fe were found to be higher in the frontal area 
compared to the hippocampus. Se was higher in the hippocampus compared to the 
temporal area. Se was also found to be significantly higher in the thalamus compared 
to the temporal area and hippocampus and Fe was found to be higher in the thalamus 
compared to the frontal area and hippocampus.
In the Alzheimer’s subjects, Cu and Fe in the parietal area and Zn, Fe and Hg in the 
temporal area were found to be significantly higher compared to the frontal area and 
Cu and Fe were found to be higher in the parietal areas compared to the hippocampus 
and thalamus. Se was found to be significantly higher in the parietal area compared to 
the temporal area and Fe was found to be significantly higher in the hippocampus and 
thalamus compared to the temporal area. Hg and Mn were higher in the hippocampus 
compared to the frontal and parietal area and Mn was higher in the hippocampus 
compared to the temporal area. The thalamus showed the highest concentration of
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elements compared to the other areas especially for the non essential elements, Cd 
and Hg and also for Se and Mn.
In the subjects with SICC, the Multiple Sclerosis subject was taken out. Zn was found 
to be slightly higher in the hippocampus and thalamus compared to the frontal and 
parietal area. Mn was found to be higher in the hippocampus compared to the frontal, 
parietal and temporal area. Mn, Cd and Hg were significantly higher in the thalamus 
compared to all other areas. When the MS subject was included the only notable 
differences were Cd became more significant and Hg became less significant.
In general for all three groups, the thalamus showed the highest concentration of 
elements compared to the other areas especially for the non essential elements Cd and 
Hg and also Mn showed higher concentrations in the thalamus compared to other 
areas.
7.8 Concentration Correlations with Age
As described in the previous chapter for the ‘Normal’ subjects (NORM) the age range 
was large from 38 years to 87 years, the Alzheimer’s Disease (AD) ranged from 62-92 
years and the Subjects with Senile Involutive Cortical Changes, (SICC) subjects 
ranged from 64-88 years. Table 7.16 shows the significant correlations for each 
element with age for each region of the brain. Because no significant differences were 
found between hemispheres, apart for Mn and Pb at a low level of significance, the 
results from combined hemispheres have been shown.
For Fe and Mn there were no correlations for age except in the Fe (AD) and Fe 
(SICC) subjects where there was a negative correlation with age (p<0.005) and 
(p<0.01), respectively and when the SICC subject with MS was taken out of the group 
it was even more significant (p<0.002). When subjects < 65 years were excluded, 
correlations were still significant. There were some positive correlations with age for 
Zn (NORM) (p<0.02) and Cu (NORM) (p<0.002). There was a highly significant 
positive correlation for Cd (NORM) with age (p<0.001) and Cd (AD) (p<0.1), 
however when subjects < 65 years were excluded, correlations were no longer 
significant. For Hg (NORM) and Hg (SICC) there were negative correlations
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(p<0.001) and (p<0.1) respectively, which became more significant when the subjects 
< 65 years were removed as shown in table. Stedman, (Ste96) found no significant 
correlation for Fe, Zn and Cd with age (69-93 years ) and Duflou, (DufflT) found Fe 
concentrations to increase rapidly in the first 20 years of life and then remain stable 
but in general few papers have discussed correlations between elemental bram
concentrations and age.
Figures 7.10 and 7.11 show Fe and Cu respectively in ‘Normal’ Subjects, Figures 7.12 
and 7.13 show Fe and Cu in Alzheimer’s Disease Subjects and Figures 7.14 and 7.15 
show Fe and Cu with Subjects with SICC. Figures 7.10 and 7.11 show Zn and Cd 
respectively in ‘Normal’ Subjects, Figures 7.16 and 7.17 show Zn and Cd in 
Alzheimer’s Disease Subjects and Figures 7.14 and 7.15 show Zn and Cd with 
Subjects with SICC. Finally show Hg versus age for ‘Normals’ and Alzheimer s 
Subjects in Figures 7.16 and 7.17 respectively, in all subject groups
The positive correlation of Cu and Zn with age in the ‘normal’ subjects was not such 
a high level of significance and in the case of Cu when the subjects <65 years were 
removed, there was no longer a significant correlation so Cu may increase until <65 
years and then remain constant. The negative correlations with age in the SICC 
subjects for Zn and Cu could be a cause of oxidative stress and removing the subject 
with MS made the results were even more significant (p<0.05) and (p<0.005).
It is documented that Cd is a toxic element that increases with age and this is also 
expected for Hg so why Hg concentrations in ‘normal’ brain and SICC subjects at a 
lower level of significance and decreasing with increasing age is difficult to explain, 
when the two subjects 38 and 48 were taken out of the group the results became even
more significant (p<0.001).
7.9 Concentration Correlations with Post Mortem Interval
Post mortem intervals did not exceed 10.45 hours, the maximum found in 
two*normal’ subjects, so correlations were only calculated for the ‘normal’ subjects 
and a negative correlation was found for Zn (p<0.01) and for Cu (p<0.01). However,
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Figure 7.10 (Fe 'Norm als')
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Figure 7.11 (Zn 'Normals')
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Figures 7.10 and 7.11: Fe and Cu Fresh Weight Concentrations,
(ug/g) respectively, versus Age in years of Combined Hemispheres of
Male and Female 'Normal' Subjects
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Figure 7.12 (Fe Alzheimer's)
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Figure 7.13 (Cu Alzheimer's)
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Figures 7.12 and 7.13: Fe and Cu Fresh Weight Concentrations,
(ug/g), respectively, versus Age in years of Combined Hemispheres of
Male and Female Alzheimer's Disease Subjects
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Figure 7.14 (Fe SICC)
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Figure 7.15 (Cu SICC)
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Figures 7.14 and 7.15: Fe and Cu Fresh Weight Concentrations, 
(ug/g), respectively, versus Age in years of Combined Hem ispheres of 
Male and Female Subjects with Senile Involutive Cortical Changes 
(SICC) and one Female Subject with SICC and Multiple Sclerosis (MS)
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Figure 7.16 (Zn 'Normals')
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Figure 7.17 (Cd Normals')
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Figures 7.16 and 7.17: Zn and Cd Fresh Weight Concentrations,
(ug/g), respectively, versus Age in years of Combined Hemispheres of
Male and Female 'Normal' Subjects
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Figure 7.18 (Zn Alzheimer's)
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Figure 7.19 (Cd Alzheimer's)
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Figures 7.18 and 7.19: Zn and Cd Fresh Weight Concentrations,
(ug/g), respectively, versus Age in years of Combined Hemispheres of
Male and Female Alzheimer's Disease Subjects
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Figure 7.20 (Zn SiCC)
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Figure 7.21 (Cd SICC)
110
O)
D )3
oo
c
o
c
8c
o0
CD
1 
I
L L
T 3
O
Age in years
Maie Frontal Lobe 
Male Parietal Lobe 
Male Temporal Lobe 
Male Hippocampus 
Male Thalam us 
Female Frontal Lobe 
Female Parietal Lobe 
Female Temporal Lobe 
Female Hippocampus 
Female Thalam us
Figures 7.20 and 7.21: Zn and Cd Fresh Weight Concentrations, 
(ug/g), respectively, versus Age in years of Combined Hem ispheres of 
Male and Female Subjects with Senile Involutive Cortical C hanges 
(SICC) and one Female Subject with SICC and Multiple Sclerosis (MS)
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Figure 7.22 (Hg Normals')
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Figure 7.23 (Hg Alzheimer's)
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Figures 7.22 and 7.23: Hg Fresh Weight Concentrations, (ug/g) versus
Age in years of Combined Hemispheres of Male and Female 'Normal'
Subjects and Alzheimer's Disease Subjects, respectively.
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Figure 7.24 (Hg SiCC)
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Figures 7.24: Hg Fresh Weight Concentrations, (ug/g), respectively, 
versus Age in years of Combined Hem ispheres of Male and Female 
Subjects with Senile Involutive Cortical C hanges (SICC) and one 
Female Subject with SICC and Multiple Sclerosis (MS)
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when these samples were removed, there was still a correlation for Zn (p<0.01) so it 
is extremely important to obtain samples no longer after 8.5 hours after death, this 
being the next longest PM  time within the group or there may be loss in elements.
7.10 Interelement Correlations
Table 7.17 shows all significant correlation coefficients for all elements determined 
except Pb and Li. All correlations were positive except for Zn-Hg in the ‘SICC’ 
subjects.
In the ‘normal’ subjects nearly all correlations were significant apart from Zn-Hg, Cu- 
Hg and Cd-Hg. A Hg-Se correlation was seen, Hg uptake can be reduced by high 
selenium concentrations, as these two elements are bound to a specific protein at an 
equimolar ratio, (Yon97)
In the Alzheimer’s subjects there were fewer significant correlations. Fe no longer 
correlated with any other elements and there were in particular two significant 
correlations, Zn-Cu and Mn-Cd. Zn and Cu is expected because the protein 
metallothionin regulates and stores Zn and Cu.
For the subjects with SICC, with and without the MS subject, there were significant 
correlations for Mn-Se, Mn-Cd, Mn-Hg, Zn-Hg and Cd-Hg. The only difference was 
for Fe correlations. Without the MS subject there was a significant Fe-Cu correlation 
but when the MS sample was included, there were significant correlations for Fe-Mn, 
Fe-Cd and Fe-Hg.
7.11 Effect of Disease Duration in Alzheimer’s Subjects on Concentrations
The only significant correlations were found for Zn combined hemispheres and 
regions (p<0.001), a negative correlation, in particular the frontal region (p<0.1), the 
temporal region (p<0.05) and the hippocampus (p<0.002).
Cu for combined hemispheres and regions showed a negative" correlation (pcO.OOl) 
with disease duration and Li at significance (p<0.001), showed a positive correlation 
with disease duration, in particular for the hippocampal region. The data is displayed 
for Zn, Cu and Li in Figures 7.25, 7.26 and 7.27, respectively. Apart from Stedman, 
(Ste96) who studied Na, Cl, Br and K with disease duration none of the other
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Table 7.17: Significant Interelement Correlations for Fresh Weight Concentrations for 
‘Normal’, Alzheimers Disease Subjects and Subjects with Senile Involutive Cortical 
Changes, (SICC) with and without the Multiple Sclerosis Subject (MS).
All correlations were positive except for Zn-Hg in the Subjects with SICC
Elements ‘Normal’
Subjects
Alzheimer’s
Subjects
‘SICC’ Subjects ‘SICC’ Subjects with MS 
Sample Removed
Fe-Mn <0.001 - <0.001 -
Fe-Zn <0.005 - - -
Fe-Cu <0.001 - - <0.001
Fe-Se <0.001 - - -
Fe-Cd <0.001 - <0.001 -
Fe-Hg <0.001 - <0.001 -
Mn-Zn <0.01 <0.1 - -
Mn-Cu <0.001 - - -
Mn-Se <0.001 - <0.1 <0.05
Mn-Cd <0.001 <0.001 <0.001 <0.001
Mn-Hg <0.005 - <0.001 <0.002
Zn-Cu <0.001 <0.002 - -
Zn-Se <0.005 - - -
Zn-Cd <0.002 <0.1 - -
Zn-Hg - - <0.05 (negative) <0.001
Cu-Se <0.001 - - -
Cu-Cd <0.001 - - -
Cu-Hg - - - -
Se-Cd <0.001 - - <0.05
Se-Hg <0.02 - - -
Cd-Hg - - <0.001 <0.001
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Figure 7.25 (Cu Disease Duration)
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Figure 7.26 (Zn Disease Duration)
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Figures 7.25 and 7.26: Shows the Dependence of Cu and Zn
Concentrations (ng/g), respectively on Disease Duration in
Alzheimer's Subjects
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Figure 7.27 (Li D isease Duration)
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elements described above to the authors knowledge have been studied by other 
researchers.
7.12 Correlations with Dry to Fresh Weight Ratios (DFW) and Brain Weight
For Fe (SICC) there were negative correlations between brain weight (p<0.001) and 
DFW (p<0.001), when the MS sample was removed the significance remained the 
same. When the samples < 65 years were excluded, the significance remained the 
same.
In the Mn (AD) results there was significant positive correlations with the DFW ratio 
(p<0.002) and to a lesser extent for Mn (SICC), (p<0.02) and without the MS sample 
there was no significant correlation. When the samples < 65 years were excluded, for 
Mn (AD), there was a significant correlation with DFW ratio at significance 
(p<0.005) and for the Mn(SICC), there was a correlation at significance, (p<0.01).
For Zn (NORM) and Zn (AD), there were significant positive correlations with the 
DFW (p<0.002) and (p<0.02) respectively. When the subjects < 65 years were 
removed, the positive significance changed to (p<0.001) and (p<0.02), respectively. 
For Zn (SICC) there was no significant correlation, however when the MS sample 
was removed from the Zn (SICC) subjects there were significant negative correlations 
for brain weight (p<0.05) and the FDW ratio (p<0.05) which remained the same when 
the subjects < 65 years were removed.
For Cu (NORM) there was a significant negative correlation for brain weight (p<0.01) 
but when the subjects < 65 years were removed the correlation was no longer 
significant. For Cu (SICC) no significant correlations were seen but when the MS 
sample was removed, negative correlations were seen for the brain weight at 
(p<0.01), which again was not significant when the subjects < 65 years were 
removed.
For Cd (NORM), there were significant negative correlations for brain weight 
(p<0.01) but this was no longer significant when the subjects < 65 years were
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removed. There were also significant negative correlations with the DFW ratio, 
(p<0.05) but when the subjects < 65 years were removed, significance became 
(p<0.1). For Cd(SICC) there was a significant negative correlation with brain weight 
at significance, (p<0.1), when the MS samples were removed from Cd(SICC), there 
was still a significant correlation for brain weight, (p<0.02). However, when the 
subjects less than 65 years were removed, these correlations were no longer 
significant
Hg (NORM) were positively correlated with brain weight and DFW ratio at 
significance, (pcO.OOl). This significance remained the same when the subjects < 65 
years were removed. For the Hg (SICC), there was a significant negative correlation 
with brain weight (p<0.001) and a positive correlation with DFW ratio (p<0.1). When 
the subjects < 65 years were removed, the significance of the DFW ratio changed to 
(p<0.1). For the Hg (SICC), without the MS sample the negative correlation with 
brain weight was less significant (p<0.05) and when the subjects < 65 years were 
removed the correlation became more significant (p<0.005), there was no significant 
correlation for DFW ratio. Pb (NORM) was significantly positively correlated with 
DFW ratio (p<0.05) and Li(NORM) was significantly positively correlated with brain 
weight, (p<0.001), and DFW ratio (p<0.05), respectively.
7.13 Dementia Scale and Tangles
Each element was correlated with the dementia scale (0-7) for the Alzheimer’s cases
ecudk elavcerxb
and no correlations were seen andxwas also correlated with the scale for the number 
of neurofibrillary tangles, (0-6). The Fe (AD) concentrations were negatively 
correlated with the tangles as were, the Fe (SICC) subjects when the MS sample was 
removed at significance, (p<0.001).
For the Zn (NORM) there was a positive correlation with the tangles at (p<0.1) and a 
negative correlation for the Zn(SICC) and Cu (SICC) at (p<0.05) and (p<0.05) but 
when the MS sample was removed there was no longer a correlation. Cd (NORM) 
was significantly negatively correlated with tangles at (pO.OOl) and negatively 
correlated at significance (p<0.01) in Cd(AD). Hg (NORM) concentrations were
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negatively correlated with tangles at significance (pcO.OOl) and positively correlated 
in Hg(SICC) at (p<0.05) but when the MS sample was removed the correlation was 
negative at a higher level of significance (p<0.01). There was also a correlation for Pb 
(NORM) concentrations at significance (p<0.1). It is of interest that these tangles 
correlate at a high level of significance with the non essential elements, Cd and Hg. 
Metallothionin (MT) is a protein which regulates and stores the essential metals Zn 
and Cu and may act as a free radical scavenger. Cd has a high affinity for MT and can 
displace Zn from MT when it enters the cell. The synthesis of MT is dependent on Zn, 
Cu and Cd levels, (MadOO). Cd which is not bound to metallothionein is believed to 
be associated with cytotoxicity and oxidative stress may play an important role in Cd 
induced toxicity, (MadOO). Shaikh, (Sha99) found that high levels of Cd increased 
renal gluthanione levels. Patra, (Pat99) found that renal Cd inhibited superoxide 
dismutase activity and lipoperoxide concentrations were increased suggesting 
superoxide radical formation.
7.14 Effect of Sex on Elemental Concentration
T tests were used to determine significant differences between males and females in 
the ‘normal’ subject group. All the subjects below <65 years old were removed, all 
were males, so the two groups were age matched and the only element showing 
significant differences was Hg (p<0.005) which was found to be significantly higher 
in males.
7.15 pH
The pH of the cerobrospinal fluid was correlated with each element. Significant 
correlations were found for the following elements. Fe (SICC) was negatively 
correlated at (p<0.02) and without the MS subject at (p<0.002). Zn(NORM) was 
negatively correlated at (p<0.005) and Zn (SICC) was positively correlated at 
(p<0.005) and without the MS subject at (p<0.01). Cu (AD) was negatively correlated 
at (p<0.1) and Cu(SICC) at (p<0.05) and without the MS subject at (p<0.02). 
Se(NORM) and Cd(NORM) were negatively correlated at (p<0.01) and (p<0.05) 
respectively. Hg(SICC) showed no correlation but when the MS subject was removed 
the pH positively correlated at significance (p<0.05). The pH is important because the
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superoxide anion may react with a proton at physiologic pH, to form the hydroperoxy 
radical or when peroxynitrite a powerful oxidant is protonated at physiologic pH, the 
peroxynitrite decomposes to form nitrous and hydroxyl radicals. Thus the lower value 
of pH, the more probability of free radical formation, thus in the ‘normal’ subjects Zn 
which forms part of the enzyme SOD and Se which forms part of glutanione may 
increase to reduce the number of oxidants thus explaining the significant correlation.
7.16 Concentration Variations Between ‘Normal’, Alzheimer’s Disease and 
SICC Subjects
As some of the elements followed different distributions in the ‘normal’ subjects, 
Alzheimer’s subjects and subjects with SICC, parametric t tests on the fresh weight 
concentrations and the logarithmic transformed fresh weight concentrations were 
used for determining significant differences between ‘normal’ subjects, Alzheimer’s 
subjects and subjects with SICC, (Table 7.18). All subjects less than 65 years were 
excluded so the subjects were age matched.
As can be seen from the Table 7.18 using t tests on the fresh weight concentrations 
and the logarithmically transformed fresh weight concentrations, the element 
significantly different in ‘normals’ compared to Alzheimer’s subjects is Cu, Cu was 
found to be significantly decreased in the Alzheimer’s subjects in all regions. This 
was also confirmed by Deibel et al., (Dei96) and Plantin, (Pla87). Cu is bound to 
enzymes or proteins such as SOD, cytochrome c oxidase and ceruplasmin. In 
Alzheimer’s Disease there may be a decrease in one of these, infact Connor et al., 
(Con93) found a loss of excess of 1/3 of the copper transport and antioxidant protein 
ceruplasmin in both the grey and white matter from the superior temporal gyrus in 
Alzheimer’s disease brains. Ehmann, (Ehm86) found a significant increase of Hg in 
the cortex and hippocampus of Alzheimer’s, this wasn’t confirmed by this work, 
infact, Hg concentrations were found to be increased in the normal subjects, 
particularly in the frontal, parietal lobes and hippocampus. This data did not confirm 
Stedman’s Cd data, (Ste96) who found Cd concentrations to be significantly 
decreased in Alzheimer’s tissue but these concentrations were two times higher than 
the concentrations found here with a similar age group but geographical variations
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Table 7.18: Parametric T-Tests on Fresh Weight Concentrations and Logarithmic 
Transformed Fresh Weight Concentrations Used For Determining Significant 
Differences Between ‘Normal’ Subjects (N), Alzheimer’s Disease Subjects (AD) and 
Subjects with Senile Involutive Cortical Changes (S), ex eluding the SICC subject with 
MS (S*). In brackets is shown, the group with significantly higher concentrations.
Fe log Fe Mn logMn
(N) vs (AD) All Regions - - - -
A1+A2 - - - -
B1+B2 - - - -
C1+C2 - - - -
D1+D2 - - pc0.1(N) -
E1+E2 p<0.1(N) p<0.1(N) - -
(N)vs(S) All Regions p<0.1 (N) p<0.01 (N) - -
A1+A2 p<0.1(N) p<0.1(N) - -
B1+B2 - - - -
C1+C2 - p<0.1(N) - -
D1+D2 - - - -
E1+E2 - - - -
(AD) vs(S) All Regions p<0.1 (AD) p<0.02 (AD) - -
A1+A2 - - - -
B1+B2 p<0.1 (AD) p<0.1 (AD) - -
C1+C2 p<0.02 (AD) p<0.02 (AD) - -
D1+D2 - - pcO.l (AD) pcO.l(AD)
E1+E2 p<0.1 (AD) - - -
(N) vs (S*) All Regions p<0.005 (N) p<0.001 (N) - -
A1+A2 p<0.1 (N) p<0.1(N) - -
B1+B2 - p<0.1(N) - -
C1+C2 p<0.05 (N) p<0.05 (N) - -
D1+D2 p<0.1 (N) p<0.1(N) - -
E1+E2 p<0.05 (N) p<0.05 (N) - -
(AD) vs (S*) All Region p<0.001 (AD) pcO.OOl (AD) - -
A1+A2 - - - -
B1+B2 p<0.02 (AD) pc0.02 (AD) - -
C1+C2 p<0.005 (AD) pcO.Ol (AD) pcO.l (AD) pcO.l (AD)
D1+D2 p<0.002 (AD) pc0.05 (AD) pcO.l (AD) pc0.1(AD)
E1+E2 -(AD) - - -
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Table 7.18 cont: Parametric T-Tests on Fresh Weight Concentratio-
Zn logZn Cu logCu
(N) vs (AD) All Regions p<0.05 (N) pcO.l (N) pcO.OOl (N) pcO.OOl (N)
A1+A2 - - pcO.OOl (N) pcO.OOl (N)
B1+B2 - - - -
C1+C2 - - pc0.005 (N) pc0.002 (N)
D1+D2 - - pcO.OOl (N) pcO.OOl (N)
E1+E2 - - pc0.05 (N) pc0.05 (N)
(N)vs(S) All Regions p<0.1 (N) pcO.l (N) - -
A1+A2 - - - -
B1+B2 - - - -
C1+C2 - - - -
D1+D2 - - - -
E1+E2 - - pcO.l pcO.l
(AD) vs (S) All Regions pcO.OOl (S) pcO.OOl(S) pcO.OOl (S) pcO.OOl (S)
A1+A2 - - pcO.005 (S) pcO.005 (S)
B1+B2 p<0.1 (S) pcO.l (S) pc0.02 (S) pcO.Ol (S)
C1+C2 - - pcO.005 (S) pcO.005 (S)
D1+D2 - - pc0.05 (S) pc0.02 (S)
E1+E2 pcO.l (S) pcO.l (S) pcO.l (S) pc0.05 (S)
(N)vs (S*) All Regions p<0.05 (N) pcO.05 (N) - -
A1+A2 - - - -
B1+B2 - - ■ - -
C1+C2 - - - -
D1+D2 - - - -
E1+E2 - - - -
(AD) vs (S*) All Regions pcO.OOl (S*) pcO.OOl (S*) pcO.OOl (S*) pcO.OOl (S*)
A1+A2 - - pcO.002 (S*) pcO.OOl (S*)
B1+B2 pcO.l (S*) pcO.l (S*) pcO.005 (S*) pc0.002 (S*)
C1+C2 - - pc0.002 (S*) pc0.002 (S*)
D1+D2 pcO.l (S*) pcO.l (S*) pcO.05 (S*) pc0.05 (S*)
E1+E2 - - - -
where A, B, C, D and E are the superior frontal gyrus, superior parietal gyrus, medial
temporal gyrus, hippocampus and pulvinar thalamus respectively.
1 and 2 are left and right hemispheres, respectively.
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Table 7.18 cont: Parametric T-Tests on Fresh Weight Concentratio-
Se log Se Cd log Cd
(N) vs (AD) All Regions - - - -
A1+A2 - - - -
B1+B2 - - - -
C1+C2 - - - -
D1+D2 - - - p<0.1(N)
E1+E2 - - - -
(N)vs(S) All Regions - - p<0.1 (N) p<0.1 (N)
A1+A2 - - - -
B1+B2 - - p<0.1(N) pcO.l (N)
C1+C2 - - - -
D1+D2 - - - -
E1+E2 - - - -
(AD) vs (S) All Regions - - - -
A1+A2 - - - -
B1+B2 p<0.05 (AD) - p<0.1 (AD) -
C1+C2 - - p<0.05 (AD) p<0.05 (AD)
D1+D2 - - p<0.01 (AD) p<0.002 (AD)
E1+E2 - - - -
(N)vs (S*) All Regions - - p<0.02 (N) p<0.05 (N)
A1+A2 - - - -
B1+B2 - - p<0.1 (N) pcO.l (N)
C1+C2 - - - -
D1+D2 - - - -
E1+E2 - - - -
(AD) vs (S*) All Regions - - p<0.02 (N) p<0.05 (N)
A1+A2 - - - -
B1+B2 - - - -
C1+C2 - - p<0.05 (N) p<0.1 (N)
D1+D2 - - p<0.005 (N) pcO.OOl (N)
E1+E2 - - - -
where A, B, C, D and E are the superior frontal gyrus, superior parietal gyrus, medial
temporal gyrus, hippocampus and pulvinar thalamus, respectively.
1 and 2 are left and right hemispheres, respectively.
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Table 7.18 cont: Parametric T-Tests on Fresh Weight Concentratio-
Hg log Hg Pb log Pb Li log Li
(N) vs (AD) All Regions p<0.1 (N) p<0.5 (N) - - p<0.1 (N) -
A1+A2 - -
B1+B2 p<0.1(N) p<0.1(N)
C1+C2 - -
D1+D2 - -
v E1+E2 p<0.1(N) p<0.1(N)
(N)vs(S) All Regions - - - - p<0.05 (N) -
A1+A2 - -
B1+B2 - -
C1+C2 - -
D1+D2 - -
E1+E2 - -
(AD) vs (S) All Regions - - - - - -
A1+A2 - -
B1+B2 - -
C1+C2 - -
D1+D2 - -
E1+E2 - -
(N)vs (S*) All Regions p<0.02 (N) p<0.05 (N) - - p<0.05 (N) -
A1+A2 p<0.1 (N) -
B1+B2 p<0.1(N) -
C1+C2 p<0.1 (N) p<0.1 (N)
D1+D2 - -
E1+E2 - -
(AD) vs ($*) All Regions - - - - - -
A1+A2 - -
B1+B2 - -
C1+C2 p<0.1 (N) -
D1+D2 - -
E1+E2 - -
where A, B, C, D and E are the superior frontal gyrus, superior parietal gyrus, medial
temporal gyrus, hippocampus and pulvinar thalamus, respectively.
1 and 2 are left and right hemispheres, respectively.
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could also account for these differences. Stedman et a l, (Ste96) also found Se 
concentrations to be significantly decreased and these findings were not confirmed so 
to ensure the accuracy of the data in this work, in the following chapter a comparison 
between two methods has been carried out, even though the CRM gave excellent 
results. Fe was found to be significantly increased in the normals
compared to the subjects excluding the MS sample. Also expected that Li as Na with 
a small ionic radius would be increased in concentration in the Alzheimer’s subjects 
as described by Ehmann, (Ehm86). This is not the case but most of the concentrations 
in brain are below the LOD or very close so any technique determining Li 
concentrations in brain should be sensitive at the pg/g level. Cu and Zn concentrations 
were found to be significantly higher in the SICC subjects compared to the 
Alzheimer’s, with and without the MS subject and Fe concentrations were found to be 
significantly lower in the SICC subjects and at a higher level og significance when the 
MS subject was included.
7.17 Cluster Analysis
Cluster analysis may be used to categorise data. Briefly, objects are linked together 
and larger and larger clusters of increasingly dissimilar elements are aggregated. 
Finally all objects are linked together where the vertical axis denotes the linkage 
distance. When the data contains a clear structure in terns of cluster of objects that are 
similar to each other the structure becomes a hierararchical tree of distinct branches. 
The simplest way of computing distances in multidimensional space is to Euclidean 
compute distances. Euclidean data is computed from raw data only. A linkage rule is 
needed to determine when two clusters are sufficiently similar to be linked together.
The nearest neigbours across clusters may be used to determine the distances between 
clusters, this method is called single linkage. Clusters are chained together by only 
single objects that are close together or another method is the complete linkage when 
clusters are farthest away from each other. The unweighted pair group average is a 
medium of the above two methods and it is the distance between two clusters
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calculated as the average distance between all pairs of objects in two different 
clusters. STATISTICA has been used for Cluster analysis in this work.
For the analysis the fresh weight concentrations of Fe, Mn, Cu, Zn, Cd, Hg and the 
FDW ratio were used, only for these elements were there a full sample set. In addition 
all age groups were used. The results are displayed in figure 7.28 a, b and c. In the 
‘normal’ cases the thalamus forms one cluster, the hippocampus another, the regions 
of the left cortex another and the right cortex another. The right parietal gyri is 
separate from the rest of the cortex and is grouped more with the hippocampus which 
is mostly grey matter. This agrees with the work of (Ste98) who also found that the 
right parietal gyri fell into a separate cluster. The left temporal gyri to a lesser extent 
is less linked with the rest of the cortex, whereas the thalamus which is mostly mixed 
matter, (or more white matter as discussed in chapter 6), clusters with the cortex 
which is half grey and white.
In the Alzheimer’s subjects, the right temporal gyri is grouped with the left parietal 
gyri and the left temporal gyri with the right parietal gyri, the right thalamus is linked 
with the hippocampus and the right and left frontal gyri with the left thelamus. 
Whereas in the ‘normals’ the different regions of the same hemisphere are more 
similar than corresponding regions in the other hemisphere. In the Alzheimer’s 
subjects different regions within the hemispheres are more similar. The thalamus and 
frontal gyri form a separate cluster in Alzheimer’s disease.
In the subjects with senile involutive cortical changes, even though at first glance the 
dendrogram is similar to the normal subjects where the thalamus froms one cluster 
and the hippocampus another and the cortex another, as opposed to the ‘normal’ 
subjects, the hippocampus is linked with the cortex and also the right parietal gyri 
joins the rest of the cluster. This suggests that during the senility process there may be 
changes in elemental composition and FDW ratio within the right parietal gyrus and 
the relationship between cortex-thalamus and cortex-hippocampus in terms of the 
elemental composition and DFW ratio.
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7.18 Conclusions
The concentrations in ten brain regions in ‘normal’ subjects, alzheimer’s and subjects 
with senile involutive cortical changes have been determined with ICP-MS.
Se was determined by adding < 1 % butanol to the digested samples. Recovery, 
precision, accuracy and homogeneity using ICP-MS gave excellent results,
Fe, Mn, Cu, Zn and Se agreed with published literature values. For Cd, Hg, Pb and Li, 
there is so much conflict within the literature, it is hard to compare these results.
For normal subjects, Li, Fe, Zn and Se followed normal distributions whereas Mn, Cu, 
Cd, Hg and Pb followed lognormal distributions.
For Alzheimer’s Li, Fe, Cu, Se and Zn followed normal distributions and Hg and Pb 
followed lognormal distributions. Mn and Cd followed neither distribution.
For all subjects with SICC, all elements followed lognormal distributions, apart from 
Mn, Cd and Pb which didn’t follow either distribution. When the MS subject was 
excluded, Fe followed a normal distribution and all elements followed a lognormal 
distribution. Again Mn and Pb followed neither distributions. This suggests that 
during the senility process, there is an alteration of trace elements towards toxic levels 
which may not persist until the end of disease.
There were few elemental variations between hemispheres but strong variations 
between regions and in the ‘normal’ subjects there were strong positive correlations 
with age for Cu, Zn and Cd whereas, Hg showed a negative correlation. There were 
also correlations for Zn and Cu with postmortem interval but when the samples, taken 
after 8.5 hours were removed, the correlation was no longer significant. There was 
also negative correlations for Zn and Cu with disease duration and a positive 
correlation for Li. No correlations were seen for any elements and the dementia scale 
and Cd and Hg in the ‘normal subjects’ and Cd in the Alzheimer’s Disease subjects 
correlated positively with the tangles at a high level of significance. When comparing 
sexes, for the normal subjects, the only significant difference was found for Hg.
When comparing the ‘normals’ and Alzheimer’s disease subjects, it was found that 
Cu was significantly decreased in the Alzheimer’s disease subjects as compared to the 
controls. Zn was increased in the ‘normal’ subjects as were Hg and Li. No significant
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differences were found for Fe, Mn, Se, Cd and Pb. When comparing the ‘normals’ 
and the SICCs excluding the MS subject, Fe was found to be higher in the ‘normals’ 
subjects in all areas, as were Zn, Cd and Hg. No significant differences were found 
for Mn, Cu, Se, Pb. Li at a low level of significance was found to be higher in the 
‘normals’. When the MS subject was included, of interest is the results for Fe which 
became much less significant. When comparing the SICC subjects excluding the MS 
subject and the Alzheimer’s , Fe, Mn, Zn , Cu, Cd were found to be increased in the 
Alzheimer’s and when including the MS subject all these results became much more 
significant, apart from Cd.
Cluster analysis was used for the different brain regions for all elements, of interest is 
in the ‘normal’ subjects, the right parietal gyrus formed its own cluster, which is not 
the case for the SICC subjects. Also in the ‘normals’, different regions of the same 
hemisphere are more similar than corresponding regions of the opposite hemisphere, 
whereas in the Alzheimer’s Disease subjects, different regions within the same 
hemisphere are more similar. In the Alzheimer’s disease subjects, the thalamus and 
frontal gyri formed their own separate clusters.
277
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CHAPTER 8
Elemental Concentrations with INAA
8.1 Elemental Concentrations Determined by INAA (HER reactor, Petten)
23 samples were analysed using the reactor at Petten. The results were initially used 
to identify any significant differences between left and right hemispheres. The method 
is identical to that described for the porcine brains in chapter 5
Sections of brain tissue were sampled from six brain regions of three ‘normal’ or non­
demented (no known neurological symptoms) human brains and two Alzheimer’s 
disease brains. The ‘normal’ subjects were two males aged 78 and 69 years 
respectively and one female aged 77 years and the Alzheimer’s disease brains were 
two females 82 and 83 years old.
Tissue samples were taken from the frontal, parietal and temporal lobes (grey and 
white matter) of both hemispheres. Small section of samples of approximate 40 mg, 
mass were placed in acid pre-cleaned quartz vials for irradiation and pressed down 
with a titanium spatula. Five samples, three reference materials, NIST 1566 Oyster 
Tissue, 1577a Bovine Liver and IAEA A13 Animal Blood of approximate mass 100 
mg and one blank quartz vial was placed in each aluminium can. Quartz vials were 
irradiated in the PIF position of the High Flux Reactor at Petten, 2* 1014 neutrons cm "2 
s'1 (4) for 12 hours. The gamma spectra were detected by a HPGe detector (25% 
efficiency) after a waiting time of fourteen days and twenty eight days. The spectra 
were analysed using the software package NED A. Blank values from the empty 
quartz vials were subtracted.
8.1.1 Variation in Concentrations between Hemispheres
Elemental concentrations are obtained using the comparator method of analysis. 
Mean dry weight concentrations (pg/g) of Fe, Rb, Se, Zn, Co, Cr, Ag and Hg for each 
brain region for combined ‘normal’ and Alzheimer’s brains are given in Tables 8.1 a 
and 8.1b. Comparing concentrations in the right and left hemisphere, it can be seen 
that generally concentrations are higher in the right hemisphere than the left
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hemisphere. This doesn’t agree with the ICP-MS results but a much smaller sample 
group was used here. Fe concentrations are found to be significantly higher (p<0.05) 
in the frontal lobe of the right hemisphere compared to the frontal lobe of the left 
hemisphere and Zn concentrations are found to be higher in the right temporal lobe 
compared to the left temporal lobe. For the elements Ag, Co, Cr and Hg it was 
difficult to draw conclusions because of the small number of samples.
8.1.2 Variation in Concentrations within Regions
Comparing concentrations within each hemisphere, of the combined ‘normal’ and 
Alzheimer’s disease brains. Tables 8.1 a and b, Cr is found to be significantly lower 
(p< 0.05) in the left parietal lobe compared to the left temporal lobe.
8.1.3 Interelement Correlations
Correlation Coefficients have been calculated for all elements for both hemispheres 
for the five human brains. Table 8.2. All significant correlations were found to be 
positive except for Co-Hg. There are strong correlations for Fe-Rb, Fe-Se, Rb-Co, Se- 
Cr, Fe-Cr. It may be expected that elements such as Fe, Rb, and Se which are 
primarily intracellular will vary closely together. There have been few papers which 
publish interelement correlations but the Se-Fe and Rb-Zn correlation agrees with 
Ehmann (Ehm86). Stedman found Fe-Se correlated at a low level of significance in 
‘normals’ and Alzheimer’s Disease subjects and Fe-Rb correlated in Alzheimer’s 
subjects only.
8.1.4 Conclusions
This preliminary work showed that there were differences in trace elemental 
concentrations between the right and left hemispheres of the brain and within 
hemispheres. Therefore, when comparing sections of brain tissue within a group, it 
may be necessary to use the same hemisphere. However, it is difficult to draw 
conclusions, from this study, for all elements because of the small number of samples. 
It should also be noted that the variation in elemental concentrations between the five 
brains, both ‘normal’ and Alzheimer’s disease may depend on sex, age and duration 
of the disease, thus further studies need to be made on a larger sample population.
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Table 8.2: Linear Correlation Coefficients Between Elements for Both Hemispheres
of Both ‘Normal’ and Alzheimer’s Disease
Elements Correlation P-Value
Fe-Rb 0.881 <0.01
Fe-Se 0.788 <0.05
Fe-Zn 0.200 -
Fe-Co 0.660 -
Fe-Cr 0.758 <0.1
Fe-Hg -0.055 -
Rb-Se 0.589 -
Rb-Zn 0.562 -
Rb-Co 0.911 < 0.005
Rb-Cr 0.619 -
Rb-Hg -0.353 -
Se-Zn -0.295 -
Se-Co 0.497 -
Se-Cr 0.816 <0.05
Se-Hg -0.340 -
Zn-Co 0.595 -
Zn-Cr -0.238 -
Zn-Hg -0.178 -
Co-Cr 0.152 -
Co-Hg -0.659 -
Cr-Hg -0.231 -
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8.2 Elemental Concentrations Determined by INAA (IRI, Delft)
8.2.1 Detection Limits
The LOD for each of the elements determined by INAA are shown in Table 8.3. 
Detection Limits were established by analysis of 12 batches, each containing between 
5-9 samples. A comparison of the detection limits with ICP-MS will follow later.
Table 8.3: Limit of Detection for Elements Determined by INAA
Elements LOD(ug/g)
Na 6.6 ±3.6
K 1400 ± 1700
Fe 2.0 ±0.5
Zn 1.4 ±0.3
Se 0.016 ±0.003
Br 0.089 ±0.021
Rb 0.042 ±0.011
Ag 0.018 ±0.003
Cs 0.003 ±0.0005
Ba 0.76 ± 0.20
Eu 0.007± 0.0002
8.2.2 Elemental Concentrations
Of the remaining samples from the cortex, 68 were irradiated at Delft and will be 
described separately. The elemental concentrations and standard deviation determined 
by INAA are shown in Tables 8.4, with the number of samples. Also stated are the 
range, arithmetic mean and standard deviation, geometric mean and standard 
deviation and the median. Frequency distributions were plotted, for Na, Figures 8.1a 
and b, for K, Figures 8.2a and b, for Fe, Figures 8.3a and b, for Zn Figures 8.4a and b, 
for Se, Figures 8.5a and b, for Br, Figures 8.6a and b, for Rb, Figures 8.7 a and b and 
for Cs, Figures 8.8 a and b for both the ‘normals’ and Alzheimer’s Disease subjects. 
Each distribution is for both hemispheres and all areas.
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With the Lillifors test, in the ‘normal’ subjects, Na, K, Fe, Zn, Se, Cs, Ba and Eu 
follow normal distributions whereas Br, Rb and Ag fit a lognormal distribution, this is 
unexpected for Rb and also probably for Br which is considered borderline essential, j  
However, for the ‘normal’ subjects only a small number of samples were analysed j 
which means the sample distribution is much more subject to changes. In the 
Alzheimer’s subjects Na, K, Fe, Zn, Se, Br, Rb and Ba fit normal distributions and 1 
Ag, Cs and Eu fit a lognormal distribution.
8.2.3 Variations in Concentrations between Hemispheres
Because of the small number of samples, differences were calculated only for Na, Fe,
Zn, Se, Br and Rb. In the ‘normal’ subjects there was no difference in Br between 
hemispheres, whereas for the Alzheimer’s subjects, Br was higher in the left parietal 
gyrus compared to the right parietal gyrus at significance (p<0.1). Na in the 
Alzheimer’s subjects, at significance (p<0.05) was found to be higher in the left j
parietal gyrus compared to the right. In the ‘normals’ Se and Rb concentrations in the 
left frontal gyrus was higher than in the right at significance (p<0.05) and (p<0.01) 
respectively.
!
8.2.4 Variations in Concentration between Regions
For the ‘normals’ there were significant differences for the following elements. K was 
found to be elevated at (p<0.05) in the temporal gyrus as compared to the parietal 
gyrus and Se was found to be higher in the parietal gyrus as compared to the temporal !
gyrus, at significance (p<0.1). In the Alzheimer’s Disease brains the concentration of 
Br (p<0.02) was found to be significantly higher in the parietal gyrus as compared to j
the frontal gyrus and Br (p<0.05) was also elevated in the parietal gyrus as compared !
to the temporal gyrus.
Tables 8.4: Fresh Weight Concentrations, Arithmetic Mean, Geometric Mean 
Standard Deviations and Median for ‘Normal’ and Alzheimer’s Disease Subjects
Using Combined Hemispheres
REGION ‘NORMAL’ SUBJECTS
Arithmetic Geometric Median Range N
Mean SD Mean SD
Na A1+A2 1733 331 1701 1.22 1763 1074-2217 8
ug/g B1+B2 1547 395 1504 1.29 1457 1092-2151 9
C1+C2 1663 562 1591 1.36 1557 928-3001 9
K A1+A2 2474 277 2460 1.12 2545 2012-2774 6
ug/g B1+B2 1998 783 2237 1.11 2176 1961-2682 8
C1+C2 2935 730 2852 1.31 2945 1718-3154 7
Fe A1+A2 53.5 9.3 52.3 1.18 52.3 43.5-67.5 8
ug/g B1+B2 55.2 6.3 54.8 1.13 57.0 50.4-63.2 9
C1+C2 49.4 8.8 48.7 1.20 49.5 35.8-60.3 9
Zn A1+A2 12.5 1.8 12.8 1.17 13.0 9.9-15.5 8
ug/g B1+B2 11.5 2.2 11.3 1.20 10.8 8.9-14.3 9
C1+C2 14.0 3.9 13.3 1.44 14.9 5.6-18.8 9
Se A1+A2 128 29 128 1.27 133 81-171 8
ug/g B1+B2 128 15 127 1.13 125 106-147 9
C1+C2 104 36 96 1.57 108 37-150 9
Br A1+A2 331 213 124 1.50 364 96-847 8
ug/g B1+B2 357 ' 208 1140 1 1.29 255 131-749 9
C1+C2 330 254 122 1.39 241 77-798 9
Rb A1+A2 2338 929 2218 1.50 2551 1261-3357 8
ug/g B1+B2 2085 705 1993 1.36 1839 1429-3512
9
C1+C2 2141 811 1987 1.54 1856 841-3209 9
Ag A1+A2 15.1 10.5 17.5 1.74 16.2 7.6-33.1 7
ug/g B1+B2 14.0 9.8 14.3 1.59 12.4 9.1-28.1 8
C1+C2 14.8 7.0 13.4 1.64 12.2 6.2-23.6 7
Cs A1+A2 11.5 10.5 9.9 1.91 12.0 3.9-20.7 8
ug/g B1+B2 14.0 9.8 9.6 1.69 9.3 4.8-21.4 9
C1+C2 14.8 7.0 9.0 1.57 10.0 4.9-14.9 9
Ba A1+A2 0.46 0.13 - - - 0.38-0.65 4
ug/g B1+B2 0.68 0.20 - - - 0.52-0.90 3.
C1+C2 0.46 0.10 - - - 0.33-0.57 4
Eu A1+A2 0.42 0.22 - - - 0.41-0.60 5
ug/g B1+B2 0.53 0.09 - - - 0.40-0.64
4.
C1+C2 0.46 0.20 - - - 0.22-0.66 5
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Fresh Weight ConcentrationsTables 8.4 cont
ALZHEIMER’S DISEASE’ SUBJECTSREGION OF 
BRAIN
MedianGeometricArithmetic 
Mean I SD Mean
1245-2466370 1866A1+A2
1300-2364328 1921ug/g B1+B2 1466-2389323 1962C1+C2
A1+A2 2547
1317-3365 
1327-3807 
31.5-80.6
ug/g B1+B2 2426
670 2684C1+C2 2773
Fe I A1+A2 55.1
ug/g B1+B2 I 61.3
46.4-84.8
40.9-77.1C1+C2 59.4
8.9-16.1A1+A2
8.5-17.6
ug/g B1+B2 9.8-20.8
C1+C2
44-210
Se I A1+A2 
ng/g I B1+B2
93-225
62-187
386-1560
551-1832
567-1455
1244-2774
1186-2822
1172-2820
C1+C2
A1+A2
B1+B2
C1+C2
A1+A2
B1+B2
C1+C2
8.4-17.9A1+A2
9.1-16.9C1+C2
3.5-11.3A1+A2
3.9-13.8
2.9-10.6
C1+C2
0.34-0.62
A1+A2
0.23-0.54
B1+B2
C1+C2
0.33-0.54
0.26-1.77
A1+A2
0.27-0.74
B1+B2
0.43-0.70
C1+C2
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where A, B and C are the superior frontal gyrus, superior parietal gyrus and medial 
temporal gyrus, respectively.
1 and 2 are the left and right hemispheres, respectively.
(for <5 samples no geometric mean has been calculated).
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Tables 8.5: Lillifors probabilities for ‘Normal’ Subjects
‘Normal’ Subjects
Element Normal Lognormal Distribution
Lillifors (p) Lillifors (p)
Na >0.20 Normal
K >0.20 Normal
Fe >0.20 Normal
Zn >0.20 Normal
Se <0.05 <0.01 Normal
Br <0.01 >0.20 Lognormal
Rb <0.05 >0.20 Lognormal
Ag <0.10 >0.20 Lognormal
Cs >0.20 Normal
Ba >0.20 Normal
Eu >0.20 Normal
Tables 8.6: Lillifors Probabilities for Alzheimer’s Subjects
Alzheimer’s Disease Subjects
Elements Normal Lognormal Distribution
Lillifors (p) Lillifors (p)
Na >0.20 Normal
K >0.20 Normal
Fe >0.20 Normal
Zn >0.20 Normal
Se >0.20 Normal
Br >0.20 Normal
Rb >0.20 Normal
Ag <0.10 >0.20 Lognormal
Cs <0.10 >0.20 Lognormal
Ba >0.20 Normal
Eu <0.01 >0..20 Lognormal
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Figure 8.1a (Na ’Normals)
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Figures 8.1 a and b: Frequency Distribution of Na Concentrations (gg/g) in 
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Figures 8.3a and b: Frequency Distribution of Fe Concentrations (pg/g) in
Samples taken from 'Normal' and Alzheimer's Disease Subjects.
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Figure 8.4a (Zn 'Norm als')
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Figures 8.5a and b: Frequency Distribution of Se Concentrations (pg/g) in 
Samples taken from 'Normal' and Alzheimer's Disease Subjects.
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Figure 8.7a (Rb 'Normals')
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Figures 8.7a and b: Frequency Distribution of Rb Concentrations (pg/g) in 
Samples taken from 'Normal' and Alzheimer's Disease Subjects.
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293
8.2.5 Concentration Variations with Age
In the ‘normal’ brains, for combined hemispheres and all regions, Br, Se, Ag and Eu 
concentrations were found to correlate positively with increasing age at significance, 
(p<0.002), (p<0.02), (p<0.1) and (p<0.1) respectively, (Figures 8.9, 8.10, 8.11 and 
8.12, respectively). The positive correlation with age for Se wasn’t seen in the ICP- 
MS results but below a method comparison has been undertaken and will follow at 
the end of this chapter, also the number of samples used here are smaller so more 
subject to differences. In the frontal lobe of the normal subjects, Br and Ag correlated 
positively with age at significance (p<0.05) and (p<0.02), respectively, in the parietal 
lobe Br correlated positively at significance (p<0.05) and in the temporal lobe K and 
Se correlated positively at significance (p<0.05) and (p<0.02).
In the Alzheimer’s brains for combined hemispheres and all regions, there was a 
negative correlation for Fe with age, (p<0.1). Figure 8.13, and a positive correlation 
with Cs at significance (p<0.05), Figure 8.14. In the frontal and temporal lobes no 
correlations were found for any elements with age. Fe correlated negatively in the 
parietal lobe at significance (p<0.01) and Cs correlated positively at (p<0.02).
8.2.6 Concentration Correlations with Post Mortem Intervals
Correlations were only calculated for the ‘normal’ subjects for Na, K, Fe, Zn, Se, Br, 
Rb, Cs and Eu and a negative correlation was found for Se (p<0.05), Rb(p<0.01) and 
for Eu (p<0.1). However, when the post mortem interval interval of 10.45h was 
removed Se was no longer significant but there was still a correlation for Rb (p<0.05) 
but at a lower level of significance and Eu was even more significant (p<0.05). 
However, the number of samples was quite small, so it is hard to draw conclusions 
from this for Eu. However, the importance of obtaining samples no longer than 8.5 
hours after death, must be stressed.
8.2.7 Interelement Correlations
Correlation coefficients were calculated for Na, K, Fe, Zn, Se, Br, Rb, Cs and Eu. For 
the Alzheimer’s Disease subjects almost all elements correlate strongly at (p<0.001) 
Na-Zn, K-Zn, K-Rb, Fe-Se, Zn-Se, Zn-Rb and Se-Rb, at significance (p<0.005), Rb-
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Cs, at (p<0.01) Na-Fe, Fe-Zn and Fe-Rb at (p<0.02) Na-Br and K-Cs and at (p<0.05), 
Na-K, Na-Se and Zn-Br and at (p<0.1) Na-Rb and K-Se. In the ‘normal’ subjects 
highly significant correlations were seen (p<0.001) for K-Zn, K-Eu, Rb-Cs and Rb- 
Eu, at a lower level of significance (p<0.005), Na-Zn, K-Rb and Br-Rb, K-Cs at 
(p<0.01) Zn-Eu, at (p<0.02) Fe-Se, Se-Br and Br-Eu, at (p<0.05) Fe-Cs, Zn-Rb and 
Se-Eu, K-Cs and at (p<0.1) Na-K.
8.2.8 Effect of Disease Duration in Alzheimer’s Subjects on Concentrations
Significant correlations were found for combined hemispheres and all areas, for Zn at 
significance, (p<0 .0 2 ), a negative correlation was seen with disease duration, as with 
the ICP-MS results. A comparison of ICP-MS and DMAA results will follow at the end 
of this chapter. Negative correlations were found for K (p<0.02), Rb (p<0.001) and Se 
(p<0.1). For Ag and Ba positive correlations were found at significance (p<0.05). For 
the frontal lobe K and Rb negatively correlated with disease duration at significance 
(p<0.1) and (p<0.02) respectively. In the parietal lobe Fe negatively correlated with 
disease duration at significance (p<0.01) and Cs correlated positively at significance 
(p<0.02). No correlations were found for the temporal lobe. Figures 8.15, 8.16, 8.17, 
8.18, 8.19 and 8.20, illustrate for K, Zn, Se, Rb, Ag and Ba dependence on disease 
duration. Stedman, (Ste96) studied Na, Cl, Br and K with disease duration and found 
Na and Br decreased with disease duration and K increased. In this work significant 
correlations for Na and Br with disease duration were not found, the graph for Na is 
shown and in this work negative correlations were found for K with disease duration. 
However, this was a much smaller sample size than Stedman’s (Ste96), who studied 
the frontal lobe and further research in this area is needed.
8.2.9 Correlations with Dry to Fresh Weight Ratio and Brain Weight
In the ‘normal’ subjects, there was a positive correlation for Rb (p<0.005) and Cs 
(pcO.001) with DFW ratio. In the Alzheimer’s subjects for DFW ratio, there were 
positive correlations for K (p<0.001), Zn (p<0.02), Se (p<0.01) and Rb (p<0.001) 
with DFW.
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Figure 8.11 (Br 'Normals')
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Figures 8.10 and 8.11: Se and Br Fresh Weight Concentrations,
(ug/g) respectively, versus Age in years of Combined Hemispheres of
Male and Female 'Normal' Subjects
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Figure 8.13 (Eu 'Normals')
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Figures 8.12 and 8.13: Ag and Eu Fresh Weight Concentrations,
(ug/g) respectively, versus Age in years of Combined Hemispheres of
Male and Female 'Normal' Subjects
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Figure 8.15 (Cs Alzheimer's)
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Figures 8.14 and 8.15: Fe and Cs Fresh Weight Concentrations,
(ug/g) respectively, versus Age in years of Combined Hemispheres of
Male and Female Alzheimer's Disease Subjects
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Figure 8.16 (K Disease Duration)
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Figure 8.17 (Zn Disease Duration)
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Figure 8.18 and 8.19: Shows the Dependence of Rb and Se
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300
Figure 8.20 (Ag D isease Duration)
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In the ‘normal’ subjects, there were negative correlations with brain weight for K 
(p<0.05), Zn (p<0.01), Se (p<0.05), Br (p<0.001), Rb (p<0.05) and Eu (p<0.02). 
however, in the Alzheimer’s subjects there were positive correlations with brain 
weight for K (p<0.05), Fe (p<0.05). Se (p<0.1) and Rb (p<0.02)
8.2.10 Dementia Scale and Tangles
The concentration of elements were correlated with the dementia scale for the 
Alzheimer’s cases and a positive correlation was seen for Br (p<0.02) and a negative 
correlation was seen for Cs (p<0.001). Elements were also correlated with the scale 
for the number of tangles. In the ‘normal’ subjects there were positive correlations for 
Se (p<0.1) and Br (pO.Ol) and a negative correlation for Cs (p<0.1), whereas, in the 
Alzheimer’s subjects there were negative correlations for K (p<0.02), Zn (p<0.05), Se 
(p<0.1), Rb (pO.OOl) and Cs (pO.OOl). Br was positively correlated with the tangles 
at significance (p<0 .1 ).
8.2.11 pH
Significant positive correlations were found in the ‘Normals’ and Alzheimer’s 
subjects at the same level of significance for Br, (pO.OOl) and Ag (pO.OOl).
8.2.12 Concentration variations between ‘Normals’ and Alzheimer’s
Table 8.7 shows the total number of samples and the number of samples in the 
frontal, parietal and temporal lobes, range of ages, mean and standard deviations. 
There are significant differences between the two groups (pO.OOl) when the two 
groups are not age matched but when age matched there is no longer a significant 
difference.
Because of the small number of samples when the subjects are age matched 
comparisons have been made between combined hemispheres of all regions.
As some of the elements followed different distributions in the ‘normal’ subjects and 
Alzheimer’s subjects, parametric t tests on the fresh weight concentrations and the 
logarithmic transformed fresh weight concentrations were used for determining 
significant differences between ‘normal’ subjects and Alzheimer’s subjects. Table 8 . 8
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shows the results.
Table 8.7: The total number of samples and the number of samples in the frontal, 
parietal and temporal lobes, range of ages, mean and standard deviations.
Number of Samples Range Age
Total Group Total A1+A2 B1+B2 CH-C2
‘Normals’ 26 8 9 9 38-87 64.) +/-18.6
Alzheimer’s Disease 42 16 14 1 2 62-92 753+/-11 .5
Age Matched Group
‘Normals’ 12 5 4 4 69-87 %  -&+/- 4 -3-
Alzheimer’s Disease 32 1 2 1 1 9 67-92
where A, B and C are the superior frontal gyrus, superior parietal gyrus and medial 
temporal gyrus, respectively.
and 1 and 2  are the left and right hemispheres, respectively
From Table 8 .8 , Br was found to show the most significant differences. Na, Fe and Br 
concentrations in the Alzheimer’s brains were found to be significantly increased in 
the cortex. There was no significant differences in concentrations of K, Zn, Se, Rb, 
Ba, and Eu. In any areas in the ‘normal’ cases, compared to the Alzheimer’s Disease. 
Cs and Ag were found to be decreased in the Alzheimer’s brains.
For some elements this agrees with the work of Ehmann, (Ehm8 6 ), who found Br, Cs 
and Na concentrations in the whole cortex to be significantly increased as compared 
to the normals and no significance difference for Se and K. The only element for 
which a significant difference was found compared to Ehmanns was for Rb which 
Ehmann found to be depleted in the Alzheimer’s cases. ICP-MS. Stedman (Ste96) 
also found significant increases in the frontal lobe for Na, Br in the Alzheimer’s cases
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Table 8  8  Significant difference between the age matched ‘normal’ and Alzheimer’s 
subjects using parametric t tests on the fresh weight concentrations
Element Fresh Weight 
Concentrations
(P)
Logarithmic Transformed 
Fresh Weight 
Concentrations (p)
Increased
Group
Na (p<0 .0 2 ) (pO.02) AD
K NS NS
Fe (p<0 .1 ) NS AD
Zn NS NS
Se NS NS
Br (pO.OOl) (pO.OOl) AD
Rb NS NS
Ag (pO.05) (pO.05) Normals
Cs (P<0.1) NS Normals
Ba NS NS
Eu NS NS
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and a significant decrease for K, Rb and Se in the frontal lobe of the Alzheimer’s 
subjects and no significant differences for Fe, Zn and Cs. Deng, (Den94) 
determined 79 elements using ICP-MS, in six normals and six Alzheimer’s cases and 
saw a significant decrease (70-50%) for Rb and Cs in the Alzheimer’s Subjects. In 
this work, Rb was found to be lower in the Alzheimer’s cases but not significantly so. 
Ward, (War8 6 ) also found no significant decrease of Rb in the Alzheimer’s cases.
8.2.13 Cluster Analysis
For the INAA the concentrations of Na, Fe, Zn, Se, Rb, Br and the DFW ratio were 
used, only for these elements were there a full sample set. The resulting dendogram 
for both groups is shown in Figures 8.22 and 8.23
Within the ‘normal’ subjects as before in terms of elemental composition, the 
different regions within the same hemisphere are more similar.
In the Alzheimer’s subjects, the right frontal gyrus forms a cluster with the left 
temporal and parietal gyrus and the left frontal gyrus links with the right parietal 
gyrus which are linked to the right temporal gyrus, as with the ICP-MS results 
different regions within the two hemispheres are more similar. However, of interest 
is the right frontal gyrus links with the left temporal and parietal gyri and the left 
frontal gyrus links with the right temporal and parietal gyri.
8.2.14 Bromine
This study shows that in particular Br concentrations in the cortex were found to be 
significantly increased in the Alzheimer’s Disease subjects as compared to the 
‘normals’.
Bromide salts were used as hypnota-sedatives and for the treatment of convulsive 
seizures before the introduction of barbituates. Today bromide salts are still used in a 
few patients but toxicity resulting in neurological and dermatological symptoms are 
rarely seen. Few papers have been presented, concerning the role of Br in the brain of 
the Alzheimer’s Disease subjects. The synthesizing enzyme of acetycholine is coline 
acetylchole, (CAT). CAT is reduced in the cortex of Alzheimer’s Disease brains and 
this decrease of CAT correlates well with the plaques and tangles.
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F igures 8 .2 2  and 8 .23: C luster A n a lysis  for S ix  Brain R eg io n s  
from 'Normal' and A lzheim er's D is e a s e  S u b jec ts
Figure 8.22
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Figure 8.23
Unweighted pair-group average 
Euclidean distances
250
200
150
J2 100
C2A2
A, B, C, D and E are the superior frontal gyrus, th e su p erior parietal 
gyrus, th e  m edial tem poral gyrus, th e  h ip p ocam p u s and  th a lam u s, 
resp ectiv e ly  and  1 = left h em isp h ere  and 2  = right h em isp h ere ,
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Bromoacetylcholine, bromoacetyl-CoA and 3-bromoacetonyltrimethylammonium 
inhibit CAT. Increased levels of Br from possible environmental sources may 
suppress CAT, (Ehm8 8 ). Another possibility is the highly toxic oxidant, HOBr, which 
may produce damaging protein free radicals leading to protein destruction, (Ehm8 8 ),
8.2.15 Method Intercomparison
The Wilcoxon matched pair tests was applied to both the INAA and ICP-MS results 
for Fe, Se and Zn. The same samples were compared from both methods. The average 
of the results and the number of samples used are shown in Table 8 .8 .
Table 8.9: Averages of Results Using ICP-MS and INAA and the Number of Samples 
Used.
Element/Group/T echnique N Average ± SD (pg/g) 1
Fe Normals INAA 24 52.0±7.8
Fe Normals ICP-MS 24 50.2111.7
Fe Alzheimer’s INAA 40 58.7113.2
Fe Alzheimer’s ICP-MS 40 55.7110.6
Zn Normals INAA 24 12.713.0
Zn Normals ICP-MS 24 13.214.0
Zn Alzheimer’s INAA 40 13.813.0
Zn Alzheimer’s ICP-MS 40 13.712.6
Se Normals INAA 16 0.11810.035
Se Normals ICP-MS 16 0.16710.111
Se Alzheimer’s INAA 33 0.14210.039
Se Alzheimer’s ICP-MS 33 0.14110.037
The results of the intercomparison methods for Fe and Zn were excellent, no 
significant differences between groups for the three elements were found.
The detection limits for Se, Fe and Zn with ICP-MS are 1.6, 32.3 and 240 ng/g 
respectively and with INAA are 16, 1400 and 2000 ng/g respectively, therefore 
detection limits using ICP-MS for these elements are much lower.
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Making a comparison of the results using ICP-MS and INAA. Both for ICP-MS using 
10 regions of the brain and INAA using 6 regions of the brain,, in the ‘normal’ and 
Alzheimer’s Disease subjects, Fe, Se and Zn were found to follow normal 
distributions. A positive correlation, however, with age (p<0.02) for Se was found 
with INAA which was not seen with the ICP-MS results.
Comparing the groups ‘normals’ with Alzheimer’s Disease, using both techniques, no 
significant differences were found for Se but Zn using ICP-MS was found to be higher 
in ‘normals’ at a low level of significance but no significant difference was found in 
the cortex alone which agrees with the results for INAA. Fe determined by INAA was 
found to be higher than in the ‘normals’ but at a low level of significance (p>0,05), 
this wasn’t found with the ICP-MS results.
8.2.14 Conclusions
The concentrations in 6 brain regions in ‘normal subjects and Alzheimer’s subjects 
have been determined using two different reactor and counting facilities. The results 
by both techniques agree with those given by the literature.
The initial results obtained with the JRC, Petten reactor were used to determine any 
significant differences between hemispheres. Fe, Rb, Se, Zn, Co, Cr, Ag and Hg 
concentrations in the frontal lobe of the right hemisphere were found to be higher 
than the left hemispheres and Zn was found to be higher in the right temporal lobe 
compared to the left. However, it was a small sample group so it was difficult to draw 
conclusions.
For the results from the IRI reactor, for the ‘normal’ subjects, Na, K, Fe, Se, Zn, Cs, 
Ba, Eu were found to follow normal distributions using Lillifors probabilities, 
whereas Br, Rb and Ag followed lognormal distributions. In the Alzheimer’s subjects, 
Na, K, Fe, Zn, Se, Br and Ba followed normal distributions, whereas Ag, Cs and Eu 
followed lognormal distributions.
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In the ‘normals’ Se and Rb were found to be higher in the left frontal lobe compared 
to the right and in the Alzheimer’s subjects, Na was found to be higher in the left 
parietal lobe compared to the right. No signficant differences were found between 
hemispheres.
Br, Se, Ag and Eu correlated positively with age in the ‘normal’ subjects and in the 
Alzheimer’s there was a negative correlation with age for Fe and a positive 
correlation with age for Cs. With disease duration, there were negative correlations 
for Zn, K, Rb and Se, whereas for Ag and Ba positive correlations were seen. Positive 
correlations for Br and Cs were seen with the dementia scale. In the ‘normal’ 
subjects, tangles correlated positively for Se and Br and correlated negatively for Cs 
and in the Alzheimer’s subjects, there were negative correlations with the tangles for 
K, Zn, Rb and Se and Cs and positive correlations for Br.
When comparing ‘normals’ with Alzheimer’s, Br, Na and Fe in the Alzheimer’s were 
found to be increased. K, Zn, Se, Rb, Ba and Eu showed no significant differences. Cs 
and Ag were found to be increased in the ‘normal’ subjects.
Using cluster analysis it was found that within the ‘normal’ subjects in terms of 
elemental composition different regions within the same hemisphere were more 
similar and as for the ICP-MS results, the same region in both hemispheres are more 
similar.
A method intercomparison was undertaken for Fe, Se and Zn which were determined 
using ICP-MS and INAA Delft, the results of the same samples determined by both 
techniques were found to be excellent with no significant differences found. The 
detection limits of ICP-MS were found to be greater for these elements than INAA.
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Chapter 9
Conclusions and Suggestions for Further Work
Inductively Coupled Plasma Mass Spectrometry, (ICP-MS), Instrumental Neutron 
Activation Analysis, (INAA) and Electrothermal Atomic Absorption Spectrometry, 
(ETAAS) have been used to determine minor and trace elements in porcine brain and 
human brain from ‘normal’ Alzheimer’s Disease and Subjects with Senile Involutive 
Cortical Changes, SICC, where subjects with SICC show symptoms of senility with 
some degree of plaques and tangles and disruption of the intemeuronal network. 
These subjects have been placed in a separate group because they are not strictly 
‘normal’. It is difficult to find age matched ‘normal’ subjects showing no signs of 
senility.
Veiy few papers have published regional distribution of elemental concentrations 
using state-of-the-art ICP-MS. INAA determinations using the HER reactor, Petten 
and the IRI reactor, Delft has also been carried out. At JRC, Ispra characterisation of 
the detector was carried out. At Delft, the detector systems were already 
characterised, (Bod93) and the laboratory and software was accredited.
To establish procedures for sample preparation and for the development of methods, 
initial work was carried out on the freeze dried, homogenised, cortex of porcine brain 
tissue using ICP-MS, INAA and ETAAS. For ICP-MS and ETAAS digestion 
! methods, the amount and type of acid used was evaluated, as was the length of the 
digestion period, according to (Tho98), (Whi98), (Tho98). For ICP-MS, elements 
were selected because of their possible roles in Alzheimer’s Disease and elements for 
use as internal standards were also selected. For the INAA, JRC, Ispra, the counting 
j geometry of the detector system and the counting periods were evaluated. For the 
ETAAS elements were selected according to availability. Detection Limits were 
evaluated for all three techniques.
The accuracy of the three techniques was evaluated using NIST Bovine Liver a and b 
and IAEA Animal Blood. Concentrations for all elements were found to be in 
agreement with the Certified Reference Values, (CRY). The results for the Certified
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Reference Material, (CRM) for Se determined by ICP-MS was found to be high, so 
when determining Se in the human samples <1% butanol was added and the CRM 
was found then to give excellent results.
In the cortex of the porcine brain, Zn and Cu were found to have similar 
concentrations to human brain, Fe concentrations were much lower than the human 
brain and Mn and Se were found to be slightly lower. The pigs are fed high 
concentrations of Cu for fattening and this leads to Fe deficiency, explaining the low 
concentrations of Fe. The possibly toxic elements, Pb, Hg and Cd were found to have 
extremely low concentrations. These elements tend to accumulate in the brain over 
time and since the pigs were slaughtered early, the levels of these elements may be 
expected to be quite low.
The average DFW ratio was found to be 0.202 ± 0.009. This value was expected to be 
lower because of the young age of the pigs but white matter contains a higher DFW 
ratio than grey matter so the cortex of the porcine brain may contain more white 
matter, since it is less convoluted than the human brain.
There were no significant differences between the right and left hemispheres, apart 
from Fe which was found to be significantly higher in the left lobe compared to the 
right. Fe however, is a difficult element to determine because of the possibility of 
blood contamination.
The cortex was selected since this area displays the largest number of plaques and 
tangles. The hippocampus also shows severe histopathological alterations in 
Alzheimer’s Disease and almost all information that enters the cortex first comes 
through the thalamus and hippocampus. The thalamus was selected as it is the 
processing centre of the cerebral cortex and coordinates and regulates all functional 
activity of the cortex. Few papers have published elemental concentrations in the 
thalamus.
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The DFW ratios for the samples sent from the Netherlands Brain Bank have also been
differences Lr\
discussed. In the ‘normal’ subjects, no significanbOFW ratios was found between 
regions. For the Alzheimer’s the DFW ratio was highest in the thalamus and in the 
subjects with SICC DFW ratios were found to be highest in the hippocampus. For the 
‘normals’ and Alzheimer’s disease, no significant differences between sex and 
hemispheres was found. For the subjects with SICC, no differences between 
hemispheres was found but DFW ratios were found to be higher in females.
For the ‘normals’ until 65 years there was an increase of DFW ratio with age and for 
the ‘normals’ and SICC subjects after 65 there was a negative correlation with age. 
There was no correlation with age for the Alzheimer’s subjects.
Comparing age matched ‘normals’ with the Alzheimer’s, DFW ratios were increased 
in the temporal regions and hippocampus of the ‘normal’ subjects and comparing the 
‘normals with the SICC subjects, DFW ratios were found to be increased in temporal 
region of the ‘normal’ subjects. In dementia, volume loss initially occurs in the 
hippocampus and temporal regions and in these findings, the water content of the 
temporal and hippocampal regions was found to be lower in the ‘normal’ subjects 
compared to the other groups.
The distribution of elements in 10 regions from ‘normal’ Alzheimer’s subjects and 
subjects with SICC have been determined using ICP-MS. For the ‘normal’ subjects, 
using Lillifors probabilities, for combined hemispheres and all regions, Li, Fe, Se and 
Zn followed normal distributions whereas Mn, Cu, Cd, Hg and Pb followed 
lognormal distributions. In the Alzheimer’s subjects, Li, Fe, Cu, Se and Zn followed 
normal distributions and Hg and Pb followed lognormal distributions, whereas Mn 
and Cd followed neither distribution. For the SICC subjects excluding the Mn subject 
all elements followed lognormal distributions apart from Pb and Mn where no 
distribution could be established using Lillifors probabilities. When the MS subject 
was excluded from the SICC group, Fe followed a normal distribution and all other 
elements followed a lognormal distribution. Mn and Pb followed neither distribution 
using Lillifors probabilities. In further work, more complex tests for checking
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distributions should be used such as the Shapiro Wilks test and the Anderson Darling 
tests.
There were few elemental variations between hemispheres but strong variations 
between regions. In ‘normals’ Cu, Zn and Cd showed strong positive correlatiosn with 
age and Hg showed a negative correlation with age. With disease duration negative 
correlations were seen for Zn and Cu and a positive correlation was seen for Li.
Cd and Hg in the normal subjects and Cd in the Alzheimer’s Disease subjects 
correlated negatively with the degree of tangles at a high level of significance. 
Metallothionein, (MT) is considered to be a free radical scavenger. Cd bound to MT 
by some mechanism slows the production of the tangles. In the Alzheimer’s Disease 
subjects, Zn was found to be reduced and this may be due to Cd which displaces Zn 
from MT in an attempt to reduce the degree of tangles. This correlation is of interest 
because Zn deficiency has been found to hasten tangle formation, (Nac96) and in this 
work Zn has been found to correlate negatively with disease duration. Perhaps in the 
Alzheimer’s subjects the free Cd is being bound to MT as a mechanism to reduce the 
number of tangles, this probably explains why in the Alzheimer’s subjects Cd no 
longer follows a lognormal distribution. In the SICC subjects Cd follows a lognormal 
distribution so maybe Cd is being used after the tangles have already been formed. 
More work is needed in this area to research into the role of this protein and Cd and 
Zn in Alzheimer’s Disease.
When comparing groups, it was found that Cu was significantly decreased in the 
Alzheimer’s group as compared to the ‘normals’. Cu is bound to enzymes or proteins 
such as SOD, cytochrome c oxidase and ceruplasmin. In Alzheimer’s Disease there 
may be a decrease in one of these. Cu (I) which behaves as a catalyst in free radical 
production may be reduced to Cu(II), so spéciation studies may be required to give 
additional information on the state of Cu. However, the concentrations of free ions is 
generally a very small proportion of total with 99% or more of the metal being 
complexed, (Bra92).
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Comparing the ‘normals’ and Alzheimer’s Zn, Hg and Li were found to be increased 
in ‘normal’ subjects and no significant differences for Fe, Mn, Se, Cd and Pb were 
found. When comparing the ‘normal’ and the SICC, excluding the MS subject, Fe, 
Zn Cd and Hg were found to be higher in the ‘normal’ subjects. During the senility 
process there is a reduction of these elements. No significant differences for Mn, Cu, 
Se and Pb were found. Also of interest is the MS subject which contained high 
concentrations of Fe, especially in the thalamus. Fe may be behaving as a catalyst in 
the production of free radicals in this disease.
Finally, when comparing the SICC subjects (excluding the MS subject) and 
Alzheimer’s subjects, Fe, Mn, Zn and Cd were found to be increased in the 
Alzheimer’s and when including the MS subject the results became even more 
significant. This is of interest suggesting that there are alterations in brain trace 
elements during senility, which may not persist until the end of the disease.
These results show there maybe some evidence for the role of trace elements in 
oxidative stress. Cu and Zn were found to be significantly decreased in the 
Alzheimer’s compared to the ‘normals’ and Fe and Zn were found to be significantly 
reduced in the SICC group compared to the ‘normals’ and Alzheimer’s . However no 
significant differences for Se were found.
From the literature conflicting findings of increased and decreased levels of Zn have 
been reported. Excess Zn may play a role in aggregation of amyloid beta peptide 
which may generate free radicals, (Nac96), whilst Zn deficiency leads to tangle 
production. In this work Zn was found to be reduced in the SICC and Alzheimer’s 
group and increased in the ‘normal’ group suggesting Zn supplementation could be 
administered to the demented subjects. Zn supplementation has been given to subjects 
with severe cognitive impairment.
INAA was carried out on samples taken from the cortex only. For the INAA results 
from Delft, for the ‘normal’ subjects for combined hemispheres and regions, Na, K, 
Fe, Se, Zn, Cs, Ba and Eu were found to follow a normal distribution using Lillifors
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probabilities and Br, Rb and Ag were found to follow a lognormal distribution. In the 
Alzheimer’s subjects Na, K, Fe, Zn, Se and Br followed a normal distribution whereas 
Ag, Cs and Eu followed a lognormal distribution.
Br, Se, Ag and Eu correlated positively with age in the ‘normal’ subjects and negative 
correlations with age were found for Fe and positive correlations with age for Cs. 
With disease duration, negative correlations for Zn, K, Rb and Se were seen, whereas, 
for Ag and Ba positive correlations were seen. Positive correlations with the dementia 
scale were seen for Br. In the ‘normal’ subjects tangles correlated positively for Se 
and Br and correlated negatively for Cs and in the Alzheimer’s negative correlations 
were found for K, Zn, Rb, Se and Cs with the tangles and a positive correlation was 
seen for Br.
When comparing ‘normals’ with Alzheimer’s Br, Na and Fe were found to be 
increased in the Alzheimer’s subjects and K, Zn, Se, Rb, Ba and Eu showed no 
significant differences. Cs and Hg were found to be increased in the ‘normal’ 
subjects.
Of particular interest from the INAA results is Br where no evidence has been found 
that this is an essential element although high concentrations of Br in human tissue 
are found. Also Br was found to correlate positively with age, with the dementia scale 
and with the degree of tangles. However, no correlation was seen with disease 
duration. More research work into the role of Br in human biological functions is 
needed.
A method intercomparison for ICP-MS and INAA was undertaken for Fe, Se and Zn 
no significant differences were found between the two methods for the same samples. 
The results from the ICP-MS are excellent and is a technique offering excellent 
detection limits. More work should be carried out with the ICP-MS, perhaps with 
different introduction systems such as Electrothermal Vaporisation, (ETV) which may 
give lower detection limits.
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Elemental concentrations in Alzheimer’s Disease is still an area of research where 
much work is needed. Here the cortex, thalamus and hippocampus have been studied 
but it would be of interest to study the amygdala which is involved with memory 
functions and the Nucleus Basalis of Meynert, which is the primary cholinergic 
projection to the cortex. Further work is needed on age matched and sex matched 
samples. It would also be of interest to carry out elemental determinations of hair, 
blood, nails and CSF fluid of living patients. Although Molina et al., (Mol98) have 
recently, carried out much work on CSF fluids from Alzheimer’s subjects.
Also Cutts et al., (CutOO) have carried out parallel studies using in-vivo Positron 
Emission Tomography and elemental concentrations on brain tissue obtained from the 
Institute of Psychiatry, London, U.K. Research into functional imaging of cerebral 
blood flow and metabolism is an important area of research.
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